Document:

Asset Purchase Agreement

 Exhibit 10.1 
 ASSET PURCHASE AGREEMENT 
 dated as of May 12, 2008 
 by and among 
 KENSEY NASH
CORPORATION, 
 ILT ACQUISITION SUB, INC., 
 KENSEY NASH HOLDING CORPORATION 
 and 
 THE SPECTRANETICS CORPORATION 

 Table of Contents 
  

					
	 	  	Page
	RECITALS	  	1
		
	DEFINITIONS	  	2
			
		 	DEFINED TERMS	  	2
		 	OTHER DEFINED TERMS	  	12
		
	SALE AND PURCHASE OF ACQUIRED ASSETS AND ASSUMED LIABILITIES	  	14
			
		 	CLOSING	  	14
		 	TRANSFER OF ACQUIRED ASSETS	  	16
		 	ASSUMPTION OF LIABILITIES	  	16
		 	RETAINED LIABILITIES	  	16
		 	PURCHASE PRICE	  	18
		 	ADDITIONAL CONSIDERATION	  	20
		 	ALLOCATION	  	20
		 	TRANSFER TAXES	  	21
		 	ALTERNATIVE ARRANGEMENTS	  	21
		
	REPRESENTATIONS AND WARRANTIES RELATING TO THE BUSINESS	  	22
			
		 	ORGANIZATION	  	22
		 	AUTHORITY; NO CONFLICT; REQUIRED FILINGS AND CONSENTS	  	23
		 	TAX MATTERS	  	24
		 	ABSENCE OF CERTAIN CHANGES OR EVENTS	  	25
		 	TITLE TO PROPERTY AND ASSETS	  	28
		 	INTELLECTUAL PROPERTY	  	28
		 	MATERIAL CONTRACTS	  	35
		 	COMPLIANCE WITH LAWS	  	37
		 	LITIGATION	  	38
		 	HEALTH CARE COMPLIANCE	  	38
		 	CUSTOMERS AND SUPPLIERS	  	40
		 	BOOKS AND RECORDS	  	41
		 	AFFILIATE TRANSACTIONS	  	41
		 	WARRANTIES; PRODUCT LIABILITY	  	41
		 	FINANCIAL INFORMATION	  	41
		 	RECEIVABLES	  	41
		 	INVENTORY	  	42
		 	DISCLOSURE	  	42
		 	NO BROKERS	  	42
		 	DISTRIBUTORS	  	42
		 	ENTIRE BUSINESS	  	42
		 	LABOR MATTERS OF KNE	  	42
		 	KNE BALANCE SHEET	  	44
		 	ABSENCE OF UNDISCLOSED LIABILITIES OF KNE	  	44
		 	ASSETS OF KNE	  	44
		
	REPRESENTATIONS AND WARRANTIES RELATING TO THE PURCHASER	  	45
			
		 	ORGANIZATION OF THE PURCHASER	  	45
		 	AUTHORITY; NO CONFLICT; REQUIRED FILINGS AND CONSENTS	  	45
		 	CAPITAL RESOURCES	  	45
		 	LITIGATION	  	46
		 	NO BROKERS	  	46
		 	INDEPENDENT ANALYSIS	  	46

  

 i 

 Table of Contents 
 (continued) 
  

					
	 	 	 	  	Page
		 	NO OTHER REPRESENTATIONS	  	46
		
	PRE-CLOSING COVENANTS OF THE SELLER PARTIES	  	47
			
		 	CONDUCT OF BUSINESS PRIOR TO THE CLOSING	  	47
		 	ACCESS TO INFORMATION	  	50
		 	SATISFACTION OF CONDITIONS PRECEDENT	  	50
		 	NO SOLICITATION	  	51
		 	NOTIFICATION	  	51
		 	CONSENTS AND NOTIFICATIONS	  	52
		
	CERTAIN COVENANTS AND AGREEMENTS	  	52
			
		 	CONFIDENTIALITY	  	52
		 	NO PUBLIC ANNOUNCEMENT	  	53
		 	FURTHER ASSURANCES	  	53
		 	THE PURCHASER’S FINANCIAL STATEMENTS	  	53
		 	USE OF NAMES	  	53
		 	TAX MATTERS	  	54
		 	PURCHASER SALES FORCE	  	57
		 	EMPLOYEES OF KNE	  	57
		 	PROCESSING AGREEMENT	  	57
		 	PENDING APPLICATIONS	  	57
		
	CONDITIONS TO CLOSING	  	57
			
		 	CONDITIONS PRECEDENT TO OBLIGATIONS OF THE SELLER PARTIES	  	57
		 	CONDITIONS PRECEDENT TO OBLIGATIONS OF THE PURCHASER	  	58
		
	TERMINATION AND AMENDMENT	  	59
			
		 	TERMINATION	  	59
		 	EFFECT OF TERMINATION	  	59
		 	FEES AND EXPENSES	  	59
		
	INDEMNIFICATION	  	60
			
		 	SURVIVAL OF REPRESENTATIONS, ETC.	  	60
		 	INDEMNIFICATION BY THE SELLER PARTIES	  	60
		 	INDEMNIFICATION BY THE PURCHASER	  	61
		 	GENERAL INDEMNIFICATION PROVISIONS	  	61
		 	LIMITS ON INDEMNIFICATION	  	62
		 	TAX TREATMENT OF INDEMNIFICATION PAYMENTS	  	64
		
	MISCELLANEOUS	  	64
			
		 	NOTICES	  	64
		 	INTERPRETATION	  	65
		 	COUNTERPARTS	  	65
		 	ENTIRE AGREEMENT; NO THIRD-PARTY BENEFICIARIES	  	66
		 	GOVERNING LAW	  	66
		 	CONSENT TO JURISDICTION; VENUE; WAIVER OF CERTAIN DAMAGES
AND JURY TRIAL	  	66
		 	ASSIGNMENT	  	67
		 	AMENDMENT	  	67
		 	EXTENSION; WAIVER	  	67
		 	SEVERABILITY	  	67
		 	COMPANY DISCLOSURE SCHEDULE	  	68
		 	LICENSE	  	68

  

 ii 

 ASSET PURCHASE AGREEMENT 
 This Asset Purchase Agreement, dated as of May 12, 2008 (this “Agreement”), is by and among The Spectranetics Corporation, a
Delaware corporation (the “Purchaser”), on the one hand, and Kensey Nash Corporation, a Delaware corporation (the “Company”), ILT Acquisition Sub, Inc., a Delaware corporation and wholly owned
subsidiary of the Company (“ILT”), and Kensey Nash Holding Corporation, a Delaware corporation and wholly owned subsidiary of the Company (“KNH” and, together with the Company and ILT, the
“Seller Parties”), on the other hand. 
 RECITALS: 
 A. The Seller Parties are engaged, in part, in the business of inventing, researching, developing, manufacturing and/or marketing the Acquired Technology
for sale anywhere in the world (the “Business”, it being clarified that KNE’s entire business shall be included in such definition). 
 B. The Seller Parties desire to sell any and all of their right, interest and title in and to the Acquired Assets and the Purchaser desires to acquire the Seller Parties’ right, interest and title in and to the
Acquired Assets and agrees to assume the Assumed Liabilities, in each case on the terms and subject to the conditions set forth herein. 
 C.
Upon the Closing, the Seller Parties (as the case may be) and the Purchaser shall enter into a Development and Regulatory Services Agreement and a Manufacturing and Licensing Agreement, pursuant to which the Seller Parties (as the case may be) will,
among other things agree to, (1) manufacture the QuickCat products during an initial period after Closing for sale by the Purchaser, (2) manufacture the ThromCat and SafeCross products during such initial period and a second period after
the Closing for sale by the Purchaser during such periods after the Closing, (3) undertake certain development and regulatory activities in connection with the Acquired Technology or otherwise as may be agreed between the parties and
(4) assist in the transfer to the Purchaser of the know-how, trade secrets and similar intellectual property rights included in the Acquired Assets, in each case on the terms and subject to the conditions set forth therein. 
 D. Upon the Closing, the Company, ILT and the Purchaser shall enter into a Non-Competition and Confidentiality Agreement. 
 E. Upon the Closing, the Purchaser and the Company shall enter into a License Agreement whereby the Purchaser shall license back to the Company certain
of the Acquired Assets for orthopedic applications on terms and conditions set forth therein. 
 Accordingly, in consideration of the
foregoing premises and the mutual representations, warranties, covenants and agreements set forth in this Agreement, the parties hereto, intending to be legally bound hereby, agree as follows: 

 ARTICLE I 
 DEFINITIONS 
 1.1 Defined Terms. Capitalized terms defined in this Agreement whenever used
herein (including, without limitation, the Exhibits and Schedules hereto) shall have the meanings given to such terms in this Agreement. The terms defined in this Section 1.1, whenever used herein (including, without limitation,
the Exhibits and Schedules hereto), shall have the following meanings for all purposes of this Agreement: 
 (a) “Acquired
Assets” shall mean, except for any Excluded Assets, all the right, title and interest that any of the Seller Parties or any Affiliate of any of the Seller Parties possess in and to the following properties, assets and rights of any
kind, whether tangible or intangible, including those listed on the Schedule of Acquired Assets attached as Exhibit 1 hereto (the “Schedule of Acquired Assets”), currently owned by any of the Seller Parties or
any Affiliate of any of the Seller Parties: 
 (i) all Assumed Contracts (provided, the transfer of certain Assumed Contracts
as noted on the Schedule of Acquired Assets will occur upon the expiration of the QuickCat Manufacturing Period and the SC/TC Manufacturing Period, each as defined in the Manufacturing and Licensing Agreement); 
 (ii) the KNE Share; 
 (iii) all Intellectual Property Rights; 
 (iv) all other technology rights and licenses, franchises, know-how,
inventions, designs, specifications, plans and drawings used exclusively in the Business; 
 (v) all Books and Records,
including without limitation, all Product Records; 
 (vi) all Registrations and other Permits in the name of the Seller
Parties that relate primarily to, or are otherwise necessary to, the manufacture, sale and distribution of the Acquired Technology (provided, such transfer may be delayed to the extent reasonably necessary for the Company to perform its obligations
under the Services Agreement); 
 (vii) all Promotional Materials related to the Acquired Technology; 
 (viii) all causes of action, rights and remedies arising under the Intellectual Property Rights prior to or after Closing; 
 (ix) all rights, claims, credits, causes of action, choses in action and rights of set-off against third parties to the extent relating to
any of the 

  

 2 

 
Acquired Assets or any of the Assumed Liabilities, including all rights in and to products sold or leased (including products returned after the Closing and
rights of rescission, replevin and reclamation) in the operation or conduct of the Business and all guarantees, representations, warranties, indemnities and similar rights in favor of the Seller Parties to the extent relating to any of the Acquired
Assets or any of the Assumed Liabilities (other than any such rights set forth in this Agreement); 
 (x) the Trade
Receivables; 
 (xi) all Fixtures and Equipment and other non-Inventory tangible assets used primarily in the Business;

 (xii) all Inventory related to the QuickCat Aspiration product line (it being understood that all other Inventory shall be
treated under the terms of the Manufacture and License Agreement); and 
 (xiii) all other properties, assets and rights of
any kind used primarily in the Business. 
 (b) “Acquired Technology” shall mean collectively the following products
of the Seller Parties: (a) the QuickCat Aspiration Catheter product line, (b) the ThromCat Thrombectomy Catheter System product line and (c) the Safe-Cross RF CTO System product line (including the Safe-Cross Console), and such
modifications and accessories thereto as would be covered by the Registrations and/or claims included within the Intellectual Property Rights. For the sake of clarity, except where used in Article III, Acquired Technology shall also
include any improvements or other deliverables developed under the Services Agreement. 
 (c) “Action” shall mean any
action, claim, suit, litigation, proceeding, labor dispute, arbitral action, governmental audit, inquiry, criminal prosecution, investigation or unfair labor practice charge or complaint. 
 (d) “Affiliate” shall mean, with respect to any Person, (a) any other Person of which securities or other ownership
interests representing more than five percent (5%) of the voting interests are, at the time such determination is being made, beneficially owned or Controlled by such Person, or (b) any other Person which, at the time such determination is
being made, is Controlling, Controlled by or under common Control with such Person. For the purposes hereof, (i) “Control,” whether used as a noun or verb, refers to the possession, directly or indirectly, of the power
to affirmatively direct, or affirmatively cause the direction of, the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise, and (ii) a “beneficial owner” of a
security is any Person who, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise has or shares (x) voting power, which includes the power to vote, or direct the voting of, such security, or
(y) investment power, which includes the power to dispose, or to direct the disposition of, such security. A Person shall lose its status as an Affiliate of a party if it no longer falls within the preceding definition of “Affiliate.”

  

 3 

 (e) “Agreement for Services” means the Agreement for Services, dated
April 28, 2006, between the Company and KNE. 
 (f) “Assignment and Assumption Agreement” means the Assignment
and Assumption Agreement in the form attached hereto as Exhibit 3, whereby the Selling Parties will assign, and Purchaser will assume, in each case with any required consents of any third parties thereto, each of the Assumed Contracts.

 (g) “Assumed Contracts” shall mean all Contracts listed on Schedule A of the Schedule of
Acquired Assets under the heading “Assumed Contracts”. 
 (h) “Bill of Sale” means the Bill of Sale in the
form attached hereto as Exhibit 6. 
 (i) “Books and Records” shall mean (a) all records and
lists, including those relating to customers, suppliers or personnel, (b) all financial, legal, regulatory, accounting and personnel records and files, (c) all other books, ledgers, files, laboratory notebooks, reports, plans, drawings and
operating records, whether in hard copy or computer or other format (including historical files and documents of the Business stored on computer systems or backup files), maintained by or for the Seller Parties, and (d) all files relating to
the Intellectual Property Rights, but in the case of each of (a)-(c) above, only to the extent necessary for the Business. For the avoidance of doubt, in no event shall “Books and Records” be deemed to include any
records or files relating to Taxes other than sales or use Taxes or Property Taxes, copies of which will be provided to the Purchaser. 
 (j)
“Business Day” means any day other than a Saturday, Sunday or other day on which commercial banks in New York City are required or authorized by Law to be closed. 
 (k) “Code” means the United States Internal Revenue Code of 1986, as amended. 
 (l) “Commissionaire Agreement” means the Commissionaire Agreement, dated as of June 26, 2006 between the Company and KNE.

 (m) “Company Disclosure Schedule” means the disclosure schedule and related attachments attached hereto as
Exhibit 2. 
 (n) “Confidentiality Agreements” shall mean, collectively, the Confidentiality
Agreement, dated on or about October 3, 2007 between the Company and the Purchaser and the letter agreement dated as of March 14, 2008 between the Company and the Purchaser. 
 (o) “Contract” shall mean any agreement, contract, note, loan, evidence of indebtedness, purchase order, letter of credit,
indenture, security or pledge agreement, franchise agreement, undertaking, covenant not to compete, covenant not to sue, employment agreement, license, instrument, obligation or commitment to which (i) any Seller Party is a party or is bound
and that relates to the Business or the Acquired Assets, whether oral or written, or (ii) to which 

  

 4 

 
KNE is a party or is bound, irrespective of whether it relates to the Business or the Acquired Assets. 
 (p) “Copyrights” shall mean all U.S. and non-U.S. registered copyrights, applications for copyright registration and unregistered
copyrights owned or otherwise controlled by any of the Seller Parties that primarily relate to, or are otherwise necessary to the use, development, manufacture and sale of, the Acquired Technology, including without limitation, those listed on
Schedule B of the Schedule of Acquired Assets. 
 (q) “Cumulative Revenue” shall mean the aggregate
Sales Price of products of the Acquired Technology sold during the relevant period of determination. 
 (r)
“Environment” means any surface water, groundwater, land surface, subsurface strata, river sediment, plant or animal life, natural resources, air (including indoor air and ambient air) and soil. 
 (s) “Environmental Laws” means all applicable international, federal, state, local and foreign laws, statutes, rules,
regulations, codes, ordinances, orders, decrees, judgments, injunctions, treaties or binding agreements issued, promulgated or entered into by any Governmental Entity (as defined below), and any Permits issued thereunder, relating in any way to the
Environment, to preservation or reclamation of natural resources or endangered species, to exposure to Hazardous Materials, to Handling of Hazardous Materials, or to the presence or management of any Release or threat of Release of Hazardous
Materials. 
 (t) “Excluded Assets” shall mean the following assets of the Seller Parties which are not to be
acquired by the Purchaser hereunder: 
 (i) the corporate charters and other organizational documents of the Seller Parties or
any of their respective Affiliates (other than KNE) qualifications to conduct business as a foreign corporation, arrangements with registered agents relating to foreign qualification, taxpayer and other identification numbers, seals, minute books,
stock transfer books, blank stock certificates, and other documents relating to the organization, maintenance, and existence of the Seller Parties or any of their Affiliates (other than KNE) as a corporation; 
 (ii) all cash, cash equivalents and investments; 
 (iii) any Permits that are not Acquired Assets; 
 (iv) all claims, causes of action, choses in action, rights of recovery and rights of set-off of any kind against any Person to the extent
related to the Liabilities that are not Assumed Liabilities; 
 (v) except for the KNE Share, all equity interests and other
capital stock that is owned by the Company, ILT or KNH; 
  

 5 

 (vi) the assets listed on Schedule 1 attached hereto under the heading
“Excluded Assets”; 
 (vii) all rights of any Seller Party under Contracts that are not Assumed Contracts or KNE
Contracts; 
 (viii) the rights of the Seller Parties under this Agreement and the other agreements entered into in connection
herewith; 
 (ix) all rights of the Seller Parties to any Tax refunds, Tax deposits, Tax payments and estimated Taxes,
provided, however, this exclusion shall not affect the liability of the Seller Parties for Property Taxes pursuant to Section 6.6(c) or Taxes of KNE for Pre-Closing Tax Periods pursuant to Section 9.2(viii);

 (x) all insurance policies in the name of the Seller Parties or any of their Affiliates (other than KNE), and any rights to
payment (whether matured or unmatured) with respect thereto; and 
 (xi) copies of all Books and Records that any Seller Party
is required by Law or good business practice to retain in its possession. 
 (u) “FDA” means the United States Food
and Drug Administration. 
 (v) “FDA Act” means the United States Food, Drug and Cosmetic Act, as amended, and
applicable regulations and guidances thereunder. 
 (w) “Final Base Purchase Price” shall mean: 
 (i) an amount equal to the Preliminary Base Purchase Price; plus 
 (ii) the Dollar amount of the assets included in the line item “cash and cash equivalents” of KNE as of the Closing Date and
shown in the KNE Closing Balance Sheet; plus 
 (iii) the Dollar amount of the assets included in the line item
“Intercompany A/R” of KNE as of the Closing Date and shown in the KNE Closing Balance Sheet; plus  
 (iv)
the Dollar amount of the assets included in line item “Input VAT” of KNE as of the Closing Date and shown in the KNE Closing Balance Sheet; minus 
 (v) the aggregate Dollar amount of any and all liabilities and/or accruals of KNE (including, without limitation, (i) any
category of liabilities or accruals included in line items denoted with a “K” in the KNE Balance Sheet and (ii) all Liabilities, payments and obligations relating to the termination of the 

  

 6 

 
KNE Lay-Off Employees or otherwise arising under the KNE Lay-Off Employee Ancillary Contracts, whether to be accrued under GAAP or not) as of the Closing
Date and shown in the KNE Closing Balance Sheet. 
 (x) “Fixtures and Equipment” shall mean the machinery, spare
parts, tools, supplies, equipment and other tangible personal property owned or leased by any Seller Party listed on Schedule C of the Schedule of Acquired Assets, including all warranty rights with respect thereto. 
 (y) “Force Majeure Event” means any natural disaster, destruction, casualty, act of God, war, terrorist act, fire or labor strike
with respect to the manufacturing operations of the Business located at 735 Pennsylvania Avenue, Exton, Pennsylvania, in each case only to the extent that such event that would render impossible the Company’s ability to perform its obligations
under the Manufacture and License Agreement as of the Closing Date, without regard to any cure periods or Force Majeure conditions contained therein. 
 (z) “GAAP” shall mean generally accepted accounting principles in effect in the United States, applied on a consistent basis. 
 (aa) “German Contract” means that certain Contract between KNE and Azenio Business Centre GmbH & Co. KG dated
February 1, 2007. 
 (bb) “German Contract Condition” means that, prior to the Closing, the German Contract has
been amended by the parties thereto in writing in order to provide that the German Contract may thereafter be terminated by KNE upon no more than sixty (60) days’ prior written notice and that in the event of such notice KNE shall not be
obligated to make any payment to the counterparty of the German Contract for any period following such termination of the German Contract. 
 (cc) “Governmental Entity” shall mean any court or any governmental or other administrative or regulatory authority, department, ministry, agency or commission, whether federal, state or local, U.S. or non-U.S.,
including notified bodies designated by the member states of the European Union and the European Free Trade Association. 
 (dd)
“Handling of Hazardous Materials” shall mean the production, use, generation, Release, storage, treatment, formulation, processing, labeling, distribution, transportation, recycling, or other handling or disposition of, or
exposure to, Hazardous Materials. 
 (ee) “Hazardous Material” means any waste, substance, product, pollutant or
material, whether solid, liquid or gaseous, that (1) is or contains petroleum or any fraction thereof, asbestos, urea formaldehyde foam insulation, polychlorinated biphenyls, radon gas, radioactive substances, oil, or chlorofluorocarbons or any
other ozone depleting substance, (2) requires removal, remediation or reporting under any Environmental Law, or is defined, listed or identified in any Environmental Law as a “contaminant”, “pollutant”, “toxic
substance”, “toxic material”, “hazardous waste” or “hazardous substance” or words of similar meaning and regulatory effect thereunder, or (3) is toxic, explosive, corrosive, flammable, infectious, 

  

 7 

 
radioactive, carcinogenic, mutagenic or otherwise hazardous and is regulated as such by any Governmental Entity under any Environmental Law. 
 (ff) “Intellectual Property Rights” shall mean the following intellectual property rights, whether protected, created or arising
under the Laws of the United States or any other jurisdiction: (i) Trademark Rights; (ii) Patent Rights; (iii) Copyrights; (iv) Trade Secrets; (v) moral rights, publicity rights and any other proprietary, intellectual or
industrial property rights of any kind or nature that exclusively relate to, or are otherwise necessary to the use, manufacture, offer for sale, sale, and importation of, the Acquired Technology, are owned or otherwise controlled by any of the
Seller Parties, and do not comprise or are not protected by Trademark Rights, Patent Rights, Copyrights or Trade Secrets and (vi) the right to sue for past, present or future infringement of any of the foregoing. 
 (gg) “Inventory” shall mean all inventory of the Acquired Technology held for resale and all raw materials, work in process,
finished products, wrapping, supply and packaging items and similar items with respect to the Acquired Technology and in each case whether owned or held by the Seller Parties, their Affiliates (including without limitation KNE) or their customers
and wherever the same may be located. 
 (hh) “KNE” shall mean Kensey Nash Europe GmbH, a wholly owned foreign
subsidiary of KNH, organized under the laws of Germany. 
 (ii) “KNE Balance Sheet” shall mean the unaudited balance
sheet of KNE dated as of March 31, 2008 attached hereto as Schedule 3. 
 (jj) “KNE Share” shall
mean a share (Geschäftsanteil) in KNE in a nominal amount of EUR 600,000 (in words: Euro six hundred thousand) representing the entire registered share capital of KNE. 
 (kk) “KNE Share Transfer Agreement” means the Share Transfer Agreement Regarding the Assignment and Transfer of All Shares in KNE
in the form attached hereto as Exhibit 7. 
 (ll) “Knowledge” shall mean the actual knowledge that
each of the officers and employees of the Company, ILT and KNH listed on Schedule 4 would have had, had such persons made all reasonable inquiries and investigations and the actual knowledge that each of the managing directors of KNE
would have had, had such persons made all reasonable inquiries and investigations. 
 (mm) “Laws” shall mean any law,
constitution, statute, ordinance, regulation, rule, directive, notice requirement, court decision, agency guideline, order, writ, injunction, award, judgment, decree, resolution, code, edict, treaty or binding agreement issued, enacted, adopted,
promulgated, implemented, entered into or otherwise put into effect by or under the authority of any Governmental Entity. 
 (nn)
“Liabilities” shall mean, as to any particular Person, any direct or indirect liability, indebtedness, obligation, commitment, claim, deficiency or guaranty of or by such Person of any type, whether known or unknown, disputed
or undisputed, secured or unsecured, 

  

 8 

 
due or to become due, vested or unvested, liquidated or unliquidated, accrued, absolute, contingent, matured or unmatured, whether or not the same is
required to be accrued on the financial statements of such Person. 
 (oo) “License Agreement” shall mean the License
Agreement, dated as of the Closing Date, between the Purchaser and the Company, in the form attached hereto as Exhibit 8. 
 (pp) “Liens” means any and all mortgages, liens, pledges, charges, restrictions or encumbrances of any nature whatsoever. 
 (qq) “Manufacturing and Licensing Agreement” shall mean the Manufacturing and Licensing Agreement, dated as of the Closing Date, between the Purchaser and the Company, in the form attached
hereto as Exhibit 9. 
 (rr) “Material Regulatory Issue” means any development in applicable Law that
would render the Seller Parties unable to sell in compliance with applicable Law any of the three products included in the Acquired Technology, so long as such development is not reasonably expected to be cured within thirty (30) days thereof.

 (ss) “Non-Competition Agreement” means the Non-Competition Agreement, in the form attached hereto as Exhibit
10, between the Purchaser, the Company and ILT. 
 (tt) “Patent Assignment” means the Patent Assignment in
the form attached hereto as Exhibit 4. 
 (uu) “Patent Rights” shall mean all U.S., foreign and
international patents and patent applications, inventor’s certificates, utility models, design registrations, provisional applications, nonprovisional applications, substitutions, extensions, reissues, reexaminations, renewals, divisions,
continuations, continuations-in-part, parents and other related applications and foreign counterparts of all of the foregoing owned or otherwise controlled by any of the Seller Parties that exclusively relate to, or are otherwise necessary to the
use, manufacture, offer for sale, sale, and importation of, the Acquired Technology listed in each case on Schedule D of the Schedule of Acquired Assets. 
 (vv) “Permit” means each Registration and each federal, state, county, local or non-U.S. application, license, permit, approval, clearance, registration, certificate, filing, consent or order,
and all supplements and amendments thereto filed with or issued or granted by, any Governmental Entity (including the FDA and any other Governmental Entity engaged in the regulation of the Acquired Technology or the Business), required for the
operation of the Business as currently conducted, the holding of any interest in any of its properties and assets, or the operation of its facilities, that primarily relate to, or are otherwise necessary for the operation of the Business.

 (ww) “Permitted Liens” means (i) Liens arising under equipment or maintenance financing or leasing
agreements, (ii) Liens for Taxes not yet due and payable or which are being contested in good faith and by appropriate proceedings, (iii) mechanics’, workmen’s, repairmen’s, warehousemen’s, and carriers’ Liens, or
Liens of a similar type, arising in the ordinary course of business and/or (iv) Liens expressly set forth in any Assumed Contract. 
  

 9 

 (xx) “Person” means an individual, corporation, partnership, limited liability
company, firm, joint venture, association, joint stock company, trust, unincorporated organization or other entity, or any Governmental Entity or quasi-governmental body or regulatory authority. 
 (yy) “Post-Closing Tax Period” means any Tax period beginning after the Closing Date and that portion of a Straddle Period
beginning on the Closing Date. 
 (zz) “Pre-Closing Tax Period” means any Tax period ending before the Closing Date
and the portion of any Straddle Period ending before the Closing Date. 
 (aaa) “Preliminary Base Purchase Price”
shall mean Ten Million Dollars ($10,000,000). 
 (bbb) “Processing Agreement” shall mean the Processing Agreement,
dated November 15, 2002, between Isomedix Operations Inc., a wholly owned subsidiary of Steris Corporation, and the Company. 
 (ccc)
“Product Records” means all Books and Records related to the Acquired Technology, including copies of all customer and supplier lists, account lists, call data, sales histories, call notes, marketing studies, consulting
reports, physician databases, and correspondence with respect to the Acquired Technology to the extent maintained by the Seller Parties, and all complaint files and adverse event files with respect to the Acquired Technology. 
 (ddd) “Promotional Materials” means the advertising, promotional and media materials, sales and training materials, trade show
materials (including displays) and videos, used primarily or exclusively for the commercialization of the Acquired Technology. 
 (eee)
“Property Taxes” means shall mean all real property Taxes, personal property Taxes and similar ad valorem Taxes. 
 (fff) “Proprietary Rights” means all U.S. and foreign trademarks and trademark rights, trade names and trade name rights, service marks and service mark rights, service names and service name rights, domain names,
copyrights and copyright rights, patents and patent rights, mask works, brand names, trade dress, industrial or product designs, business and product names, logos, slogans, trade secrets, inventions (whether or not patentable), invention
disclosures, processes, formulae, industrial models, designs, specifications, data, databases and data collections, technology, methodologies, computer programs (including all source codes, object codes, firmware, Software, development tools, files,
records and data), manufacturing, engineering and technical drawings, and any other trade secret or other technical information, whether or not subject to statutory registration, and all common law and world-wide rights to registrations of
trademarks, service marks and copyrights, and the right to sue for patent infringement, if any, in connection with any of the foregoing, and all documents, disks and other media on which any of the foregoing is stored. 
 (ggg) “Registrations” means the regulatory clearances, approvals, authorizations, certificates, agreements and other permissions
issued by Governmental Entities and held by the Seller Parties required for the commercial marketing and sale of the Acquired 

  

 10 

 
Technology, including without limitation, the clearances issued under Section 510(k) of the FDA Act covering the Acquired Technology numbered K001992,
K010531, K012169, K011986, K021323, K021243, K021638, K030984, K031417, K031692, K032784, K031842, K033708, K032031, K033929, K040037, K040481, K041973, K050916, K050915, K073162, K072195, K060016, K060092 and K073519, and any supplements,
amendments or modifications thereto, submitted to or required by the FDA prior to the Closing Date. 
 (hhh)
“Release” means any release, spill, emission, leaking, pumping, injection, deposit, disposal, discharge, dispersal, leaching, or migration at, into or onto the Environment, including movement or migration through or in the
Environment, whether sudden or non-sudden and whether accidental or non-accidental, or any release, emission or discharge as those terms are defined in any applicable Environmental Law. 
 (iii) “Sales Price” means the price per unit at which a product is sold by the Purchaser (or is Affiliates, successors or
assigns). For the avoidance of doubt, the following items shall not be included in the calculation of the “Sales Price”: (i) any refunds, credits or allowances actually given or credited to any party due to rejections,
defects or returns of products, (ii) any sales, use, occupation or excise taxes, duties or other governmental charges imposed on, and paid by the Purchaser during, the importation, exportation, use or sale of products, and (iii) any
freight, postage or insurance charges actually incurred. 
 (jjj) “Services Agreement” shall mean the Development and
Regulatory Services Agreement, dated as of the Closing Date, between the Purchaser and the Company, in the form of Exhibit 11 hereto. 
 (kkk) “Software” shall mean any and all computer programs, including any and all software implementations of algorithms, models and methodologies, whether in source code or object code, databases and compilations,
including any and all data and collections of data, whether machine readable or otherwise, and all documentation, including user manuals and training materials, relating to any of the foregoing; provided, however, that the term
“Software” shall specifically exclude any computer programs that are generally available to the public, including computer programs available pursuant to “shrink wrap,” “click wrap” and other similar license agreements.

 (lll) “Straddle Period” means any Tax period beginning before and ending on or after the Closing Date. 

(mmm) “Tax” means any federal, state, local or foreign income, gross receipts, license, payroll, employment, excise,
severance, stamp, occupation, premium, windfall profits, environmental, customs duties, capital stock, franchise, profits, withholding, social security, unemployment, disability, real property, personal property, sales, use, transfer, registration,
ad valorem, value added, alternative or add-on minimum, estimated tax, all taxes and charges accessory to taxes (Steuern und steuerliche Nebenleistungen) within the meaning of § 3 of the German Tax Code (Abgabenordnung) or social security
contributions (Sozialversicherungsbeiträge) or other tax of any kind whatsoever, including any interest, penalty, or addition thereto, whether disputed or not. 
  

 11 

 (nnn) “Tax Return” means any report, return, declaration, information return,
statement or other information required to be supplied to a taxing authority with respect to any Tax or Taxes, including any schedule or attachment thereto, and including any amendments thereof. 
 (ooo) “Trade Receivables” means the trade accounts receivable and notes receivable of the Business as of the Effective Time.

 (ppp) “Trade Secrets” shall mean non-public know-how, inventions, discoveries, improvements, concepts, ideas,
methods, processes, designs, schematics, drawings, formulae, technical data, specifications, research and development information, technology, data bases, inventions for which patent applications have not yet been filed and other technical
information owned or otherwise controlled by any of the Seller Parties that relate primarily to, or are otherwise necessary to the manufacture and sale of, the Acquired Technology, but excluding any Copyrights or Patent Rights that may cover or
protect any of the foregoing. 
 (qqq) “Trademark Assignment” means the Trademark Assignment in the form attached
hereto as Exhibit 5. 
 (rrr) “Trademark Rights” shall mean (i) those certain trademarks,
including all U.S. and non-U.S. registered trademarks, applications to register trademarks, intent-to-use applications, or other registrations or applications related to trademarks, common-law trademarks and rights, service marks, trade dress,
logos, trade names and corporate names listed on Schedule E of the Schedule of Acquired Assets, (ii) all rights arising from the use of or existing in connection with the domain names: “intraluminal.com” and
“intraluminal.info”, and (iii) all goodwill associated with the foregoing and all registrations and applications for registration of any of the foregoing. 
 (sss) “Transaction Documents” means this Agreement, the Bill of Sale, the Manufacturing and Licensing Agreement, the License Agreement, the Non-Competition and Confidentiality Agreement, the
Services Agreement, the various Assignments, and all other agreements, documents, certificates and instruments to be delivered pursuant to or in connection with this Agreement. 
 1.2 Other Defined Terms. The following terms shall have the meanings defined for such terms in the Sections set forth below: 
  

			
	 Term
	  	 Section

	“Acquisition Proposal”	  	5.4(b)
	“Agreement”	  	Preamble
	“Allocation”	  	2.7(a)
	“Allocation Statement”	  	6.6(d)
	“Assumed Liabilities”	  	2.3
	“Base Purchase Price Determination Certificate”	  	2.5(c)(i)
	“Base Purchase Price Settlement Payment”	  	2.5(b)
	“Basket Threshold”	  	9.5(a)
	“Business”	  	Recitals

  

 12 

			
	“Cap”	  	9.5(b)
	“Closing”	  	2.1(a)
	“Closing Date”	  	2.1(a)
	“COBRA”	  	2.4(a)
	“Company”	  	Preamble
	“Company Disclosure Schedule Supplement”	  	5.5
	“Confidential Information”	  	6.1(a)
	“Confidentiality Parties”	  	6.1(a)
	“Cumulative Revenue Report”	  	2.6(a)
	“Disputed Items”	  	2.5(c)(iii)
	“Effective Time”	  	2.1(a)
	“Financial Information”	  	3.15
	“Harmful Code”	  	3.6(o)
	“Health Care Laws”	  	3.10(a)
	“ILT”	  	Preamble
	“Indemnitee”	  	9.4(a)
	“Indemnitor”	  	9.4(a)
	“Independent Accounting Firm”	  	6.6(d)
	“Intellectual Property Contracts”	  	3.6(b)
	“KNE Closing Balance Sheet”	  	2.5(c)(i)
	“KNE Contracts”	  	3.7(d)
	“KNE Lay-Off Employees”	  	6.8
	“KNE Lay-Off Employee Ancillary Contracts”	  	6.8
	“KNE Other Employees”	  	6.8
	“KNH”	  	Preamble
	“Losses”	  	9.2
	“Material Contracts”	  	3.7(a)
	“Neutral Auditor”	  	2.5(c)(iv)
	“Post-Closing Payment”	  	2.6
	“Publicly Available Software”	  	3.6(p)
	“Purchaser”	  	Preamble
	“Purchaser Indemnified Parties”	  	9.2
	“Purchaser’s Returns”	  	6.6(d)
	“Registered Intellectual Property Rights”	  	3.6(a)
	“Representatives”	  	4.7
	“Retained Liabilities”	  	2.4
	“Revised Base Purchase Price Determination Certificate”	  	2.5(c)(iii)
	“Safety Notices”	  	3.10(h)
	“Seller Indemnified Parties”	  	9.3
	“Seller Parties”	  	Preamble
	“Tax Claim”	  	6.6(j)
	“Third Party Claims”	  	9.4(b)
	“Transfer Taxes”	  	2.8

  

 13 

 ARTICLE II 
 SALE AND PURCHASE OF ACQUIRED ASSETS AND ASSUMED LIABILITIES 
 2.1 Closing. 
 (a) The closing (the “Closing”) of the transactions contemplated herein with respect to the Business shall be held at 8:00 a.m.,
local time, at the offices of Katten Muchin Rosenman LLP (except for the notarization of the KNE Share Transfer Agreement, which shall take place at the offices of Latham & Watkins LLP, Reuterweg 20, 60323 Frankfurt am
Main/Germany) on May 30, 2008, or such earlier date as the Purchaser and the Company shall mutually agree upon in writing (such date, the “Closing Date”). The consummation of the Closing shall be deemed to have
occurred as of 12:01 a.m. Eastern time on the Closing Date (the “Effective Time”).
 (b) Closing Deliveries to the
Seller Parties. At the Closing, the Seller Parties shall have received, and the Purchaser shall deliver, or, if applicable, cause its Affiliates or its permitted assigns to deliver, duly executed copies (as applicable) of each of the following:

 (i) the Preliminary Base Purchase Price; 
 (ii) the Services Agreement; 
 (iii) the License Agreement; 
 (iv) the Manufacture and License Agreement; 
 (v) the Bill of Sale; 
 (vi) the Assignment of Patent Rights; 
 (vii) the Assignment of Trademark Rights; 
 (viii) the Assignment of Copyrights; 
 (ix) the Assignment of Other Intellectual Property Rights; 
 (x) the Assignment and
Assumption Agreement; 
 (xi) the Non-Competition and Confidentiality Agreement; 
 (xii) letters from the Purchaser to the FDA and each other applicable Governmental Entity in the form and including the content required
under applicable Laws, duly executed by the Purchaser, assuming responsibility for the Registrations from the Seller Parties; and 
 (xiii) the legal opinion of the Vice-President, General Counsel, of the Purchaser, dated the Closing Date and addressed to the Seller Parties, in the form attached hereto as Exhibit 12. 
  

 14 

 In addition, at the Closing, the Purchaser and KNH shall (via authorized representatives) enter into the KNE Share
Transfer Agreement in front of a German notary public. 
 (c) Closing Deliveries to the Purchaser. At the Closing, the Purchaser shall
have received, and the applicable Seller Party shall deliver, or if applicable, cause the applicable third party (other than the Purchaser) to deliver duly executed copies (as applicable) of, each of the following: 
 (i) the Services Agreement; 
 (ii) the License Agreement; 
 (iii) the Manufacture and License Agreement; 
 (iv) the Bill of Sale; 
 (v) the Assignment of Patent Rights; 
 (vi) the Assignment of Trademark Rights; 

(vii) the Assignment of Copyrights; 
 (viii) the Assignment of Other Intellectual Property Rights; 
 (ix) the Assignment and
Assumption Agreement; 
 (x) the Non-Competition and Confidentiality Agreement; 
 (xi) duly executed resignation letters, effective at or prior to the Closing Date, of Mrs. Wendy DiCicco and Mr. Günter
Ernst, providing for their resignation as managing directors of KNE and a duly adopted shareholders’ resolution of KNE providing for the appointment of such person(s) as new managing directors of KNE as nominated by the Purchaser to the Seller
Parties at least three (3) Business Days prior to the Closing Date; 
 (xii) certification by an officer of the
Company, in form and substance reasonably satisfactory to the Purchaser, certifying that its Board of Directors has approved this Agreement and the transactions contemplated hereby; 
 (xiii) resolutions duly adopted by the Board of Directors and sole stockholder of ILT, KNH and KNE approving this Agreement and the
transactions contemplated hereby; 
 (xiv) the legal opinion of Katten Muchin Rosenman LLP, counsel to the Company, dated the
Closing Date and addressed to the Purchaser, in the form attached hereto as Exhibit 13; 
 (xv) letters from the
Seller Parties to the FDA and each other applicable Governmental Entity in the form and including the content required 

  

 15 

 
under applicable Laws, duly executed by the Seller Parties, transferring the rights to the Registrations to the Purchaser; and 
 (xvi) all reasonably necessary forms and certificates complying with applicable Law duly executed and acknowledged by the Seller Parties,
certifying that the transaction contemplated hereby is exempt from withholding under Section 1445 of the Code. 
 In addition, at the Closing, KNH (via
authorized representatives) and the Purchaser shall enter into the KNE Share Transfer Agreement in front of a German notary public. 
 2.2
Transfer of Acquired Assets. Upon the terms and subject to the conditions contained herein, at the Closing, the Seller Parties will sell, convey, transfer, assign and deliver to the Purchaser, and the Purchaser shall purchase and acquire from
the Seller Parties, the Acquired Assets free and clear of all Liens except Permitted Liens. 
 2.3 Assumption of Liabilities. Upon the
terms and subject to the conditions contained herein, at the Closing, the Purchaser shall assume and pay, discharge and perform as and when due, and the Seller Parties shall assign to the Purchaser the following, and only the following, Liabilities
of the Seller Parties relating to the Business (the “Assumed Liabilities”): 
 (a) all Liabilities of the Seller
Parties or their Affiliates arising from and after the Closing under all Assumed Contracts; 
 (b) all Liabilities set forth on
Schedule 2 attached hereto; and 
 (c) all Liabilities arising out of or related to the ownership and use of the Acquired
Assets and the operation and conduct of the Business on and after the Closing Date. 
 2.4 Retained Liabilities. Neither the Purchaser
nor any Affiliate of the Purchaser shall assume, or otherwise be responsible for any and all Liabilities of the Seller Parties and their Affiliates not expressly assumed as an Assumed Liability in Section 2.3, whether liquidated
or unliquidated, or known or unknown, whether arising out of occurrences prior to, at or after the Closing Date (the “Retained Liabilities”). Without limitation of the foregoing provisions of this
Section 2.4, it is expressly agreed and understood that neither the Purchaser nor any Affiliate of the Purchaser shall assume any of the following liabilities of the Seller Parties: 
 (a) any Liability of the Seller Parties to or in respect of any employees or former employees of the Seller Parties or their Affiliates, including,
(i) any claim or demand of a current or former employee relating to or arising as a result of employment, termination by the Seller Parties thereof, or an employment agreement, whether or not written, between a Seller Party or its Affiliates
and any Person, including, for this purpose, with respect to any Person claiming entitlements or benefits on the basis of a claimed employer-employee relationship between a Seller Party and such Person, (ii) any Liability under any employee
plan at any time maintained, contributed to or required to be contributed to by or with respect to a Seller Party or its Affiliates or under which a Seller Party or its Affiliates may incur Liability, or any contributions, benefits or Liabilities
therefor, or any Liability with respect to a Seller Party’s or 

  

 16 

 
its Affiliates’ withdrawal or partial withdrawal from or termination of any employee plan, (iii) any Liability under the Consolidated Omnibus
Budget Reconciliation Act of 1985 (“COBRA”) arising as a result of any act or omission by the Seller Parties, (iv) any Liability of a Seller Party or its Affiliates under the WARN Act, and any similar state, local U.S.
or non-U.S. law or regulation, (v) any Liability of a Seller Party or its Affiliates for severance, accrued vacation and/or paid time and/or mandatory or customary payment and/or benefit and/or entitlement for employees of a Seller Party or its
Affiliates, and (vi) any claim of an unfair labor practice, or any claim under any state unemployment compensation or worker’s compensation law or regulation or under any federal, state or non-U.S. employment discrimination law or
regulation, which shall have been asserted prior to the Closing Date or is based on acts or omissions by any Seller Party which occurred prior to the Closing Date; 
 (b) any Liability of Seller, or otherwise imposed on the Acquired Assets or with respect to the Business, in respect of any Tax, including without limitation any Liability of Seller for the Taxes of any other Person
under Treasury Regulation Section 1.1502-6 (or any similar provision of state, local or foreign law), as a transferee or successor, by contract or otherwise, but excluding any Property Taxes to the extent specifically allocated to the Purchaser
pursuant to Section 6.6(c); 
 (c) any Liability to the extent arising from any injury to or death of any person or damage
to or destruction of any property, whether based on negligence, breach of warranty, strict liability, enterprise liability or any other legal or equitable theory arising from defects in or use or misuse of products sold or from services performed by
or on behalf of any Seller Party or any other Person prior to the Closing Date; 
 (d) any Liability of the Seller Parties for any Action to
the extent arising out of or related to claims (i) asserted prior to the Closing Date against any Seller Party or against or in respect of any Acquired Assets or (ii) with respect to which the action or occurrence giving rise to such claim
shall have arisen prior to the Closing Date; 
 (e) except as expressly provided in this Agreement with respect to Assumed Contracts, any
Liability of the Seller Parties to the extent resulting from entering into, performing its obligations pursuant to or consummating the transactions contemplated by this Agreement; 
 (f) any Liability of a Seller Party or its Affiliates that arises out of or relates to any Excluded Asset; 
 (g) any Liability of a Seller Party or the Business to any Seller Party’s Affiliates arising prior to the Closing Date; 
 (h) any Liability of a Seller Party for the payment of fees or expenses of any broker or finder in connection with the origin, negotiation or execution
of this Agreement or in connection with any transaction contemplated hereby; and 
 (i) any Liability of a Seller Party arising out of or
relating to the ownership or operation of the Business or the Acquired Assets prior to the Closing Date, including outstanding 

  

 17 

 
(immediately prior to the Closing) debts or obligations owed to third parties under any Assumed Contracts. 
 2.5 Purchase Price. 
 (a)
Preliminary Base Purchase Price. In consideration for the sale and transfer of the Acquired Assets, the Purchaser shall pay or cause to be paid to the Company at the Closing, by wire transfer of immediately available funds and in lawful
currency of the United States to one or more accounts designated in writing by the Seller Parties, cash equal to the Preliminary Base Purchase Price. 
 (b) Payment of Final Base Purchase Price. Following the Closing Date, (i) if the Final Base Purchase Price exceeds the Preliminary Base Purchase Price, the Purchaser shall pay to the Seller Parties an
amount equal to such excess in cash, or (ii) if the Final Base Purchase Price is less than the Preliminary Base Purchase Price, the Seller Parties shall pay to the Purchaser an amount equal to such shortfall in cash (such payment, as the case
may be, by the Seller Parties to the Purchaser or the Purchaser to the Seller Parties the “Base Purchase Price Settlement Payment”). The Base Purchase Price Settlement Payment shall be made within five (5) Business Days
from the date on which the Base Purchase Price Determination Certificate has become final and binding upon the parties hereto. Any amounts not paid when due shall bear interest at the rate of prime plus three percent (3%) per annum. 

(c) Preparation and Certification of KNE Closing Balance Sheet. 
 (i) For the purpose of determining the Final Base Purchase Price, as promptly as practical, but in any event within thirty
(30) Business Days after the Closing Date, the Seller Parties shall prepare, and the Seller Parties shall deliver to the Purchaser (i) a balance sheet for KNE as of the Closing Date (the “KNE Closing Balance
Sheet”), which shall be prepared in accordance with the consistently applied accounting and valuation principles used in the preparation of the KNE Balance Sheet and GAAP (except as otherwise agreed herein) and (ii) a written
certificate derived from the KNE Closing Balance Sheet (the “Base Purchase Price Determination Certificate”) setting forth the Seller Parties’ calculation of the Final Base Purchase Price and the amount of Base Purchase
Price Settlement Payment. The parties agree to work together in good faith to determine the amount of all Liabilities, payments and obligations relating to the termination of the KNE Lay-Off Employees or otherwise arising under the KNE Lay-Off
Employee Ancillary Contracts, and that all such Liabilities, payments and obligations shall be included on the KNE Closing Balance Sheet, whether to be accrued under GAAP or not, it being understood that the Seller Parties shall cause KNE to have an
amount of cash and cash equivalents as of the Closing Date equal to or greater than such Liabilities, payments and obligations. 
 (ii) For the purpose of reviewing the KNE Closing Balance Sheet and the Base Purchase Price Determination Certificate as well as for the resolution of disputes, the Seller Parties shall grant the Purchaser access to all 

  

 18 

 
reasonably required information, in order to enable the Purchaser to review the KNE Closing Balance Sheet and the Base Purchase Price Determination
Certificate. 
 (iii) Any objections of the Purchaser to the KNE Closing Balance Sheet and the Base Purchase Price
Determination Certificate must be raised within thirty (30) Business Days after receipt of the KNE Closing Balance Sheet and the Base Purchase Price Determination Certificate by providing the Seller Parties with (i) a written statement of
objections (the “Disputed Items”), specifying in detail the grounds for the objections and (ii) a revised version of the Base Purchase Price Determination Certificate (the “Revised Base Purchase Price
Determination Certificate”) taking the Purchaser’s position as to the Disputed Items into account. If and to the extent that the Purchaser does not timely state its Disputed Items in accordance with the requirements of the
foregoing sentence, the Base Purchase Price Determination Certificate provided by the Seller Parties shall, with the expiration of such period, become final and binding upon the Parties. 
 (iv) If the Purchaser has duly delivered a written statement of objections, the Seller Parties and Purchaser shall, within thirty
(30) Business Days following receipt of the written statement of objections by the Seller Parties (or within any other period of time mutually agreed upon between the Seller Parties and the Purchaser), use all reasonable efforts to reach an
agreement on the Disputed Items. If and to the extent that, during such period, the Seller Parties and the Purchaser cannot reach an agreement on the Disputed Items either of them may present the matter to a neutral auditor from an auditing firm of
international standing to be jointly appointed by them (the “Neutral Auditor”). If the Seller and the Purchaser cannot agree on the Neutral Auditor within ten (10) Business Days of a written request of either of them for
such appointment, the Neutral Auditor shall at the request of either of them be a German certified accountant to be determined by the institute of Chartered Accountants in Dusseldorf after consideration of the proposals and comments by the
Seller Parties and the Purchaser. The Seller Parties and the Purchaser shall jointly instruct the Neutral Auditor to decide the issues in dispute in accordance with the provisions of this Agreement. 
 (v) Unless jointly instructed otherwise by the Seller Parties and the Purchaser, the Neutral Auditor shall limit its decisions to the
Disputed Items, but shall as basis for such decisions also duly take into account the undisputed parts of the KNE Closing Balance Sheet and the Base Purchase Price Determination Certificate. If and to the extent the Neutral Auditor’s decisions
require the interpretation of provisions of this Agreement, the Neutral Auditor shall be entitled to interpret them as far as necessary to determine the Disputed Items and to reach a decision on them. Other decisions, e.g. concerning disputes
about legal procedures or the fulfillment of procedural requirements, shall not be within the scope of the Neutral Auditor’s tasks. The Neutral Auditor shall act as an expert and not as an arbitrator. 
  

 19 

 (vi) The Parties shall make available to the Neutral Auditor the KNE Closing Balance
Sheet and the Base Purchase Price Determination Certificate, the written statement of Disputed Items, the Revised Base Purchase Price Determination Certificate and all other documents and other data reasonably required by the Neutral Auditor to make
the required decisions and determination. The Neutral Auditor shall immediately submit copies of all documents and other data made available by one party to the respective other party. Before deciding on the Disputed Items put to it by the Seller
Parties and the Purchaser, the Neutral Auditor shall grant the Seller Parties and the Purchaser the opportunity to present their respective positions, which shall include the opportunity of at least one oral hearing in the presence of both of them
and their professional advisers. The Seller Parties and the Purchaser shall instruct the Neutral Auditor to use its best efforts to deliver its written opinion with reasons for the decisions as soon as reasonably practical, but not later than within
two (2) months of the issues in dispute having been referred to the Neutral Auditor. Except for manifest error or intentional fault, the Neutral Auditor’s decisions on the KNE Closing Balance Sheet and the Base Purchase Price Determination
Certificate as determined by the Neutral Auditor shall be final and binding upon the parties for the purpose of determining the KNE Closing Balance Sheet and the Base Purchase Price Determination Certificate. The fees and disbursements of the
Neutral Auditor shall be shared between the Seller Parties and the Purchaser in proportion to their respective success and defeat as determined by the Neutral Auditor. 
 (d) Following the Closing, the Seller Parties shall promptly pay to the Purchaser any amounts that may be received by any of the Seller Parties after the Effective Time with respect to any of the Acquired Assets,
including, without limitation, the Trade Receivables. 
 2.6 Additional Consideration. As additional consideration for the
transactions contemplated by this Agreement, the Purchaser shall pay to the Seller Parties the additional consideration (the “Post-Closing Payment”), as follows: 
 (a) From and after the Closing Date, the Purchaser shall, within thirty (30) days of the end of each fiscal quarter of the Purchaser, deliver to the
Company a written report, in form and substance reasonably satisfactory to the Company, detailing the Cumulative Revenue for such fiscal quarter and the aggregate Cumulative Revenue since the Closing Date (each, a “Cumulative Revenue
Report”). 
 (b) Post-Closing Payment. Within ten (10) Business Days after delivery of the Cumulative Revenue Report
in which it is reported that the aggregate Cumulative Revenue since the Closing Date meets or exceeds $20,000,000, the Purchaser shall pay to the Seller Parties an amount equal to $6,000,000. 
 2.7 Allocation. 
 (a) No later than
sixty (60) days following the Closing Date, the Purchaser will submit to the Seller Parties its allocation of the Purchase Price, the Post-Closing Payment plus Assumed Liabilities and any other items of consideration for purposes of
Section 1060 of 

  

 20 

 
the Code, in each case, to the extent properly taken into account under the Code and the applicable Treasury Regulations, among the Acquired Assets and the
non-competition undertakings contained in the Non-Competition and Confidentiality Agreement, subject to the approval of the Seller Parties, which approval shall not be unreasonably withheld (the “Allocation”). The Allocation
will be made in accordance with Section 1060 of the Code and the Treasury regulations promulgated thereunder. The Purchaser and the Seller Parties agree to revise the Allocation to reflect any Final Base Purchase Price, Post-Closing Payment,
Assumed Liabilities or any other item of consideration for purposes of Section 1060 of the Code, in each case to the extent not previously taken into account for purposes of the Allocation. 
 (b) The Purchaser and the Seller Parties agree to (i) be bound by the Allocation, (ii) act in accordance with the Allocation in the filing of
all Tax Returns (including filing Form 8594 with their United States federal income Tax Return for the taxable year that includes the Closing Date) and in the course of any Tax audit, Tax review or Tax litigation relating thereto, and
(iii) take no position and cause their Affiliates to take no position inconsistent with the Allocation for income Tax purposes, including United States federal and state income Tax and non-U.S. income Tax, unless otherwise required pursuant to
a “determination” within the meaning of Section 1313(a) of the Code. Not later than thirty (30) days prior to the filing of their respective Forms 8594 relating to this transaction if such filing is required by Law, each of
the Purchaser and the Seller Parties shall deliver to the other a copy of its Form 8594. 
 2.8 Transfer Taxes. All transfer, stamp,
documentary, sales, recording, conveyance, notary fees and similar Taxes imposed by reason of the transfers of Acquired Assets provided hereunder and any deficiency, interest or penalty asserted with respect thereto (“Transfer
Taxes”) shall be shared equally by the Purchaser, on the one hand, and the Seller Parties, on the other hand; provided, however, that the Seller Parties shall be solely responsible for any and all Transfer Taxes in excess of Fifty
Thousand Dollars ($50,000). All Transfer Taxes shall be paid to the relevant Taxing authority by the Seller Parties when due, subject to prompt reimbursement by the Purchaser in accordance with the foregoing. The Seller Parties shall file all
necessary Tax Returns and other documentation with respect to all such Transfer Taxes; provided, that, the Seller Parties shall permit the Purchaser to review and comment on each such Tax Return and other documentation prior to filing and
shall make such revisions to each such Tax Return and other documentation as are reasonably requested by the Purchaser. If required by applicable Law, the Purchaser will, and will cause its Affiliates to, join in the execution of any such Tax
Returns and other documentation. The Seller Parties shall provide the Purchaser with evidence satisfactory to the Purchaser that such Transfer Taxes have been paid by the Seller Parties. Notwithstanding anything herein to the contrary, for any
Acquired Asset for which any Transfer Taxes have already been imposed in connection with the Closing, the term Transfer Taxes shall not include any additional Taxes imposed by reason of any subsequent transfer from the Seller Parties to the
Purchaser of Acquired Assets following the Closing. 
 2.9 Alternative Arrangements. Notwithstanding anything contained herein or in
any agreement or certificate executed and delivered in connection with the transactions contemplated hereby to the contrary, neither this Agreement nor any such agreement or certificate shall constitute an agreement to assign any Contract, Permit or
any claim or right or any benefit arising thereunder or resulting therefrom if an attempted assignment thereof, without 

  

 21 

 
the consent of a third party thereto, would constitute a default thereof. If such consent is not obtained, or if an attempted assignment thereof would be
ineffective or would affect the rights thereunder so that the Purchaser would not receive all such rights, the Seller Parties shall use commercially reasonable efforts to effect alternative arrangements in the form of a license, sublease, or
operating agreement in form and substance reasonably satisfactory to the Purchaser and the Seller Parties until such time as such consent or approval has been obtained that results in the Purchaser receiving substantially all of the benefits under
and bearing all the ordinary course costs, liabilities and other obligations with respect to any such Contract or Permit. Upon obtaining the requisite third party consent thereto, each such non-assignable Contract or Permit shall be transferred and
assigned to the Purchaser hereunder. 
 ARTICLE III 
 REPRESENTATIONS AND WARRANTIES RELATING TO THE BUSINESS 
 The Seller Parties hereby, jointly and
severally, represent and warrant to the Purchaser as follows, which representations and warranties shall (subject to the terms and conditions set forth in this Agreement) be true and correct as of the date hereof and as of the Closing Date:

 3.1 Organization. 
 (a)
Seller Parties. Each of the Seller Parties is an entity duly formed, validly existing and in good standing (in jurisdictions that recognize the concept of “good standing”) under the Laws of the jurisdiction of its organization, has
all requisite company, corporate or other power to own, lease and operate its properties and assets and to carry on the Business as now being conducted. Each of the Seller Parties is duly qualified or licensed to do business and is in good standing
as a foreign entity in each jurisdiction in which the nature of its business or ownership or leasing of its properties or assets makes such qualification or licensing necessary. 
 (b) KNE. 
 (i) KNE is
a limited liability company (Gesellschaft mit beschränkter Haftung) duly organized and validly existing under the laws of Germany, registered with the commercial register (Handelsregister) of the local court (Amtsgericht)
of Frankfurt am Main under registration number HRB 53985 and having its registered office in Frankfurt am Main/Germany. Schedule 3.1(b) of the Company Disclosure Schedule contains true and complete copies of KNE’s current
articles of association and commercial register excerpt. Except as set forth on Schedule 3.1(b) of the Company Disclosure Schedule, there are no shareholder resolutions or other facts which require any registration in KNE’s
commercial register which have not been registered therein. KNE is not a party to any agreement that grants any third party (including the Sellers Parties and their Affiliates) any rights with respect to the corporate governance or the profits (or a
portion thereof) of KNE, including inter-company agreements (Unternehmensverträge) within the meaning of sections 291 et seq. of the German 

  

 22 

 
Stock Corporation Act, silent partnership agreements (stille Beteiligungsverträge) and similar agreements. 
 (ii) KNE has all requisite corporate power to own, lease and operate its properties and assets and to carry on the Business as now being
conducted, and is duly qualified and/or licensed to do business and is in good standing as a foreign corporation in each jurisdiction in which the nature of its business or ownership or leasing of its properties and assets makes such qualification
or licensing necessary. 
 (iii) The registered share capital of KNE amounts to EUR 600,000 (in words: Euro six hundred
thousand). KNE’s entire registered share capital is represented by the KNE Share. The KNE Share is duly authorized and validly issued. The KNE Share is legally and beneficially owned by KNH, which is a wholly-owned subsidiary of the Company.
There are no agreements or commitments providing for the issuance of additional shares in KNE. The KNE Share is fully paid-up and all non-cash contributions have been made at values not exceeding the fair market value of such contribution. No (cash
or non-cash) contribution or any portion thereof has been (neither directly nor indirectly) repaid or otherwise returned. No hidden distribution of profits (verdeckte Gewinnausschüttung) have been made. There is no obligation to make any
outstanding or additional capital contribution with respect to the KNE Share. The KNE Share is free and clear of any Liens or other rights of third parties. There are no pre-emptive rights, rights of first refusal, options or other rights of any
third party to purchase or acquire the KNE Share. 
 (iv) No bankruptcy, insolvency, reorganization, liquidation or similar
proceedings (whether mandatory or voluntary) are pending and no filing for such proceedings has been made or is required with respect to KNE. KNE has not entered into any moratorium agreement or similar agreement with its creditors. KNE has not
stopped or suspended payment of its debts, become unable to pay its debts or otherwise become insolvent in any jurisdiction. No assets of KNE have been seized or confiscated by or on behalf of any third party nor are any foreclosure, forfeiture,
execution or enforcement proceedings pending with respect to KNE or its assets. There are no facts or events which may reasonably be expected to result in any proceedings, events of circumstances as referred to in this Section 3.1(b)
(iv). 
 (v) KNE does not hold any shares or equity interests in any other Person. 
 3.2 Authority; No Conflict; Required Filings and Consents. 
 (a) Each Seller Party has all requisite corporate power and authority to enter into this Agreement and to consummate the transactions contemplated hereby. This Agreement, and the consummation of the transactions
contemplated hereby, have been duly authorized by all necessary corporate action on the part of each Seller Party and KNE. This Agreement has been 

  

 23 

 
duly executed and delivered by each Seller Party. This Agreement constitutes, assuming the due authorization, execution and delivery by the Purchaser, the
valid and binding obligation of each Seller Party, enforceable against each Seller Party in accordance with its terms, except to the extent that enforceability may be limited by applicable bankruptcy, reorganization, insolvency, moratorium or other
Laws affecting the enforcement of creditors’ rights generally and by general principles of equity, regardless of whether such enforceability is considered in a proceeding at law or in equity. No vote or written consent of any holder of
securities of any Seller Party or of KNE (except as set forth in KNE’s articles of association) is necessary to approve this Agreement or any of the transactions contemplated hereby except such as has been obtained prior to the date hereof.

 (b) The execution and delivery by each Seller Party of this Agreement does not, and the consummation of the transactions contemplated
hereby will not, (i) result in the creation of any Liens on any of the Acquired Assets (other than Permitted Liens and Liens created pursuant to the terms of this Agreement and the other agreements and documents executed in connection with the
consummation of the transactions contemplated hereby), (ii) conflict with, or result in any violation or breach of any provision of the articles of organization, certificate of incorporation, bylaws or other formation documents of any Seller
Party or KNE, (iii) violate any Laws applicable to any Seller Party or KNE, or (iv) except as set forth on Schedule 3.2(b) of the Company Disclosure Schedule, conflict with or result in a breach of, or give rise to a
right of termination or amendment of or loss of benefit under, or accelerate the performance required by the terms of any judgment, court order or consent decree, or any Assumed Contract or any KNE Contract or constitute a default thereunder.

 (c) Neither the execution and delivery by the Seller Parties of this Agreement nor the consummation of the transactions contemplated
hereby will require any consent, approval, order or authorization of, or registration, declaration or filing with, or notification to any Governmental Entity or any Person, except for (i) such consents, approvals, orders, authorizations,
registrations, declarations and filings as may be required under applicable federal and state securities Laws and (ii) such other consents, approvals, authorizations, permits, filings, registrations and notifications which are listed on
Schedule 3.2(c) of the Company Disclosure Schedule. 
 3.3 Tax Matters. 
 (a) All material Tax Returns related to the Business required to be filed prior to the date hereof by the any Seller Party have been filed. All such Tax
Returns are complete and accurate in all material respects. All material Taxes of any Seller Party whether or not shown on such Tax Returns have been timely paid. The Seller Parties have withheld and paid over all Taxes related to the Business
required to have been withheld and paid over prior to the date hereof in connection with amounts paid or owing to any employee, independent contractor, or other third party. There are no Liens on any of the Acquired Assets with respect to Taxes,
other than Permitted Liens. No written claim has ever been made to a Seller Party by an authority in a jurisdiction where such Seller Party does not file Tax Returns that it is or may be subject to taxation by that jurisdiction. 
  

 24 

 (b) All material Tax Returns required to be filed prior to the date hereof by KNE have been filed in each
relevant jurisdiction. All such Tax Returns are complete and accurate in all material respects. All material Taxes of KNE whether or not shown on such Tax Returns have been timely paid, and there are no claims or Liens outstanding against KNE or any
of its property or assets with respect to any unpaid or disputed Taxes. KNE has withheld and paid over all Taxes required to have been withheld and paid over prior to the date hereof in connection with amounts paid or owing to any employee,
independent contractor, or other third party. No written claim has ever been made to KNE by an authority in a jurisdiction where KNE does not file Tax Returns that it is or may be subject to taxation by that jurisdiction. 
 (c) No Seller Party is a “foreign person” as defined in Section 1445 of the Code. 
 (d) The unpaid Taxes of KNE did not, as of the date of the KNE Balance Sheet, exceed the reserves for Tax liability (excluding any reserve for deferred
Taxes established to reflect timing differences between book and Tax income) set forth on the face of the KNE Balance Sheet (rather than in any notes thereto). Since the date of the KNE Balance Sheet, KNE has not incurred any liability for Taxes
outside the ordinary course of business consistent with past practice. 
 (e) The Tax Returns of the Seller Parties related to the Business
and the Acquired Assets or of KNE are not being audited by a taxing authority, and to the Knowledge of the Seller Parties and KNE, no such audit is threatened. Neither any Seller Party nor KNE is a party to any action or proceeding for assessment or
collection of Taxes with respect to the Business, the Acquired Assets or KNE, and, to the Knowledge of the Seller Parties and KNE, no such action or proceeding is threatened against the Business, the Acquired Assets or KNE. No waiver or extension of
any statute of limitations is in effect with respect to Taxes or Tax Returns of the Seller Parties related to the Business and the Acquired Assets or of KNE. 
 (f) No Acquired Asset (i) is property required to be treated as owned by another person pursuant to the provisions of Section 168(f)(8) of the Internal Revenue Code of 1954, as amended and in effect
immediately prior to the enactment of the Tax Reform Act of 1986, (ii) constitutes “tax-exempt use property” within the meaning of Section 168(h) of the Code or (iii) is “tax-exempt bond financed property” within
the meaning of Section 168(g) of the Code. 
 (g) KNE (i) is not and has never been a “surrogate foreign corporation”
within the meaning of Section 7874(a)(2)(B) of the Code or is not and has never been treated as a U.S. corporation under Section 7874(b) of the Code; or (ii) is not a “domestic corporation” within the meaning of
Section 7701(a)(4) of the Code. 
 3.4 Absence of Certain Changes or Events. Since June 30, 2007 through the date of this
Agreement, except as set forth on Schedule 3.4 of the Company Disclosure Schedule, no Seller Party has and KNE has not: 
  

 25 

 (a) sold, assigned, transferred or licensed, or granted any covenant not to sue based on, any patents,
trademarks, trade names, copyrights, trade secrets or other intangible assets, in each case used in connection with the Business; 
 (b)
sold, assigned, leased, licensed, transferred or otherwise disposed of any of its properties or assets used in the Business, except Inventory sold or transferred in the ordinary course of business consistent with past practice and obsolete or worn
out equipment sold or otherwise disposed of in a manner consistent with past practice which was not otherwise material (individually or in the aggregate) to the Business; 
 (c) acquired any business or Person (whether by acquisition of stock or assets, merger or otherwise); 
 (d)
suffered any damage to or destruction or casualty of (whether or not covered by insurance) any asset individually or in the aggregate material to the operation of the Business; 
 (e) failed to pay any creditor any amount arising from the operation of the Business owed to such creditor when due, other than good faith disputes and
trade payables arising in the ordinary course of business and not past due more than sixty (60) days; 
 (f) defaulted on any material
obligation related to the conduct or operation of the Business without curing such default; 
 (g) granted any allowances or discounts with
respect to the Business outside the ordinary course of business consistent with past practice or sold Inventory materially in excess of reasonably anticipated consumption for the near term outside the ordinary course of business consistent with past
practice; 
 (h) amended, cancelled or terminated, or received any notice of termination of, any Assumed Contract or KNE Contract or Permit
that is an Acquired Asset or entered into any Material Contract or obtained any Permit related to the Business; 
 (i) accelerated,
terminated, modified, or cancelled any agreement, contract, lease or license necessary for or arising exclusively from the Business and involving more than $25,000; 
 (j) delayed or postponed the payment of accounts payable or other liabilities primarily relating to or arising exclusively from the Business, or otherwise changed the practices of any Seller Party with respect to the
manner and timing of payment of accounts payable or the collection of accounts receivable; 
 (k) materially changed the practices of any
Seller Party or KNE with respect to the procurement of supplies for use in the products of the Business; 
 (l) canceled, compromised,
waived, or released any right or claim (or series of related rights and claims) relating exclusively to the Business and involving more than $25,000 individually or in the aggregate; 
  

 26 

 (m) paid, discharged, or satisfied any claims, liabilities, or obligations (absolute, accrued, asserted
or unasserted, contingent, or otherwise) exclusively arising from the Business which were outside of the ordinary course of business; 
 (n)
made or suffered any material change in the conduct or nature of any aspect of the Business, whether made in the ordinary course of the Business or not or whether or not the change had a material adverse effect on the properties, business, financial
condition or results of operations; 
 (o) failed to carry on the Business in the ordinary course and consistent with past practice so as to
preserve the Acquired Assets and the Business and the goodwill of the suppliers, customers, distributors and others having business relations with the Business; 
 (p) made or changed any election with respect to Taxes, adopted or changed any accounting method with respect to Taxes, amended any material Tax Return relating to the Acquired Assets, entered into any Tax allocation
agreement, Tax sharing agreement, Tax indemnity agreement or closing agreement, settled or compromised on any claim, notice, audit report or assessment with respect to Taxes, or consented to any extension or waiver of the limitation period
applicable to any claim or assessment with respect to Taxes, in each case to the extent of Taxes related to KNE; 
 (q) without limitation by
the enumeration of the foregoing, entered into any transaction other than in the usual and ordinary course of the Business as conducted by the Seller Parties and KNE; or 
 (r) entered into any agreement or commitment, whether in writing or otherwise, to do any of foregoing. 
 During such period,
except as set forth on Schedule 3.4 of the Company Disclosure Schedule, KNE has not: 
 (s) declared or paid any dividend,
made any other payments or distributions (except for payments in the ordinary course of Business under arm’s length service or supply agreements) or granted any loans to the Seller Parties; 
 (t) hired or promoted any employees or changed the compensation or benefits of any employee; 
 (u) made any lay-offs or other restructuring affecting its employees; 
 (v) ceased or deferred any capital expenditure in a manner that would be inconsistent with past practice; 
 (w) changed its accounting methods and policies; 
 (x) and has not entered into any agreement or commitment, whether in writing or
otherwise, to do any of foregoing. 
  

 27 

 3.5 Title to Property and Assets. Except as set forth on Schedule 3.5(a) of the
Company Disclosure Schedule, the Seller Parties have good and valid title to all of the Acquired Assets, free and clear of all Liens, except for Permitted Liens. Following the consummation of the transactions contemplated by this Agreement and the
execution of the instruments of transfer contemplated by this Agreement, the Purchaser will acquire good and marketable title to all of the Acquired Assets, free and clear of any Liens, other than Permitted Liens. Except as set forth on
Schedule 3.5(b) of the Company Disclosure Schedule, the Acquired Assets include all of the tangible and intangible property of the Seller Parties primarily used in, or otherwise necessary in the operation of, the Business. Except as
set forth on Schedule 3.5(c) of the Company Disclosure Schedule, all of the tangible Acquired Assets (other than Inventory) are (a) suitable for the uses to which they are currently employed, (b) in good operating
condition and repair, subject to normal and ordinary wear and tear, (c) regularly and properly maintained, (d) free from any material defects and (e) adequate and sufficient for all current operations of the Business. None of the
Inventory included in the Acquired Assets contains any material defect in design or materials that would materially and adversely affect the use, functionality or performance of such Inventory or the Acquired Technology. Schedule
3.5(d) of the Company Disclosure Schedule sets forth as of April 30, 2008 a true, complete and accurate list of each item, or each group of like items (stating the number), of the tangible Acquired Assets, which list identifies
(i) the type and location of each such item or group of items, and (ii) to the extent available, the original acquisition date and cost of such items. 
 3.6 Intellectual Property. 
 (a) Registered Intellectual Property Rights. Schedule
3.6(a)(i) of the Company Disclosure Schedule contains a true and complete list of all Intellectual Property Rights that have been registered with a Governmental Entity, including: (i) for each patent and patent application, the patent
number or application serial number for each jurisdiction in which the patent or application has been filed, the date filed or issued, the owner thereof, and the present status thereof; (ii) for each registered trademark, trade name or service
mark, the application serial number or registration number, for each country, province and state, and the class of goods covered, the date filed or issued, the owner thereof, and the present status thereof; (iii) for any URL or domain name, the
registration date, any renewal date and name of registry, the date filed or issued, the owner thereof, and the present status thereof; and (iv) for each registered copyrighted work, the number and date of registration for each by country,
province and state in which a copyright application has been registered, the date filed or issued, the owner thereof, and the present status thereof (the “Registered Intellectual Property Rights”). Other than the Intellectual
Property Rights listed on Schedule 3.6(a)(i) of the Company Disclosure Schedule, (A) no provisional applications, nonprovisional applications, substitutions, extensions, reissues, reexaminations, renewals, divisions,
continuations, continuations-in-part, parents or other related applications have been filed or issued with respect to the Acquired Technology, and (B) no counterpart applications of the Registered Intellectual Property Rights have been filed or
issued in any country. As of the date of this Agreement, all Registered Intellectual Property Rights are valid and subsisting. All registration, maintenance, issue, annuities, renewal, and other fees required to maintain the Intellectual Property
Rights, which were due prior to the date hereof, have been paid, and all necessary documents and certificates in connection with Registered Intellectual Property Rights have been filed with the relevant patent, copyright, trademark or other
authorities in the United States or foreign jurisdictions, as the case may be, 

  

 28 

 
for the purposes of maintaining such Registered Intellectual Property Rights. Except as set forth on Schedule 3.6(a)(ii) of the Company
Disclosure Schedule, there are no actions that must be taken by the Seller Parties or KNE, to the Company’s Knowledge, during the one hundred-twenty (120) day period beginning on the date of this Agreement, including the payment of any
registration, maintenance, issue, annuities, renewal, and other fees or the filing of any responses to U.S. Patent and Trademark Office office actions, documents, applications or certificates for the purposes of obtaining, maintaining, perfecting or
preserving or renewing any Registered Intellectual Property Rights. Except as otherwise set forth on Schedule 3.6(a)(i) of the Company Disclosure Schedule, each owner listed in Schedule
3.6(a)(i) of the Company Disclosure Schedule is listed in the records of the appropriate Governmental Entity as the sole owner of record. KNE does not own any of the Registered Intellectual Property Rights required to be listed in
Schedule 3.6(a)(i). 
 (b) Licensed Intellectual Property Rights. Schedule 3.6(b)(i) of the Company
Disclosure Schedule lists all Contracts to which any of the Seller Parties is a party with respect to any Intellectual Property Rights (“Intellectual Property Contracts”) and a summary of the Seller Parties’ remaining
payment and accounting obligations, if any, with respect to each of such Intellectual Property Contracts, other than “shrink wrap,” “click wrap” and other similar license agreements relating to software applications that are
generally available to the public. Schedule 3.6(b)(ii) of the Company Disclosure Schedule sets forth all Intellectual Property Contracts entered into between the Seller Parties or KNE and a third party for use of third party
Proprietary Rights by the Seller Parties or KNE in connection with any of the Acquired Technology. Except for “shrink wrap,” “click wrap” and other similar license agreements relating to software applications that are generally
available to the public, to the extent that any third party Proprietary Rights are incorporated into, integrated or bundled with, or used by the Seller Parties or KNE in the development, manufacture or compilation of any of the Acquired Technology,
the Seller Parties have a written agreement with such third party with respect thereto pursuant to which the Seller Parties or KNE either have obtained complete, unencumbered and unrestricted ownership of, and are the exclusive owners of, or have
obtained perpetual, nonterminable licenses sufficient for the conduct of the Business to all such third party Proprietary Rights. Notwithstanding the foregoing, the Seller Parties are the sole and lawful owners of all right, title, and interest in
and to the Patent Rights to be assigned to the Purchaser in connection with this Agreement, and the Seller Parties have good and full right and lawful authority to sell and convey such Patent Rights to the Purchaser. Except as set forth on
Schedule 3.6(b)(iii) of the Company Disclosure Schedule, as of the date of this Agreement, the Seller Parties and KNE have not granted licenses or covenants not to sue, or sold or otherwise transferred (other than standard licenses or
rights to use granted to customers and distributors in the ordinary course of its business) any of the Intellectual Property Rights to any third party, and there exists no obligation by the Seller Parties or KNE to assign, license or otherwise
transfer any of the Intellectual Property Rights to any third party (other than the obligations of the Seller Parties hereunder). No party to any Intellectual Property Contract set forth on Schedule 3.6(b)(i) of the Company Disclosure
Schedule is in breach or default in any material respect, and no written notice of termination has been given or threatened. The Seller Parties and KNE do not have an explicit or implied legal obligation, absolute or contingent, to any Person to
sell, transfer or assign any of the Intellectual Property Rights. None of the Intellectual Property Contracts listed in Schedule 3.6(b)(i) of the Company Disclosure Schedule grants, or sets forth or creates an obligation to grant, any
third party exclusive rights in, to or under any of the Intellectual 

  

 29 

 
Property Rights, or grants, or sets forth or creates an obligation to grant, any third party the right to sublicense any of the Intellectual Property Rights.
Except pursuant to the Intellectual Property Contracts set forth on Schedule 3.6(b)(ii) of the Company Disclosure Schedule, the Seller Parties and KNE are not compensating and have no obligation to compensate or account to any Person
for the use of any of the Intellectual Property Rights or Acquired Technology. The consummation of the transactions contemplated by this Agreement will not result in (i) the modification, cancellation, termination, suspension of, or
acceleration of any payments with respect to any Intellectual Property Contract, nor give any third party to any Intellectual Property Contract the right to do any of the foregoing, (ii) the forfeiture or termination of any of the Intellectual
Property Rights, or impair the right of the Purchaser or KNE to use, possess, sell or license any of the Intellectual Property Rights, (iii) the Purchaser’s or KNE’s granting to any third party any right to or with respect to any
Acquired Technology or Intellectual Property Rights owned by, or licensed to, any Seller Party or KNE, (iv) the Purchaser’s or KNE’s being bound by, or subject to, any non-compete or other restriction on the operation or scope of its
businesses, or (v) the Purchaser’s or KNE’s being obligated to pay any royalties or other amounts to any third party in excess of those payable by the Seller Parties or KNE, prior to the Closing. Following the Closing, the Purchaser
or, as the case may be, KNE, will be permitted to exercise all of the rights of the Seller Parties under the Intellectual Property Contracts to the same extent the Seller Parties or KNE would have been able had the transactions contemplated by this
Agreement not occurred and without the payment of any additional amounts or consideration other than ongoing fees, royalties or payments that the Seller Parties or KNE would otherwise be required to pay. 
 (c) Ownership. 
 (i)
Except as set forth in Schedule 3.6(c)(i) of the Company Disclosure Schedule, the Seller Parties are the sole and exclusive owner of, or otherwise have a right to use, all Intellectual Property Rights, free and clear of any Liens other
than Permitted Liens. None of the Permitted Liens will interfere with the Seller Parties’ ability to perform each of their obligations under this Agreement including, without limitation, the transfer of Intellectual Property Rights. 

(ii) Except as set forth on Schedule 3.6(c)(ii) of the Company Disclosure Schedule, no Person who has licensed
Proprietary Rights to or from the Seller Parties or KNE have ownership rights or license rights to improvements made by Company or KNE in such Proprietary Rights. 
 (iii) The Acquired Assets, including but not limited to the Intellectual Property Rights, constitute all Proprietary Rights used in or
necessary for the conduct of the Business, including the design, manufacture, license and sale of the Acquired Technology, whether currently under development or in production. For clarity, this Section 3.6(c)(iii) shall not be
applicable with respect to any allegation by a Third Party that the conduct of the Business by the Purchaser infringes, misuses, misappropriates, breaches or otherwise violates any Proprietary Rights of such Third Party, in which event
Section 3.6(d) shall be applicable. 
  

 30 

 (d) Disputes. Except as set forth on Schedule 3.6(d) of the Company Disclosure
Schedule, as of the date of this Agreement, (i) none of the Intellectual Property Rights or the Intellectual Property Contracts is the subject of any pending or threatened litigation, (ii) no third party has provided the Seller Parties or
KNE with written notice that it claims any ownership of or right to use any Intellectual Property Rights, and (iii) to the Knowledge of the Seller Parties, no third party is infringing, misusing, misappropriating, breaching or otherwise
violating any Intellectual Property Right, Intellectual Property Contract or the Acquired Technology. Except as set forth on Schedule 3.6(d) of the Company Disclosure Schedule, to the Knowledge of the Seller Parties, as of the date of
this Agreement, the conduct of the Business, including the production, servicing, design, development, use, import, branding, advertising, promotion, marketing, manufacture and sale of the Acquired Technology (including Acquired Technology currently
under development), does not and will not when conducted by the Purchaser and KNE in substantially the same manner following the Closing, infringe, misuse, misappropriate, breach or otherwise violate any Proprietary Rights of any Person (including
any right to privacy or publicity) or constitute unfair competition or trade practices under the laws of any jurisdiction. No proceedings have been instituted against, or written notices received by the Seller Parties or KNE, from any Person
alleging that such operation or any act or Acquired Technology (including Acquired Technology currently under development) infringes, misuses, misappropriates, breaches or otherwise violates any Proprietary Rights of any Person or constitutes unfair
competition or trade practices under the laws of any jurisdiction (nor do the Seller Parties have any Knowledge of any basis therefor) or that any of the Intellectual Property Rights are invalid. Without limiting the foregoing, no interference,
cancellation, opposition, reexamination, or other legal action initiated by a third party is or has been pending against the Seller Parties or KNE challenging scope, validity or ownership, anywhere in the world. Except as set forth on Schedule
3.6(d) of the Company Disclosure Schedule, neither the Seller Parties nor KNE have obtained or received any written opinion of counsel regarding any Proprietary Right of a third party. The Intellectual Property Rights and Acquired Technology
are not subject to any outstanding judgment, decree, order, writ, award, injunction or determination of an arbitrator or court or other Governmental Entity (other than office actions and correspondence regarding pending patent applications and
trademark applications) restricting the rights of the Seller Parties with respect thereto. The Seller Parties and KNE are not engaging in and have not engaged at any time in any patent or copyright misuse or any fraud or inequitable conduct,
including with respect to their respective patent applications, trademark applications or copyright registration applications. Without limiting the foregoing, to the Knowledge of the Seller Parties, there is no information, materials, facts, or
circumstances, including any information or fact that would constitute prior art, that would render any of the Intellectual Property Rights invalid or unenforceable, or would adversely affect any pending application for Proprietary Rights, and the
Seller Parties and KNE have not misrepresented, or failed to disclose, and have no Knowledge of any misrepresentation or failure to disclose, any fact or circumstances in any application for Intellectual Property Rights that would constitute fraud
or a misrepresentation with respect to such application or that would otherwise affect the validity or enforceability of Intellectual Property Rights. 
 (e) Employees. Except as set forth on Schedule 3.6(e) of the Company Disclosure Schedule, all Intellectual Property Rights owned by the Seller Parties or KNE were developed by current or former
employees, consultants, independent contractors or agents of the Seller Parties or KNE and (if not owned as a matter of law) have been assigned to the Seller 

  

 31 

 
Parties or KNE and are free of any claims of such employees, consultants, independent contractors or agents thereto. Each current or former employees,
consultants, independent contractors or agents of the Seller Parties or KNE engaged in any activity involving the design, development or other similar inventive activities on behalf of the Business have executed a valid and binding written agreement
with the applicable Seller Party or KNE sufficient to vest title in such Seller Party or KNE of all Acquired Technology and Intellectual Property Rights created by such employee, consultant, independent contractor or agent in the scope of his or her
services or employment for such Seller Party or KNE and requiring such employee, consultant, independent contractor or agent to maintain the confidentiality of all such Seller Party’s confidential information as defined therein. All such
agreements are assignable by the Seller Parties without further approvals from any other party and shall be assigned to the Purchaser as of the Effective Time. To the Seller Parties’ Knowledge, no current or former employee, consultant,
independent contractor or agent of the Seller Parties or KNE (i) is in violation of any term or covenant of any agreement relating to employment, invention disclosure, invention assignment, nondisclosure or noncompetition or any other agreement
with any third party by virtue of such employee, consultant or independent contractor being employed by, or performing services for, the Seller Parties or KNE or using trade secrets or proprietary information of others without permission,
(ii) has developed any Acquired Technology or other copyrightable, patentable or otherwise proprietary work for the Seller Parties or KNE that is subject to any agreement under which such employee, consultant or independent contractor has
assigned or otherwise granted, or is obligated to assign or otherwise grant, to any third party any rights (including Intellectual Property Rights) in or to such Acquired Technology or other copyrightable, patentable or otherwise proprietary work,
or (iii) has developed any technology, software or other copyrightable, patentable or otherwise proprietary work for the Seller Parties or KNE that is subject to any agreement under which such employee, consultant, independent contractor or
agent has assigned or otherwise granted, or is obligated to assign or otherwise grant, to any third party any rights in or to such technology, software or other copyrightable, patentable or otherwise proprietary work. The Seller Parties have no
Knowledge that any of its or KNE’s current or former employees, consultants, independent contractors or agents are obligated under any agreement, or subject to any judgment, decree or order of any Governmental Entity, that would interfere with
the use of their efforts to promote the interests of the Seller Parties and KNE or that would conflict with the Business. 
 (f)
Confidentiality. The Seller Parties and KNE have taken reasonable steps to protect and preserve the confidentiality of all confidential or non-public information, including trade secrets, included in the Intellectual Property Rights. To the
Knowledge of the Seller Parties, all use, disclosure or appropriation of such information by or to a third party has been pursuant to the terms of a written agreement between the Seller Parties or KNE and such third party. To the Knowledge of the
Seller Parties, all use, disclosure or appropriation of such information by or to the Seller Parties or KNE have been pursuant to the terms of a written agreement or other legal binding arrangement between the Seller Parties or KNE and the owner of
such information, or is otherwise lawful. Without limiting the foregoing, to the Knowledge of the Seller Parties, (i) there has been no misappropriation of any trade secrets or other confidential Intellectual Property Rights or Acquired
Technology used in connection with the business of the Seller Parties or KNE by any Person and (ii) no employee, consultant, independent contractor or agent of the Seller Parties or KNE has misappropriated any trade secrets of any other Person
in the course of performance as an employee, independent contractor or agent of the business. 
  

 32 

 (g) Transferability. After the Effective Time, all Intellectual Property Rights will be fully
transferable, alienable or licensable by the Purchaser or KNE without restriction and without payment of any kind to any third party. The Seller Parties and KNE have not transferred any portion of ownership of, granted any exclusive license of or
right to use, or authorized the retention of any exclusive rights to use or joint ownership of, any of the Intellectual Property Rights to any third party or knowingly permitted any of the Intellectual Property Rights to enter the public domain or,
with respect to any of the Intellectual Property Rights for which the Seller Parties or KNE have submitted an application or obtained a registration, to lapse (other than (i) through the expiration of a Registered Intellectual Property Right at
the end of its maximum statutory term or (ii) applications abandoned and listed in Schedule 3.6(g) of the Company Disclosure Schedule ). 
 (h) Enforcement. Except as set forth on Schedule 3.6(h) of the Company Disclosure Schedule, the Seller Parties have the right to bring actions for infringement or misappropriation of all
Intellectual Property Rights. 
 (i) Indemnity Obligations. Schedule 3.6(i) of the Company Disclosure Schedule lists all
material Intellectual Property Contracts, between the Seller Parties or KNE and any other person wherein or whereby the Seller Parties or KNE have agreed to, or assumed, any obligation or duty to warrant, indemnify, reimburse, hold harmless,
guaranty or otherwise assume or incur any obligation or liability or provide a right of rescission with respect to the infringement or misappropriation by the Seller Parties or KNE or such other Person of the Proprietary Rights of any Person other
than the Seller Parties. 
 (j) Government Funding. No (i) government funding, including funding pursuant to a government grant;
(ii) facilities or personnel of a university, college, other educational or medical institution or research center; or (iii) funding from any Person (other than the Seller Parties) was used in the development of the Intellectual Property
Rights. No current or former employee, consultant, independent contractor, or agent of the Seller Parties, who was involved in, or who contributed to, the creation or development of any Intellectual Property Rights, was employed by or has performed
services for any government, university, college or other educational or medical institution or research center during a period of time during which such employee, consultant, independent contractor, or agent was also performing services for the
Seller Parties. 
 (k) Export. To the Knowledge of the Seller Parties, (i) the Seller Parties and KNE have obtained all approvals
of Governmental Entities necessary for exporting the Acquired Technology outside the United States (with respect to the Seller Parties) or Germany (with respect to KNE) in accordance with all applicable United States or German export control,
embargo and other regulations, and importing the Acquired Technology into any country in which the Acquired Technology is now sold or licensed for use, and (ii) all such export and import approvals in the United States and throughout the world
are valid, current, outstanding and in full force and effect. 
 (l) Payments. Except as set forth on Schedule 3.6(l) of
the Company Disclosure Schedule, there are no royalties, fees, honoraria or other payments payable by the Seller Parties or KNE to any Person by reason of the ownership, development, use, license, sale 

  

 33 

 
or disposition of Intellectual Property Rights or Acquired Technology, other than salaries and sales commissions paid to employees and sales agents in the
ordinary course of business. 
 (m) Small Business Status. The Seller Parties have not claimed a particular status, including
“Small Business Status,” in the application for any Intellectual Property Rights, which claim of status was at the time made, or which has since become, inaccurate or false. 
 (n) Defects The Acquired Technology does not (a) contain any defect or error in design that would materially and adversely affect the use or
performance of the Acquired Technology; (b) with respect to the Inventory included in the Acquired Assets, contain any material defect in design that would materially and adversely affect the use or performance of the Acquired Technology; or
(c) to the Knowledge of the Seller Parties, fail to comply with any applicable warranty or other contractual commitment relating to the use, functionality or performance of such Acquired Technology. 
 (o) Harmful Code. To the Knowledge of the Seller Parties, any Software or firmware incorporated in or provided with the Acquired Technology, and
any media used to distribute it, contain at delivery no computer instructions, circuitry or other technological means whose purpose or effect is to disrupt, damage or negatively interfere with any use of any customer’s computer and
communications facilities or equipment (“Harmful Code”), and the Seller Parties have used commercially reasonable efforts to prevent the introduction of such Harmful Code to all Software, firmware and media distributed,
licensed or sold by the Seller Parties or KNE. “Harmful Code” includes (a) any instrumentality that could cause the Software or firmware to fail to be operative upon command of or by design by the Seller Parties, and
(b) any code containing viruses, trojan horses, worms, or like destructive code or code that self-replicates. None of the Software incorporated in the Acquired Technology is, in whole or in part, subject to the provisions of any open source or
quasi-open source license agreement, or any other agreement obligating the Seller Parties or KNE to make source code available to third parties or to publish source code. The Seller Parties and KNE have not entered into any agreement requiring the
Seller Parties or KNE to place the source code or other technology incorporated in the other Acquired Technology in escrow so that a licensee might obtain access to it upon the occurrence of any release condition. 
 (p) Publicly Available Software. Except as set forth on Schedule 3.6(p) of the Company Disclosure Schedule, no Acquired Technology
(including any Acquired Technology currently under development) contains any Publicly Available Software. All Publicly Available Software used by the Seller Parties and KNE has been used in its entirety and without modification. The Seller Parties
have not incorporated or otherwise used Publicly Available Software in a manner that would require, or condition the use or distribution of any Acquired Technology on the disclosure, licensing or distribution of any source code for any portion of
such Acquired Technology. “Publicly Available Software” means: (A) any Software that contains, or is derived in any manner in whole or in part from, any Software that is distributed as free Software, open source Software
(e.g. Linux) or under similar licensing or distribution models; or (B) any Software that may require as a condition of use, modification or distribution that such Software or other Software incorporated into, derived from or distributed with
such Software: (i) be disclosed or distributed in source code form; (ii) be licensed for the purpose of making derivative works; or (iii) be redistributable at no charge. 
  

 34 

 (q) Access to Information. The Seller Parties or KNE have not entered into any agreement requiring
the Seller Parties or KNE to grant any access or rights to the source code or technical design or manufacturing documentation necessary to make the Acquired Technology or to place such materials or other technology incorporated in the Acquired
Technology so that a licensee might obtain access to it upon the occurrence of any release condition. No event has occurred, and no circumstance or condition exists, that (with or without notice or lapse of time) will, or could reasonably be
expected to, result in the delivery, license, or disclosure of any source code for any Acquired Technology to any other person who is not, as of the date of this agreement, an employee of the Seller Parties or KNE. 
 3.7 Material Contracts. 
 (a) Except
as set forth on Schedule 3.7(a) of the Company Disclosure Schedule, as of the date of this Agreement, no Seller Party is a party to or bound by, and the Acquired Assets are not subject to, any of the following Contracts (in each
case below, to the extent that the same relates primarily to, or is otherwise necessary to the operation of the Business, the Acquired Assets or the Assumed Liabilities): 
 (i) any Contracts for the purchase or sale of Inventory entered into in the ordinary course of business, which either individually or in
conjunction with Contracts with the same party, and in connection with the same matter, relate to commitments in excess of $25,000 per annum (including any agreements requiring the payment of any royalties, milestones, minimum purchase payments or
other guarantees made by or on behalf of the Company); 
 (ii) any Contracts relating to the purchase, lease or similar
arrangement of any machinery, equipment, furniture, fixture or similar property having a value in excess of $25,000; 
 (iii)
any Contracts with (A) any director, officer, employee or Affiliate of any Seller Party involving payments in excess of $5,000 per annum (or the equivalent amount in another currency), or (B) to the Knowledge of the Seller Parties, any
Affiliate or family member of any of the foregoing involving payments in excess of $5,000 per annum; 
 (iv) any agreement
with any independent contractor or similar Contract that (x) involves the payment or receipt of more than $25,000 per annum and (y) is not terminable within thirty (30) days’ notice or less without penalty, liability or premium;

 (v) any currently effective collective bargaining or union agreements with respect to its employees; 
 (vi) any agreement (A) restricting any Seller Party from engaging, participating, or competing with any other Person, in any line of
business, market or geographic area, or to make use of any Intellectual Property Rights; (B) granting most favored nation pricing, exclusive sales, distribution, marketing or other exclusive rights, rights of first refusal or rights of first

  

 35 

 
negotiation to any other Person; (C) otherwise limiting the right of any Seller Party to make, use, sell, offer for sale, import, or distribute any
Acquired Technology or services related thereto; or (D) any agreement pursuant to which any Seller Party has granted exclusive rights with respect to the Acquired Technology, including any Intellectual Property Rights; 
 (vii) any agreement of guarantee, credit support, assumption or endorsement of, any indebtedness for borrowed money of other Persons;

 (viii) any line of credit, standby financing, revolving credit or other similar financing arrangement of any sort that is
secured by any Acquired Assets; 
 (ix) any agreement relating to any joint venture or partnership arrangement between any
Seller Party, on the one hand, and a third party, on the other hand; 
 (x) any leases for real property or personal property;

 (xi) any distributorship, customer sales or leasing Contracts under which any Seller Party is currently providing or
receiving products or services and involving more than $25,000 per annum; and 
 (xii) any Contract of indemnification or
warranty, other than (A) under a Seller Party’s unmodified forms of standard customer/distribution agreements, the forms of which have been made available to the Purchaser or its counsel, or (B) warranties implied by Law; 

(xiii) any Contract pursuant to which any Seller Party has acquired or divested a business or entity, or all or substantially all of
the assets of a business or entity, whether by way of merger, consolidation, purchase of stock, purchase or sale of assets, license or otherwise; 
 (xiv) any Contract with any Governmental Entity; 
 (xv) any confidentiality, secrecy or
non-disclosure Contract in effect other than (A) any such Contract entered into with customers or distributors in the ordinary course of business pursuant to a Seller Party’s standard unmodified form (a copy of which has been made
available to the Purchaser or its counsel) and (B) any such Contract entered into in connection with a possible disposition by the Company of the Business, the terms of which prohibit the applicable Seller Party from disclosing the existence of
such Contract, the parties thereto and/or the provisions thereof; 
 (xvi) any agreement pursuant to which rights of any third
party are triggered or become exercisable, or under which any other consequence, result or effect arises, in connection with or as a result of the execution of this Agreement or the consummation of the transactions contemplated hereunder, 

  

 36 

 
either alone or in combination with any other event, which trigger or exercise of rights, consequence, result or effect would materially impair the ability
of the Purchaser to consummate the transactions hereunder or operate the Business after Closing; and 
 (xvii) any Contracts
related to research or development with respect to Acquired Technology. 
 The agreements, documents and instruments set forth on
Schedule 3.7(a) of the Company Disclosure Schedule are collectively with the KNE Contracts referred to herein as “Material Contracts”. Except as otherwise set forth in Schedule 3.7(a) of the
Company Disclosure Schedule, true, complete and correct copies of each document or instrument constituting a Material Contract in its complete, current and up-to-date version and true, complete and correct written description of the material terms
of any non-written Contract listed on Schedule 3.7(a) of the Company Disclosure Schedule (Material Contracts) have been made available to the Purchaser by virtue of having been posted on the electronic data room. 
 (b) Except as set forth on Schedule 3.7(b) of the Company Disclosure Schedule, all of the Material Contracts are valid, binding in
accordance with their respective terms, in full force and effect, and enforceable against (i) the Seller Party or KNE (as applicable) which are a party thereto, and (ii) to the Knowledge of the Seller Parties and KNE, each third party
which is party thereto, in accordance with their respective terms, except, in each case, to the extent that enforceability may be limited by applicable bankruptcy, reorganization, insolvency, moratorium or other Laws affecting the enforcement of
creditors’ rights generally and by general principles of equity, regardless of whether such enforceability is considered in a proceeding at law or in equity. 
 (c) Except as set forth on Schedule 3.7(c) of the Company Disclosure Schedule, neither any Seller Party nor KNE is in default under or in breach or violation of any Material Contract. To the
Knowledge of the Seller Parties, no other party is in default under or in breach or violation of any Material Contract. 
 (d) The
agreements, documents and instruments set forth on Schedule 3.7(d) of the Company Disclosure Schedule are referred to herein as the “KNE Contracts”. Other than the KNE Contracts, KNE is not a party to any
Contract. 
 3.8 Compliance with Laws. 
 (a) The Seller Parties. Each of the Seller Parties is not in material violation of any, and has not received any written notices of a material violation with respect to any, applicable Laws with respect to the
conduct, ownership or operation of the Business. None of the Acquired Technology, the Acquired Assets, or the Inventory violates any Environmental Laws, and the manufacture, packaging, and distribution of the Acquired Technology has been in material
compliance with all Environmental Laws. 
 (b) KNE. KNE is not in material violation of any, and has not received any written notices
of a material violation with respect to any, applicable Laws with respect to the conduct, ownership or operation of the KNE’s business. KNE is in material compliance with all 

  

 37 

 
Environmental Laws, and has obtained and materially complied with all Permits applicable to it under Environmental Laws. 
 3.9 Litigation. 
 (a) Seller
Parties. Except as set forth on Schedule 3.9(a) of the Company Disclosure Schedule, there is no private or governmental Action or, to the Knowledge of the Seller Parties, investigation, pending before any Governmental Entity,
or, to the Knowledge of the Seller Parties, threatened against the Seller Parties or any of their respective officers or directors (in their capacities as such), in each case with respect to the Business or the Acquired Assets. There is no
unsatisfied judgment, decree or order against the Seller Parties, or, to the Knowledge of the Seller Parties, any of their respective directors or officers (in their capacities as such) related to the Business. As of the date hereof, there is no
Action pending or, to the Knowledge of the Seller Parties, threatened against the Seller Parties which, if adversely determined could reasonably be expected to have a material adverse effect on the Business (taken as a whole). 
 (b) KNE. Except as set forth on Schedule 3.9(b) of the Company Disclosure Schedule, there is (and there was in the past three
(3) years) no private or governmental Action or, to the Knowledge of the Seller Parties, investigation, pending before any Governmental Entity, or, to the Knowledge of the Seller Parties, threatened against KNE or any of its officers or
directors (in their capacities as such). There is no unsatisfied judgment, decree or order against KNE, or, to the Knowledge of the Seller Parties, any of its directors or officers (in their capacities as such). As of the date hereof, there is (and
there was in the past three (3) years) no Action pending or, to the Knowledge of the Seller Parties, threatened against KNE which, if adversely determined could reasonably be expected to have a material adverse effect on KNE. 
 3.10 Health Care Compliance. Without limiting the generality of Section 3.8: 
 (a) The Seller Parties, KNE and their respective directors, officers, employees, and agents (while acting in such capacity) are, and at all times during
the past three (3) years have been, in material compliance with all relevant health care Laws applicable to the Seller Parties and KNE, including, but not limited to, the FDA Act, the federal Anti-kickback Statute (42 U.S.C. §
1320a-7b(b)), the civil False Claims Act (31 U.S.C. §§ 3729 et seq.), the administrative False Claims Law (42 U.S.C. § 1320a-7b(a)), the Anti-Inducement Law (42 U.S.C. § 1320a-7a(a)(5)), and the exclusion laws, SSA
§ 1128 (42 U.S.C. 1320a-7), and the regulations promulgated pursuant to such Laws, and comparable state Laws, and all other local, state, federal, national, supranational and foreign Laws relating to the regulation of the Seller Parties and KNE
(collectively, “Health Care Laws”). None of the Seller Parties or KNE has received any notification, correspondence or any other communication from any Governmental Entity of potential or actual non-compliance by, or
liability of, such Seller Party or KNE under any Health Care Laws. To the Knowledge of the Seller Parties and KNE, no circumstances exist that would be reasonably likely to constitute a violation of any Health Care Law. 
 (b) There is no lawsuit, action, other proceeding or claim pending, received or threatened against any of the Seller Parties or KNE which relates in any
way to a violation of any Health Care Law or other Law pertaining to governmental health care programs or which could 

  

 38 

 
result in the imposition of penalties against or the exclusion of the Seller Parties or KNE from participation in any such health care program. None of the
Seller Parties, KNE or any of their respective officers, directors, employees or agents has engaged in any activity which is reasonable cause for civil penalties or mandatory or permissive exclusion from any governmental health care program.

 (c) Each of the Seller Parties and KNE has obtained and maintained each Permit, and all of such Permits are in full force and effect. All
of the Permits are listed on Schedule 3.10(c) of the Company Disclosure Schedule. None of the Seller Parties or KNE has received any communication from any Governmental Entity regarding, and, there are no facts or circumstances
(including, without limitation, the performance of the transactions contemplated under this Agreement) that are likely to give rise to, (i) any material adverse change in any Permit, or any failure to materially comply with any applicable Laws
or any term or requirement of any Permit or (ii) any revocation, withdrawal, suspension, cancellation, limitation, termination or material modification of any Permit. 
 (d) All applications, notifications, submissions, information, claims, reports and statistics and other data and conclusions derived therefrom, utilized
as the basis for or submitted in connection with any and all requests for a Permit from the FDA or other Governmental Entity relating to the Seller Parties or KNE, the Business and the Acquired Technology, when submitted to the FDA or other
Governmental Entity were true, complete and correct in all material respects as of the date of submission and any necessary or required updates, changes, corrections or modification to such applications, submissions, information and data have been
submitted to the FDA or other Governmental Entity. 
 (e) Except as set forth in Schedule 3.10(e) of the Company Disclosure
Schedule, during the past three (3) years, the Seller Parties and KNE have not had any manufacturing site subject to a Governmental Entity (including FDA) shutdown or import or export prohibition, nor received any FDA Form 483 or other
Governmental Entity notice of inspectional observations, “warning letters,” “untitled letters” or similar correspondence or notice from the FDA or other Governmental Entity in respect of the Business and alleging or asserting
noncompliance with any applicable Laws, Permits, and, to the Knowledge of the Seller Parties, neither the FDA nor any Governmental Entity is considering such action. 
 (f) All preclinical and clinical trials in respect of the Acquired Technology that have been or are being conducted by or on behalf of the Seller Parties or KNE and that have been submitted to any Governmental Entity,
including the FDA and its counterparts worldwide, in connection with any Registration or other Permit, are being or have been conducted in compliance in all material respects with the required experimental protocols, procedures and controls pursuant
to applicable Laws, including, but not limited to, the FDA Act and its applicable implementing regulations at 21 C.F.R. Parts 50, 54, 56, 58 and 812. Neither the Seller Parties nor KNE has received any notices, correspondence or other communication
from the FDA or any other Governmental Entity requiring the termination, suspension or material modification of any clinical trials conducted by, or on behalf of, a Seller Party or KNE, or in which a Seller Party or KNE has participated, and to the
Seller Parties’ Knowledge, there is not reason to believe that the FDA or any other Governmental Entity is considering such action. 
  

 39 

 (g) None of the Seller Parties is the subject of any pending or, to the Knowledge of the Seller Parties,
threatened investigation in respect of the Seller Parties or the Acquired Technology, by the FDA pursuant to its “Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities” Final Policy set forth in 56 Fed. Reg. 46191
(September 10, 1991) and any amendments thereto. None of the Seller Parties or KNE, nor any of their officers, employees or agents has been convicted of any crime or engaged in any conduct that could result in a material debarment or exclusion
(i) under 21 U.S.C. Section 335a, or (ii) any similar Law. As of the date hereof, no claims, actions, proceedings or investigations that would reasonably be expected to result in such a material debarment or exclusion are pending or
threatened against the Seller Parties, KNE or any of their officers, employees or agents. 
 (h) Except as set forth in Schedule
3.10(h) of the Company Disclosure Schedule, there have been no recalls, field notifications, field corrections, market withdrawals or replacements, warnings, “dear doctor” letters, investigator notices, safety alerts or other
notice of action relating to an alleged lack of safety, efficacy, or regulatory compliance of the Acquired Technology (“Safety Notices”) during the past two (2) years. Schedule 3.10(h) of the Company
Disclosure Schedule lists (i) all such Safety Notices, (ii) the dates such Safety Notices, if any, were resolved or closed, and (iii) to the Seller Parties’ Knowledge, any material complaints with respect to the Acquired
Technology that are currently unresolved. To the Seller Parties’ Knowledge, there have been no material product complaints with respect to the Acquired Technology, and to the Seller Parties’ Knowledge, there are no facts that would be
reasonably likely to result in (i) a material Safety Notice with respect to the Acquired Technology, (ii) a change in the marketing classification or a material change in labeling of any the Acquired Technology; or (iii) a termination
or suspension of marketing or testing of any the Acquired Technology. 
 3.11 Customers and Suppliers. 
 (a) Schedule 3.11(a) of the Company Disclosure Schedule contains a true and complete list of (i) the twenty (20) largest
customers and the ten (10) largest distributors of the Business based on sales made during the period beginning on January 1, 2007 and ending on March 31, 2008, along with the total amount of sales made by the Business thereto for
each calendar month contained in such period and (ii) the ten (10) largest suppliers of the Business, in order of dollar volume, during (x) the twelve-month period ended June 30, 2007 and (y) the nine-month period ended
March 31, 2008, showing in each case the total business in dollars from each supplier during such period. 
 (b) Except as set forth on
Schedule 3.11(b) of the Company Disclosure Schedule, since November 30, 2007, (i) there has not been any material adverse change in the business relationship of any Seller Party or of KNE with any customer or supplier
named on Schedule 3.11(a) of the Company Disclosure Schedule, (ii) neither any Seller Party nor KNE has received any written communication from any customer, original equipment manufacturer, value-added reseller, distributor
or supplier named on Schedule 3.11(a) of the Company Disclosure Schedule of any intention to terminate or materially modify existing Contracts with such Seller Party or KNE and (iii) neither any Seller Party nor KNE has
received any written communication from any supplier that such supplier expects in the foreseeable future any material difficulty in obtaining, in the quantity and quality and at a price consistent with past 

  

 40 

 
practice, the raw materials, supplies or component products required for the manufacture, assembly or production of the Acquired Technology. 
 3.12 Books and Records. The Books and Records are stated in reasonable detail and accurately and completely reflect in all material respects all
material information relating to the Business, the location of its assets and properties, and the nature of the material transactions giving rise to its obligations or accounts receivable. 
 3.13 Affiliate Transactions. Except as set forth in Schedule 3.13 of the Company Disclosure Schedule, neither any officer nor
any director of any Seller Party or KNE, nor any child, spouse, parent or sibling or any other family member of any such officer or director, or any Affiliate of any Seller Party or KNE: 
 (a) directly or indirectly owns, in whole or in part, any property, asset or right of material significance, used in connection with the Business; or

 (b) directly or indirectly has an interest in or is party to any Assumed Contract or KNE Contract. 
 3.14 Warranties; Product Liability. 
 (a) Warranties. Except as set forth in Schedule 3.14(a) of the Company Disclosure Schedule, (i) there are no warranties (other than those warranties implied by law), written or oral, with respect to any
Acquired Technology, (ii) there are no claims pending or, to the Knowledge of the Seller Parties, threatened, with respect to any such warranty, (iii) to the Knowledge of the Seller Parties, there exists no valid basis for any such claims
and (iv) the Seller Parties have determined that, under GAAP, the appropriate reserve for warranty expense related to the Business is $0. 
 (b) Product Liability. Except as set forth in Schedule 3.14(b) of the Company Disclosure Schedule, there have been no product liability claims, suits, actions or proceedings involving any Seller Party or KNE
relating to the Acquired Technology nor, to the Knowledge of the Seller Parties, has any such claim, suit, action or proceeding been threatened. 
 3.15 Financial Information. Schedule 3.15 of the Company Disclosure Schedule sets forth the aggregate U.S. and international sales of the Business, by each product included in the Acquired Technology and by month during
the period beginning on July 1, 2006 and ending on March 31, 2008 (collectively, the “Financial Information”). The Financial Information is true and correct, in all material respects, and has been prepared in
accordance with the books and records of the Seller Parties and KNE, which books and records have been maintained in a manner consistent with past practice 
 3.16 Receivables. Except as set forth in Schedule 3.16 of the Company Disclosure Schedule, all of the Trade Receivables arose out of bona fide, arms-length transactions for the sale of goods or
the performance of services in the ordinary course of the Business, and all such Trade Receivables are good and collectible (or have been collected) in the ordinary course of the Business in accordance with their terms, and at the aggregate recorded
amounts thereof, using normal collections practices. Except as set forth in Schedule 3.16 of the 

  

 41 

 
Company Disclosure Schedule, none of such receivables is or was subject to any counterclaim or set off, including any recourse from customers of the
Business. Since November 30, 2007, there has not been a material change in the aggregate amount of the Trade Receivables of any Seller Party or a material adverse change in the aging thereof with respect to the Business. None of the Seller
Parties has any outstanding sales on approval or other contingent sales with respect to the Business. 
 3.17 Inventory. Except as set
forth in Schedule 3.17 of the Company Disclosure Schedule, the Inventory (a) was acquired or produced in the ordinary course of the Business, (b) is in the physical possession of the Seller Parties or KNE or in transit to or
from a customer or supplier of the Seller Parties, (c) has not been pledged as collateral or otherwise is subject to any Lien and is not held on consignment from others and (d) is good, undamaged, non-obsolete and merchantable and is of a
quality and quantity presently useable and saleable in the ordinary course of the Business, consistent with industry custom and business practices. The Inventory is not excessive in kind or amount as slow moving, in the light of the business of the
Seller Parties and KNE has done or expected to be done. Items of below-standard quality, damaged items and items not readily saleable in the ordinary course of business have been written down in value in accordance with GAAP. The value at which the
Inventory is carried on the books of the Seller Parties reflects the lower of cost (on an average costing basis methodology) or market, and is based on quantities determined by physical count, all in accordance with GAAP. 
 3.18 Disclosure. None of this Agreement, the Company Disclosure Schedule, any Schedule, Exhibit or certificate or other instrument delivered or to
be delivered pursuant to this Agreement or any other Transaction Document contains or will contain any untrue statement of a material fact, or omits or will omit any statement of a material fact necessary to make the statements contained herein or
therein not misleading. 
 3.19 No Brokers. Except as set forth on Schedule 3.19 of the Company Disclosure Schedule, no
Seller Party is obligated for the payment of fees or expenses of any broker or finder in connection with the origin, negotiation or execution of this Agreement or in connection with any transaction contemplated hereby. 
 3.20 Distributors. Schedule 3.20 of the Company Disclosure Schedule contains a list of distributors of the Business. The Seller
Parties have made available to the Purchaser full and complete copies of all distribution Contracts with the distributors set forth on Schedule 3.20 of the Company Disclosure Schedule. Since June 30, 2006, no distribution
relationship with any Seller Party for the Business or KNE has been terminated (whether by distributor or by a Seller Party or KNE) and no distributor of any Seller Party for the Business or KNE has notified any Seller Party or KNE of its intent to
alter its distribution relationship. 
 3.21 Entire Business. Except for the Excluded Assets, the Acquired Assets, when utilized by a
labor force substantially similar to that employed by the Seller Parties in connection with the Business, are adequate to conduct the Business in all material respects as currently conducted. 
 3.22 Labor Matters of KNE. 
  

 42 

 (a) Schedule 3.22(a) of the Company Disclosure Schedule contains a true and complete list
of the managing directors and all employees of KNE as of the date hereof setting forth their name, their functions, date of employment, salaries, maximum amount of performance-related payments, sales or profit participations and all rights and other
benefits which are in excess of the statutory minimum requirements (including with respect to notice periods). True and complete copies of the managing directors’ service agreements and the employees’ employment agreements have been made
available to the Purchaser by virtue of having been posted on the electronic data room for at least three (3) days prior to the execution of this Agreement. As of the date hereof, no notice of termination of the employment of any employee has
been given nor does KNE or, to the Knowledge of the Seller Parties or of the managing directors of KNE, any employee intend to terminate such employment. Neither KNE nor, to the Knowledge of the Seller Parties or of the managing directors of KNE,
any employee is in breach of the terms of employment. KNE does not employ any free-lancers or consultants. None of KNE’s employees enjoys special dismissal protection (Sonderkündigungsschutz) including, without limitation, due to
severe disability, maternity leave, parental leave, works council membership, old-age part-time, etc. 
 (b) No works council
(Betriebsrat) exists at KNE. KNE is not a party to or obligated with respect to any collective bargaining agreements or contracts with any labor union or other representative of employees (including any works council (Betriebsrat)) and
is not bound by or obligated under any standard practices (betriebliche Übung), collective grants (Gesamtzusagen), social plans (Sozialpläne) or equalization of interest agreements (Interessenausgleiche). Except
for mandatory benefit schemes under applicable law KNE is not bound by any commitment (whether vested or non-vested) to pay any pension (including retirement and early-retirement payments, disablement pensions, pensions for surviving dependants to
any current or former managing directors or employees) or to make any contributions with respect to any retirement, death, sickness, disability or medical benefits for any of its current or former managing directors or employees. 
 (c) Except as set forth on Schedule 3.22(a) of the Company Disclosure Schedule, no stock option plans and profit participation plans under
which KNE has or will have any Liability apply to any current or former managing director or employee of KNE and no loans have been granted by KNE to any such managing directors or employees. Neither the Seller Parties nor KNE has granted or
promised to any managing director or employee any payment or benefit which will become payable or arise as a result of the transactions contemplated under this Agreement. 
 (d) No strike or union organizational activity has occurred with respect to KNE or is pending or, to the Knowledge of the Seller Parties, threatened against KNE. Except as set forth on Schedule 3.22(d)
of the Company Disclosure Schedule, there is not currently pending against KNE, nor has there been pending against KNE at any time, any allegation, claim, charge or complaint of an unfair labor practice, or of employment discrimination,
harassment or retaliation, denial of leave time or benefits or breach of contract. To the Knowledge of the Seller Parties, no employee has, in connection with his or her performance of services on behalf of KNE, breached any restrictive covenant or
any other obligation that he or she owes to any third party. Except as set forth on Schedule 3.22(d) of the Company Disclosure 

  

 43 

 
Schedule, no employee of KNE is currently on short-term disability or long-term disability or on any other leave of absence. 
 3.23 KNE Balance Sheet. The KNE Balance Sheet was prepared in accordance with GAAP and in a manner consistent with the past practices used in the
preparation of the accounts for the preceding financial year (including the consistent use of any discretionary rights – Bilanzierungs- und Bewertungswahlrechte). The KNE Balance Sheet is true and correct and gives a true and fair
view of the financial condition, assets and liabilities and results of operation of KNE as of the date specified therein and for the periods covered by such statement in conformity with GAAP applied consistently. There are no facts which would
require a change of the KNE Balance Sheet, if such facts had been known at the time when the KNE Balance Sheet was prepared. The KNE Balance Sheet has been prepared in accordance with the books and records of KNE, which books and records have
been maintained in accordance with GAAP and in a manner consistent with past practice. Such books and records are in KNE’s unrestricted possession. 
 3.24 Absence of Undisclosed Liabilities of KNE. KNE does not have any Liabilities arising out of any transaction, series of transactions, action or inaction entered into or occurring on or prior to the date
hereof, or any state of facts or condition existing on or prior to the date hereof, except (a) as and to the extent reflected and accrued for or reserved against in the KNE Balance Sheet; (b) for liabilities and obligations which have
arisen in connection with the operation of KNE’s business after March 31, 2008 in the ordinary course of business consistent with past custom and practice (none of which results from, arises out of, relates to, is in the nature of, or was
caused by any breach of Contract, breach of warranty, tort, infringement or violation of Law by KNE and none of which is, individually or in the aggregate, material); (c) for liabilities specifically delineated on Schedule 3.24 of
the Company Disclosure Schedule, and (d) for any executory obligations arising under any KNE Contract that do not arise from or relate to a breach of such contract. 
 3.25 Assets of KNE. Except as set forth on Schedule 3.25(a) of the Company Disclosure Schedule, KNE has good and valid title to all fixed and current assets reflected in the KNE Balance Sheet
(except for Inventory disposed of in the ordinary course of business consistent with past practice since the date of the KNE Balance Sheet), free and clear of all Liens, except for Permitted Liens. All of KNE’s tangible assets are
(a) suitable for the uses to which they are currently employed, (b) in good operating condition and repair, subject to normal and ordinary wear and tear, (c) regularly and properly maintained, (d) free from any material defects
and (e) adequate and sufficient for all current operations of that portion of the Business operated by KNE. All trade accounts receivable of the KNE which are reflected in the KNE Balance Sheet or which have arisen since the date of the KNE
Balance Sheet have arisen from sales or services made in the ordinary course of business, consistent with past practice. Such accounts receivable are legally existent and will be fully collectible on their respective due dates, except as set forth
on Schedule 3.25(a) of the Company Disclosure Schedule and except to the extent of any specific write-downs or provisions reflected in the KNE Balance Sheet. KNE has good title to, or valid leasehold interests or licenses in, and have
fully available, all assets (whether real, personal, tangible or intangible) required by KNE in order to carry on that portion of the Businesses currently operated by KNE. The working capital of KNE (comprising 

  

 44 

 
inventory and trade accounts receivable minus trade accounts payable) is sufficient and adequate. KNE does not own any real property. 
 ARTICLE IV 
 REPRESENTATIONS AND
WARRANTIES RELATING TO THE PURCHASER 
 The Purchaser hereby represents and warrants to the Seller Parties as follows: 
 4.1 Organization of the Purchaser. The Purchaser is a Delaware corporation, validly existing and in good standing under the Laws of the state of
its organization and has all requisite corporate power to own, lease and operate its property and to carry on its business as now being conducted and is duly qualified or licensed to do business and is in good standing in each jurisdiction where the
concept of good standing exists and in which the nature of its business or ownership or leasing of its properties and assets makes such qualification or licensing necessary. 
 4.2 Authority; No Conflict; Required Filings and Consents. 
 (a) The Purchaser has all requisite corporate power and authority to enter into this Agreement and to consummate the transactions contemplated hereby. The execution and delivery of this Agreement and the consummation
of the transactions contemplated hereby have been duly authorized by all necessary corporate action on the part of the Purchaser. This Agreement has been duly executed and delivered by the Purchaser. This Agreement constitutes, assuming the due
authorization, execution and delivery by the Seller Parties, a valid and binding obligation of the Purchaser, enforceable by the Seller Parties against the Purchaser in accordance with its terms, except to the extent that enforceability may be
limited by applicable bankruptcy, reorganization, insolvency, moratorium or other Laws affecting the enforcement of creditors’ rights generally and by general principles of equity, regardless of whether such enforceability is considered in a
proceeding at law or equity. 
 (b) The execution and delivery by the Purchaser of this Agreement does not, and consummation of the
transactions contemplated by this Agreement will not, (i) conflict with, or result in any violation or breach of any provision of the governing documents of the Purchaser, (ii) violate any Law applicable to the Purchaser, or
(iii) conflict with or result in a breach of, or give rise to a right of termination of or loss of benefit under, or accelerate the performance required by the terms of any judgment, court order or consent decree, or any material agreement to
which the Purchaser is party or constitute a default thereunder. 
 (c) Neither the execution and delivery of this Agreement by the Purchaser
nor the consummation of the transactions contemplated hereby will require any consent, approval, order or authorization of, or registration, declaration or filing with, or notification to any Governmental Entity or any Person, except for such
consents, approvals, orders, authorizations, registrations, declarations and filings as may be required under applicable federal and state securities Laws and the securities Laws of any foreign country. 
 4.3 Capital Resources. The Purchaser has available, or has access to, all necessary funds to consummate all transactions contemplated by the
Transaction Documents. 
  

 45 

 4.4 Litigation. There is no Action pending or, to the Purchaser’s Knowledge, threatened
against the Purchaser (i) which, if adversely determined, could reasonably be expected to adversely affect the Purchaser’s ability to perform hereunder, or (ii) which seeks to enjoin or obtain damages in respect of the transactions
contemplated hereby. 
 4.5 No Brokers. The Purchaser is not obligated for the payment of fees or expenses of any broker or finder in
connection with the origin, negotiation or execution of this Agreement or in connection with any transaction contemplated hereby. 
 4.6
Independent Analysis. The Purchaser has had a reasonable opportunity to ask questions of and receive information and answers from Persons acting on behalf of the Seller Parties concerning the Business and has had an opportunity to conduct a
due diligence investigation of the Company. In entering into this Agreement, the Purchaser has relied upon (i) the express representations and warranties of the Seller Parties set forth in the Agreement (including the Company Disclosure
Schedule), (ii) other express obligations of the Seller Parties that are set forth in this Agreement (including but not limited to covenants) and (iii) the Purchaser’s own due diligence and analysis. The Seller Parties acknowledge
that any investigation, examination, analysis, evaluation or due diligence conducted by the Purchaser or on its behalf shall not limit, prevent or impair any claim or other right or benefit to which the Purchaser may be entitled under this Agreement
nor any claim that the Purchaser may otherwise have for indemnification under Section 9.2 (Indemnification by the Seller Parties). 
 4.7 No Other Representations. The Purchaser acknowledges and agrees that, except as expressly set forth in this Agreement or any other Transaction Document, or in any certificate contemplated hereby or thereby
and delivered by any Seller Party in connection herewith or therewith, neither the Seller Parties nor any of their respective officers, directors, attorneys, financial advisors, agents or other representatives (collectively
“Representatives”) are not making any representation or warranty whatsoever, express or implied, (i) with respect to the Business, the Acquired Assets, the Excluded Assets, the Assumed Liabilities, the Retained
Liabilities, KNE or the transactions contemplated by this Agreement or (ii) as to the accuracy or completeness of any information regarding the Business, the Acquired Assets, the Excluded Assets, the Assumed Liabilities, the Retained
Liabilities or KNE furnished or made available to the Purchaser and its Representatives. Without limiting the generality of the foregoing, the Seller Parties make no express or implied representation or warranty to the Purchaser with respect to:
(a) any projections, estimates, forecasts or budgets heretofore delivered to or made available to the Purchaser of future revenues, expenses or expenditures or future results of operations; (b) except as expressly covered by a
representation or warranty contained in this Agreement or any other Transaction Document, or in any certificate contemplated hereby or thereby and delivered by any Seller Party in connection herewith or therewith, any other information or documents
(financial or otherwise) made available to the Purchaser, any Affiliate thereof or their respective counsel, accountants or advisers, including in certain “data rooms,” management presentations, offering memoranda or in any other form in
contemplation of the transactions contemplated by this Agreement and the Transaction Documents; or (c) merchantability or fitness for a particular purpose. With respect to any projection, estimate, forecast or budget of future revenues,
expenses or expenditures or future results of operations delivered by or on behalf of the Seller Parties, the Purchaser acknowledges that: (w) there are uncertainties inherent in attempting to make such projections, estimates, forecasts or
budgets; 

  

 46 

 
(x) it is familiar with such uncertainties; (y) it is taking full responsibility for making its own evaluation of the adequacy and accuracy of all
such projections and forecasts furnished to it; and (z) it shall have no claim against the Seller Parties with respect thereto. 
 ARTICLE V 
 PRE-CLOSING COVENANTS OF THE SELLER PARTIES 
 5.1 Conduct of Business Prior to the Closing. Except (i) as contemplated by this Agreement, (ii) as described in
Schedule 5.1 of the Company Disclosure Schedule, or (iii) to the extent that the Purchaser shall otherwise consent in writing, during the period from the date hereof until the earlier of the Closing Date and the termination
of this Agreement in accordance with its terms, the Seller Parties shall use commercially reasonable efforts (and shall procure that KNE uses commercially reasonable efforts) to conduct the operations of the Business in the ordinary course of
business consistent with past practice, to preserve intact its and KNE’s current business organizations related to the Business, keep available the service of its and KNE’s current officers and employees necessary to operate the Business
in the ordinary course of business consistent with past practice and to preserve its and KNE’s relationships with customers, suppliers, distributors, lessors, creditors, employees, contractors and others having business dealings with respect to
the Business in the ordinary course of business consistent with past practice. 
 (a) The Seller Parties: Without limiting the generality of
the foregoing, except as otherwise expressly provided in this Agreement and except as described in Schedule 5.1 of the Company Disclosure Schedule, from the date hereof through the Closing Date, the Seller Parties shall not, with
respect to the Business, without the prior written consent of the Purchaser: 
 (i) acquire or agree to acquire by merging or
consolidating with, or by purchasing an equity interest in or portion of the assets of, or by any other manner, any business or any corporation, partnership or other business organization or division, other than any such transaction that does not
involve the Business or the Acquired Assets; 
 (ii) except as permitted by clause (iii)(c) below, (a) purchase, acquire
or lease any material assets that would constitute Acquired Assets other than in the ordinary course of business consistent with past practice or (b) sell, assign, transfer, convey, lease, mortgage, pledge or otherwise dispose of, or subject to
any Lien (other than a Permitted Lien) any Acquired Assets except in the ordinary course of business consistent with past practice and, to the extent not otherwise material (individually or in the aggregate) to the Business, obsolete or worn out
equipment sold or disposed of in a manner consistent with past practice; 
 (iii) (a) enter into any Contract that would
be material to the Business, taken as a whole, (b) amend, modify, terminate or waive any right under any Assumed Contract, or (c) authorize any capital expenditures in respect of the Business that would affect an Acquired Asset or increase
the Assumed Liabilities in excess of $10,000 individually or $50,000 in the aggregate; 
  

 47 

 (iv) transfer or license to any Person or otherwise materially extend, amend or modify
any rights to any Intellectual Property Rights; 
 (v) incur any Liability for long-term interest bearing indebtedness,
guarantee the obligations of others or incur any other Liability, in each case, to the extent such Liability or guarantee would result in an increase in the Assumed Liabilities in excess of $10,000 individually or $50,000 in the aggregate;

 (vi) fail to pay the accounts payable and any debts owed or obligations due to the Business, or pay or discharge any
Liabilities related to the Business, in each case (i) in the ordinary course of business and consistent with past practice, and (ii) excluding any such payables, debts or Liabilities that are disputed by a Seller Party in good faith;

 (vii) fail to use commercially reasonable efforts to maintain the Acquired Assets in substantially their current state of
repair, excepting normal and ordinary wear and tear, or fail to use commercially reasonable efforts to replace inoperable, worn-out or obsolete or destroyed Acquired Assets; 
 (viii) fail to comply in all material respects with all Laws applicable to the Acquired Assets or the Business consistent with past
practice; 
 (ix) fail to use its commercially reasonable efforts to (a) maintain existing relationships with suppliers,
customers and others having business dealings with the Seller Parties relating to the Business in the ordinary course of business and consistent with past practice and (b) otherwise to preserve the goodwill of the Business so that such
relationships and goodwill will be preserved through the Closing in the ordinary course of business consistent with past practice; 
 (x) amend the articles of association of KNE or take any action that would require registration in KNE’s commercial register; 
 (xi) allow any Intellectual Property Rights to lapse or be abandoned prior to Closing without the written consent of the Purchaser; or 
 (xii) take or agree in writing or otherwise to take any of the actions described in Sections 5.1(a)(i) through
5.1(a)(xi). 
 (b) KNE: Without limiting the generality of the foregoing, except as otherwise expressly provided in this
Agreement and except as described in Schedule 5.1 of the Company Disclosure Schedule, from the date hereof through the Closing Date, the Seller Parties shall procure that KNE does not without the prior written consent of the
Purchaser: 
 (i) acquire or agree to acquire by merging or consolidating with, or by purchasing an equity interest in or
portion of the assets of, or by any 

  

 48 

 
other manner, any business or any corporation, partnership or other business organization or division; 
 (ii) declare or pay any dividend, make any other payments or distributions (except for payments in the ordinary course of Business under
arm’s length service or supply agreements disclosed to the Purchaser as a KNE Contract) or grant any loans to the Seller Parties; 
 (iii) factoring of any receivables or asset backed securities transactions; 
 (iv)
(a) purchase, acquire or lease any material assets or (b) sell, assign, transfer, convey, lease, mortgage, pledge or otherwise dispose of, or subject to any Lien (other than a Permitted Lien) any assets, except for inventory in the
ordinary course of business consistent with past practice and, to the extent not otherwise material (individually or in the aggregate) to KNE, obsolete or worn out equipment sold or disposed of in a manner consistent with past practice; 

(v) (a) enter into any Contract that would be material to KNE, (b) amend, modify, terminate or waive any right under any KNE
Contract (other than in connection with the German Contract Condition), or (c) authorize any capital expenditures in respect of the Business that would affect an increase the KNE’s liabilities in excess of $2,000 individually or $10,000 in
the aggregate; 
 (vi) transfer or license to any Person or otherwise materially extend, amend or modify any rights to any
Intellectual Property Rights; 
 (vii) incur any Liability for interest bearing indebtedness, guarantee the obligations of
others or incur any other Liability, in each case, to the extent such Liability or guarantee is in excess of $2,000 individually or $10,000 in the aggregate; 
 (viii) fail to pay any accounts payable and any debts owed, or fail to pay or discharge any other Liabilities when due, except for any
such payables, debts or Liabilities that are disputed by KNE in good faith; 
 (ix) fail to use commercially reasonable
efforts to maintain its assets in substantially their current state of repair, excepting normal and ordinary wear and tear, or fail to use commercially reasonable efforts to replace inoperable, worn-out or obsolete or destroyed assets; 

(x) request any advance payments on its account receivables or any other advance payments from its other creditors outside the ordinary
course consistent with past practice or take any other action that would result in an inflation of KNE’s “cash and cash equivalents” as of the Closing Date that would be inconsistent with past practice; 
  

 49 

 (xi) hire or promote any employees or managing directors or change the compensation or
benefits of any employee or managing director; 
 (xii) make any lay-offs or other restructuring affecting its employees or
managing directors; 
 (xiii) change its accounting methods and policies; 
 (xiv) fail to comply in all material respects with all applicable Laws; 
 (xv) fail to use its commercially reasonable efforts to (a) maintain existing relationships with suppliers, customers and others
having business dealings with KNE in the ordinary course of business and consistent with past practice and (b) otherwise preserve the goodwill of KNE’s business so that such relationships and goodwill will be preserved through the Closing
in the ordinary course of business consistent with past practice; 
 (xvi) allow any Intellectual Property Rights to lapse or
be abandoned prior to Closing without the written consent of the Purchaser; or 
 (xvii) take or agree in writing or otherwise
to take any of the actions described in Sections 5.1(b)(i) through 5.1(b)(xvi). 
 Notwithstanding anything to the contrary set
forth herein, in no event shall any effect, matter, action or inaction arising out of or related to the announcement of the transactions contemplated by this Agreement and the Transaction Documents constitute a breach by any Seller Party of any
representation or warranty contained in this Agreement, or of this Section 5.1. 
 5.2 Access to Information. Until
the Closing, the Seller Parties shall allow the Purchaser and its agents and representatives reasonable access during normal business hours upon reasonable notice to the books, records, representatives, employees, agents and offices, and customers,
vendors and suppliers of the Business, and shall furnish the Purchaser and its representatives all financial, operating and other data and information with respect to the Acquired Assets or the Business as the Purchaser or its Affiliates, through
their respective representatives, may reasonably request. All such access shall be subject to the terms of the Confidentiality Agreements, which agreements shall continue in full force and effect in accordance with their respective terms.

 5.3 Satisfaction of Conditions Precedent. The Seller Parties shall use their reasonable best efforts to satisfy or cause to be
satisfied all the conditions precedent that are set forth in Section 7.2 (Conditions Precedent to Obligations of the Purchaser), and to deliver, or cause to be delivered, to the Purchaser, those documents set forth in
Section 2.1(c). The Purchaser shall use its reasonable best efforts to satisfy or cause to be satisfied all the conditions precedent that are set forth in Section 7.1 (Conditions Precedent to Obligations of the
Seller Parties), and shall deliver, or cause to be delivered, to the Company, those documents set forth in Section 2.1(b). 
  

 50 

 5.4 No Solicitation. 
 (a) From the date hereof until the earlier of the Closing or the termination of this Agreement pursuant to Section 8.1 (Termination) hereof, the Seller Parties will not, and will not permit or cause
any of their officers, directors, employees, investment bankers, consultants and other agents or representatives to, directly or indirectly, take any action to solicit, initiate, encourage, respond to or facilitate the making of any Acquisition
Proposal (as defined below) or any inquiry with respect thereto or engage in discussions or negotiations with or furnish any information to any Person (other than the Purchaser, the Purchaser’s Affiliates and counsel or other representatives of
any of the foregoing) with respect thereto, or otherwise assist or participate in or facilitate or cooperate with in any other manner any effort or attempt by any Person that has made or, to the Knowledge of the Seller Parties, is contemplating
making any Acquisition Proposal. 
 (b) For purposes of this Agreement, “Acquisition Proposal” means any bona fide
offer or proposal for, or any indication of interest in, (i) a merger or other business combination involving the Business, (ii) the acquisition of the equity in KNE or (iii) the acquisition of all or any portion of the Acquired
Assets (excluding sales and other dispositions of Inventory in the ordinary course of business and obsolete or worn out equipment sold in a manner consistent with past practice which was not otherwise material (individually or in the aggregate) to
the Business), in one transaction or series of related transactions, in each case other than the transactions contemplated by this Agreement. 
 (c) The Seller Parties shall immediately cease and cause their representatives to cease any existing activities, discussions or negotiations with any Person conducted heretofore with respect to any actual or potential Acquisition Proposal.

 (d) If any Seller Party receives after the date of this Agreement and prior to the earlier of the Closing Date or the termination of this
Agreement, any offer or proposal relating to an Acquisition Proposal, the Company shall promptly notify the Purchaser that such an offer or proposal was made, and unless such offer or proposal is the subject of any confidentiality or non-disclosure
obligations existing on or prior to the date hereof, notify the Purchaser as to the identity of the offeror or the Person making any such offer or proposal or the specific material terms of such offer or proposal, as the case may be. 
 5.5 Notification. The Company shall notify the Purchaser in writing of the existence or happening of any fact, event or occurrence that is
discovered, arises or comes into existence after the date hereof, which should be included in the Company Disclosure Schedule in order to make the representations and warranties set forth in Article III true and correct in all material
respects as of the Closing Date (each such additional written disclosure, a “Company Disclosure Schedule Supplement”), it being understood and agreed that the delivery of such information shall not be deemed to amend or
otherwise modify the Company Disclosure Schedule delivered on the date hereof or the representations and warranties contained herein or otherwise have any effect on the satisfaction of the conditions to Purchaser’s obligations to close
hereunder; provided, however, that in determining after the Closing Date whether there is a breach of any representation or warranty contained in Article III for the purposes of the 

  

 51 

 
indemnification to be provided by the Seller Parties pursuant to Article IX, such representation or warranty shall be qualified by any
information provided pursuant to this Section 5.5. 
 5.6 Consents and Notifications. During the period from the
date hereof until the earlier of the Closing Date or the termination of this Agreement in accordance with its terms, the Seller Parties shall take all reasonably necessary steps to prepare and file, as promptly as practicable after the date hereof,
all documentation to effect all required notices, reports and other filings to any Governmental Entity (including, without limitation, notified bodies designated by the member states of the European Union and the European Free Trade Association),
and to take all reasonably necessary steps to obtain, as promptly as practicable after the date hereof, all consents and Permits required to be obtained by the Seller Parties from any such Governmental Entity, as necessary to consummate this
transaction and as necessary to permit the Purchaser to continue to operate the Business in the ordinary course of business consistent with past practice after the Closing. 
 ARTICLE VI 
 CERTAIN COVENANTS AND AGREEMENTS 
 6.1 Confidentiality. 
 (a) From the
Closing Date, the Seller Parties shall maintain, and shall cause their Affiliates (collectively, the “Confidentiality Parties”) to maintain, the confidentiality of all proprietary information relating to the Business,
including information relating to the technical, manufacturing or marketing information, ideas, methods, developments, inventions, improvements, business plans, trade secrets, scientific or statistical data, diagrams, drawings, specifications or
other proprietary information relating thereto, together with all analyses, compilations, studies or other documents, records or data prepared by the Seller Parties or the Purchaser or their respective Representatives which contain or otherwise
reflect or are generated from such information (“Confidential Information”), except to the extent that such information (i) is in the public domain other than as a result of a breach of this Agreement by the
Confidentiality Parties, or (ii) is required by Law to be disclosed; provided, that the Seller Parties comply with the provisions set forth in Section 6.1(c) hereof or (iii) being disclosed by or on behalf of the
Seller Parties in connection with any Action pursuant to which the Seller Parties seek to enforce their rights or remedies under this Agreement or any of the other documents, agreements, Contracts or certificates executed or delivered in accordance
with the term hereof or otherwise contemplated hereby. 
 (b) The obligations of the Seller Parties pursuant to this
Section 6.1 shall remain in effect for a period of five (5) years from the Closing. 
 (c) If any of the Seller
Parties or any Affiliate thereof is requested or required (by oral questions, interrogatories, requests for information or documents in legal proceedings, subpoena, civil investigative demand or other similar process, but excluding any Action to
enforce the rights of the Seller Parties under this Agreement or any of the other documents, agreements, Contracts or certificates executed or delivered in accordance with the term hereof or otherwise contemplated hereby) or is required by operation
of law to disclose any Confidential 

  

 52 

 
Information, the Company shall provide the Purchaser with prompt written notice of such request or requirement, which notice shall, if practicable, be at
least seventy-two (72) hours prior to making such disclosure, so that the Purchaser may seek a protective order or other appropriate remedy and/or waive compliance with the provisions of this Agreement. If, in the absence of a protective order
or other remedy or the receipt of such a waiver, any Seller Party determines, upon the advice of counsel, that such Seller Party is legally compelled to disclose Confidential Information, then such Seller Party may disclose that portion of the
Confidential Information which such counsel advises is legally required to be disclosed, provided, that such Seller Party uses its reasonable efforts to preserve the confidentiality of the Confidential Information, whereupon such disclosure
shall not constitute a breach of this Agreement. 
 (d) In the event of a breach of any provision of this Section 6.1, the
Purchaser may, in addition to other rights and remedies existing in its favor, apply to any court of competent jurisdiction for specific performance and injunctive relief in order to enforce or prevent any violation of such provisions. 

6.2 No Public Announcement. Each of the parties hereto shall consult with the other parties before issuing any press releases or otherwise
making any public statements with respect to this Agreement and the transactions contemplated hereby, and each of the parties shall not issue any such press release or make any such public statement without the express written consent of the other
parties, unless the release of such information is required by applicable Law. Notwithstanding the foregoing, each of the Purchaser and the Company shall be entitled to make a public announcement regarding the transactions contemplated hereby if
such party deems it reasonably necessary or appropriate to fulfill its obligations as a public company; provided, however, that with respect to such party’s first public announcement of this Agreement and/or the transactions
contemplated hereby, such party shall provide the other of such parties with a copy of such announcement at least twenty-four (24) hours prior to the announcement being publicized and shall in good faith consider any proposed changes thereto
reasonably requested by the other of such parties. 
 6.3 Further Assurances. Each party hereto agrees to cooperate fully with the
other parties and to execute such further instruments, documents and agreements and to give such further written assurances, as may be reasonably requested by any other party to better evidence and reflect the transactions described herein and
contemplated hereby and to carry into effect the intents and purposes of this Agreement. The Seller Parties shall take all actions reasonably necessary or required to be taken for the procurement, maintenance, enforcement and defense of the Patent
Rights. 
 6.4 The Purchaser’s Financial Statements. From and after the date hereof, upon the Purchaser’s request and at the
Purchaser’s expense, the Seller Parties shall cooperate with the Purchaser and such independent auditor as the Purchaser shall designate with respect to the preparation of such financial statements relating to the Business as the Purchaser
shall be required to file under Regulation S-X under U.S. federal securities Laws. 
 6.5 Use of Names. Following the Closing, the
Seller Parties and their Affiliates will not use the name “ThromCat”, “QuickCat”, “Safe-Cross” or any variations thereof, or any trademark, trade name or name or brand name relating thereto, or any variation or 

  

 53 

 
combination thereof; provided, however, that the Seller Parties and their Affiliates may indicate that they developed such products so long as in connection
with any such indication, they disclose Purchaser, or such other party as Purchaser may designate, as the owner of any Trademark Rights included therein. 
 6.6 Tax Matters. 
 (a) To the extent the Purchaser and the Seller Parties reasonably agree the same
are required, the Seller Parties shall use their commercially reasonable efforts to procure and provide the Purchaser with such clearance certificates or other documents as the Purchaser reasonably determines are required by any state taxing
authority to relieve the Purchaser of any obligation to withhold any portion of the payments to the Seller Parties pursuant to this Agreement. 
 (b) In the case of Taxes of KNE that are payable with respect to a Straddle Period, the portion of any such Tax that is allocable to Pre-Closing Tax Period shall be (A) in the case of Taxes that are (x) based upon or related to
income or receipts of KNE or (y) employment, social security or other similar Taxes of KNE, deemed equal to the amount which would be payable if the taxable year ended on the date immediately prior to the Closing Date; and (B) in the case
of Taxes imposed on a periodic basis with respect to any assets or otherwise measured by the level of any item (including, for the avoidance of doubt, all Property Taxes imposed with respect to the Assets) deemed to be the amount of such Taxes for
the entire period (or, in the case of such Taxes determined on an arrears basis, the amount of such Taxes for the immediately preceding period) multiplied by a fraction the numerator of which is the number of calendar days in the period ending on
the date immediately prior to the Closing Date and the denominator of which is the number of calendar days in the entire period. To the extent permitted by or required under Applicable Law, the Seller Parties and the Purchaser shall elect to treat
the Tax year of KNE as ending on the date immediately prior to the Closing Date. 
 (c) The Seller Parties shall be responsible for and shall
promptly pay when due all Property Taxes levied with respect to the Acquired Assets attributable to the Pre-Closing Tax Period, and the Purchaser shall be responsible for and shall promptly pay when due all Property Taxes levied with respect to the
Assets attributable to the Post-Closing Tax Period. All Property Taxes levied with respect to the Acquired Assets for the Straddle Period shall be apportioned between the Pre-Closing Tax Period and the Post-Closing Tax Period, as follows: the
portion allocable to the Pre-Closing Tax Period shall be deemed to be the amount of such Tax for the entire Straddle Period multiplied by a fraction the numerator of which is the number of days in the Tax period ending on the day before the Closing
Date and the denominator of which is the number of days in the entire Straddle Period. Upon receipt of any bill for such Property Taxes relating to the Acquired Assets, the Purchaser, on one hand, and the Seller Parties, on the other hand, shall
present a statement to the other setting forth the amount of reimbursement to which each is entitled under this Section 6.6(c) together with such supporting evidence as is reasonably necessary to calculate the proration amount.
The proration amount shall be paid by the party owing it to the other within ten (10) days after delivery of such statement. In the event that the Purchaser or the Seller Parties shall make (or has made) any payment for which it is entitled to
reimbursement under this Section 6.6(c), the applicable party shall make such reimbursement promptly but in no event later than ten (10) days after the 

  

 54 

 
presentation of a statement setting forth the amount of reimbursement to which the presenting party is entitled along with such supporting evidence as is
reasonably necessary to calculate the amount of reimbursement. 
 (d) Purchaser shall prepare or cause to be prepared and file or cause to be
timely filed all Tax Returns for KNE that are due on or after the Closing Date that include any Pre-Closing Tax Period (together, the “Purchaser’s Returns”). Each Purchaser’s Return shall be prepared in accordance
with the past practice of KNE in preparing its Tax Returns, provided such past practice is consistent with applicable Law, and the applicable Law and Purchaser shall provide the Seller Parties with a draft copy of each such Purchaser’s Return
(and, in the case of any Purchaser’s Return that includes a Straddle Period, a statement setting forth the allocation of Taxes reflected on such Purchaser’s Return to the Pre-Closing Period in accordance with the principles set forth in
Section 6.6(b) (an “Allocation Statement”)) for review no later than thirty (30) days before the due date of such Purchaser’s Return (taking into account any properly obtained extensions). If the
Purchaser and the Seller Parties fail to resolve any dispute with respect to any Purchaser’s Return or related Allocation Statement provided by Purchaser to the Seller Parties within fifteen (15) days after receipt of such Purchaser’s
Return and related Allocation Statement by the Seller Parties, then any such disputed matter shall be submitted to and resolved by a mutually agreed nationally recognized in Germany independent accounting firm (the “Independent Accounting
Firm”). The Independent Accounting Firm shall be directed to render a written report on the unresolved disputed issues as promptly as practicable, but in no event greater than ten (10) days after such submission to the Independent
Accounting Firm, and limit its review to the unresolved issues. The resolution of any dispute by the Independent Accounting Firm shall be final and binding on the Purchaser and the Seller Parties. The fees and expenses of the Independent Accounting
Firm shall be allocated between the Purchaser and the Seller in the proportion that the amounts determined by the Independent Accounting Firm against each party bear to the total amount in dispute (determined with respect to dollar amount).

 (e) Purchaser shall not, and shall not permit any of its Affiliates to, (i) make any election under Section 338(g) of the Code
with respect to the acquisition of the KNE Interests contemplated by this Agreement, (ii) make any election under Treasury Regulation 301.7701-3 with respect to KNE effective on or before the Closing Date, or (iii) without the prior
written consent of the Sellers Parties, which such consent shall not be unreasonably withheld (except in the event such action could result in a claim for indemnification by the Purchaser against the Seller Parties, then without the prior written
consent of the Seller Parties): (y) file, re-file, or amend any Tax Return for KNE that was due before the Closing Date or (z) amend any Purchaser’s Return prepared and filed pursuant to Section 6.6(d). 

(f) Purchaser and its Affiliates, on the one hand, and the Seller Parties, on the other hand, shall cooperate fully, as and to the extent reasonably
requested by the other party, in connection with the filing of Tax Returns pursuant to Section 6.6(d) and any audit, litigation or other proceeding with respect to Taxes relating to the Acquired Assets. Such cooperation shall
include the retention and (upon the other party’s request) the provision of records and information that are reasonably relevant to any such audit, litigation or other proceeding and making employees available on a mutually convenient basis to
provide additional information and explanation of any material provided hereunder. The Seller Parties and Purchaser agree to 

  

 55 

 
(A) to retain all books and records with respect to Tax matters pertinent to the Acquired Assets relating to any taxable period beginning before the Closing
Date until the expiration of the statute of limitations (and, to the extent notified by Purchaser or the Seller Parties, any extensions thereof) of the respective taxable periods, and to abide by all record retention agreements entered into with any
Tax authority, and (B) to give the other party reasonable written notice prior to transferring, destroying or discarding any such books and records and, if the other party so requests, the Purchaser and its Affiliates or the Seller Parties, as
the case may be, shall allow the other party to take possession of such books and records. 
 (g) Each Seller Party shall deliver to the
Purchaser at Closing a certificate of non-foreign status (in such form as reasonably requested by Purchaser) conforming to the requirements of Section 1.1445-2(b)(2) of the United States Treasury Regulations. Purchaser and the Seller Parties
further agree, upon request, to use their commercially reasonable efforts to obtain any certificate or other document from any governmental authority or any other Person as may be necessary to mitigate, reduce or eliminate any Tax that could be
imposed (including, but not limited to, with respect to the transactions contemplated hereby). 
 (h) All tax-sharing agreements or similar
agreements with respect to or involving KNE, on one hand, and the Seller Parties and their Affiliates (other than KNE), on the other hand, shall be terminated as of the Closing and, after the Closing, KNE shall not be bound thereby or have any
liability or claim for benefit thereunder. 
 (i) Purchaser shall pay the Seller Parties any Tax refunds received by the Purchaser or its
Affiliates with respect to Taxes of the KNE for all Pre-Closing Tax Periods within fifteen (15) business days of receipt of any such Tax refund. Any such payments shall be treated as an adjustment to the Final Base Purchase Price. 

(j) The Purchaser shall promptly notify the Seller Parties, in writing upon receipt of notice of any pending or threatened federal, state, local or
foreign Tax audits or assessments relating to the income, properties or operations of the Seller Parties that reasonably may be expected to result in a claim for indemnification under this Agreement (each, a “Tax Claim”).
Purchaser’s failure to notify the Seller Parties of a Tax Claim will not relieve any of the Seller Parties of any liability that they may have, except to the extent the defense of such Tax Claim is prejudiced by Purchaser’s failure to give
such notice. Such notice shall include a copy of the relevant portion of any correspondence received from the relevant Tax authority. The Seller Parties may elect within ten (10) days of receiving notice of a Tax Claim to represent the
Purchaser or any of its Affiliates in any such Tax Claim, and to employ counsel of their choice at their expense, provided that the Seller Parties may not agree to settle any Tax Claim without Purchaser consent, which consent shall not be
unreasonably conditioned, withheld or delayed. If Purchaser unreasonably refuses to give its consent to any proposed settlement, then the Seller Parties liability under this Agreement with respect to such Tax Claim shall be limited to the aggregate
amount of the proposed settlement. If the Seller Parties choose to direct a Tax Claim, Purchaser shall (i) cause powers of attorney authorizing the Seller Parties to represent the Purchaser or its Affiliates, as the case may be, before the
relevant Tax authority and such other documents as are reasonably necessary for the Seller Parties to control the conduct of any such Tax Claim and (ii) have the right to participate in the Tax Claim at its own expense (which expense shall not
be deemed a Loss for purposes of this Agreement). In the event of any conflict 

  

 56 

 
between the provisions of this Section 6.6(j) and Section 9.4, this Section 6.6(j) shall govern.
Notwithstanding the foregoing, if any issue raised in a Tax Claim could have an impact on the Taxes of the Purchaser, KNE, the Business or the Acquired Assets for any Post-Closing Tax Period, then the Purchaser shall have the opportunity to jointly
control the conduct and resolution of the portion of such Tax Claim which could have an impact on such Taxes for any Post-Closing Tax Period. 
 6.7 Sales and Marketing Efforts. The Purchaser agrees and acknowledges that it will use commercially reasonable efforts to market and sell the Acquired Technology. 
 6.8 Employees of KNE. Immediately prior to the Closing, the Seller Parties shall cause KNE to give, without undue delay, notice of termination to
up to five (5) employees and/or two (2) managing directors of KNE as may be indicated by the Purchaser to the Seller Parties in writing no later than five Business Days prior to the Closing Date (the employees and/or managing directors so
indicated herein referred to as the “KNE Lay-Off Employees” and any other current or former employees and/or managing directors which are not KNE Lay-Off Employees hereinafter referred to as the “KNE Other
Employees”). In addition, the Seller Parties shall cause KNE to give, without undue delay, notice of termination under any contracts to which KNE is party in respect of the employment of the KNE Lay-Off Employees, including without
limitation contracts relating to car leases and cell phones (“KNE Lay-Off Employee Ancillary Contracts”). 
 6.9
Processing Agreement. The Company and the Purchaser agree to use their commercially reasonable efforts to amend the Processing Agreement following the Closing and prior to the expiration of the QuickCat Manufacturing Period (as defined in the
Manufacturing and Licensing Agreement) in order to meet the specifications of each of the Company and the Purchaser for the services to be provided under the Processing Agreement following the expiration of the QuickCat Manufacturing Period.

 6.10 Pending Applications. The Company shall complete the application procedures for any applications or Permits pending as of the
date hereof related to the Acquired Technology. 
 ARTICLE VII 
 CONDITIONS TO CLOSING 
 7.1 Conditions Precedent to Obligations of the Seller
Parties. The obligation of the Seller Parties to consummate the transactions contemplated by this Agreement shall be subject to the fulfillment or waiver, at or prior to the Closing, of each of the following conditions: 
 (a) Representations and Warranties; Covenants. (i) The representations and warranties of the Purchaser contained in this Agreement shall be true and
correct in all material respects as of the Closing as if made on the Closing Date (other than those representations and warranties that are qualified as to materiality which shall be true and correct in all respects and other than those
representations and warranties made as of another date, which representations and warranties shall have been true and correct as of such date); (ii) the covenants contained in 

  

 57 

 
this Agreement to be complied with by the Purchaser on or before the Closing shall have been complied with in all material respects; and (iii) the
Seller Parties shall have received a certificate of the Purchaser to such effect signed by a duly authorized executive officer. 
 (b) No
Governmental Order; Legal Proceedings. No federal, state or local law, ordinance, rule, regulation or order shall have been enacted or promulgated and no preliminary or permanent injunction or other order issued by any Governmental Entity shall
be in effect, nor shall there be pending, or threatened, any action, suit or proceeding before any Governmental Entity, that would restrain, enjoin or otherwise prohibit the consummation of the transactions contemplated hereby or materially
adversely affect the ability of the Purchaser to conduct the Business following the Closing substantially as it currently is being conducted. 
 (c) Ancillary Agreements. The Purchaser shall have executed and delivered to the Seller Parties the agreements and instruments referred in Section 2.1(b) of this Agreement. 
 7.2 Conditions Precedent to Obligations of the Purchaser. The obligations of the Purchaser to consummate the transactions contemplated by this
Agreement shall be subject to the fulfillment or waiver, at or prior to the Closing, of each of the following conditions: 
 (a)
Representations and Warranties; Covenants. (i) The representations and warranties of the Seller Parties contained in this Agreement shall be true and correct in all material respects as of the Closing as if made on the Closing Date
(other than those representations and warranties that are qualified as to materiality which shall be true and correct in all respects and other than those representations and warranties made as of another date, which representations and warranties
shall have been true and correct as of such date); (ii) the covenants contained in this Agreement to be complied with by the Seller Parties on or before the Closing shall have been complied with in all material respects; and (iii) the
Purchaser shall have received a certificate of the Seller Parties to such effect signed by a duly authorized executive officer of each of the Seller Parties. 
 (b) No Governmental Order; Legal Proceedings. No federal, state or local law, ordinance, rule, regulation or order shall have been enacted or promulgated and no preliminary or permanent injunction or other
order issued by any Governmental Entity shall be in effect, nor shall there be pending, or threatened, any action, suit or proceeding before any Governmental Entity that would restrain, enjoin or otherwise prohibit the consummation of the
transactions contemplated hereby. 
 (c) No Material Regulatory Issue or Force Majeure Event. Between the date hereof and the Closing
Date, there shall have been no Material Regulatory Issue or Force Majeure Event. 
 (d) Ancillary Agreements. The Seller Parties
and/or their Affiliates, as applicable, shall have executed and delivered, or caused to be executed and delivered, to the Purchaser the agreements and instruments referred to in Section 2.1(c) of this Agreement. 
 (e) Approvals. All consents, authorizations and approvals, waivers or exemptions, and filings and registrations, required to be obtained from or
made with any Person in connection with the execution, delivery and performance by the Seller Parties of this 

  

 58 

 
Agreement and each document to be executed and delivered by the Seller Parties pursuant to this Agreement or in connection with the transactions contemplated
hereby and the consummation by the Seller Parties of the transactions contemplated hereby and thereby shall have been obtained or made, including all such consents, authorizations and approvals set forth in Schedule 5 of the Company
Disclosure Schedule or otherwise required under Section 5.6, and all required filings shall have become effective. 
 (f)
KNE Contracts. The Company and KNE shall have terminated the Agreement for Services and the Commissionaire Agreement. The Purchaser, the Company and/or KNE shall have entered into a new agreement similar to the Agreement for Services which
appoints KNE as the Authorized Representative (as defined in the Agreement for Services) of KNC for so long as the Products (as defined in the Manufacturing and License Agreement) are sold under the Company’s name until such time as the
Purchaser has obtained the necessary Permits to sell such Products under the Purchaser’s name, at which point, KNE shall be appointed as the Authorized Representative of the Purchaser. Notwithstanding the foregoing, in the event that the
parties have failed to enter into such new agreement similar to the Agreement for Services, the Seller Parties shall be deemed to have satisfied the conditions set forth in this Section 7.2(f) so long as they have worked in
good faith with the Purchaser to enter into such agreement and offered and attempted to enter into such agreement on terms that a reasonable person would find to be commercially reasonable under the circumstances. 
 ARTICLE VIII 
 TERMINATION AND
AMENDMENT 
 8.1 Termination. This Agreement may be terminated at any time prior to the Closing: 
 (a) by mutual written consent of the Purchaser and the Seller Parties; and 
 (b) by the Seller Parties or the Purchaser if the Closing shall not have occurred on or before June 30, 2008. 
 8.2 Effect of Termination. In the event of termination of this Agreement as provided in Section 8.1, this Agreement shall immediately become void and have no effect and there shall be no liability or obligation on
the part of the Purchaser, any Seller Party or their respective officers, directors, stockholders, members, or Affiliates, except that (a) in the case of any breach arising prior to such termination, the rights and remedies hereunder with
respect thereto shall survive any such termination and continue in full force and effect and (b) the provisions of Section 6.1, Article VIII and Article X of this Agreement shall survive any such
termination and continue to be and remain in full force and effect. 
 8.3 Fees and Expenses. All fees and expenses incurred in
connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring such expenses, whether or not the transactions contemplated hereby are consummated. 
  

 59 

 ARTICLE IX 
 INDEMNIFICATION 
 9.1 Survival of Representations, Etc. All of the representations and
warranties made by each party in this Agreement or in any attachment, exhibit, schedule, certificate, document or list delivered by any such party pursuant hereto shall survive the Closing for a period equal to eighteen (18) months, except that
claims based upon or arising out of representations and warranties contained in Sections 3.1 (Organization), 3.2(a) (Authority), 3.3 (Tax Matters), 3.5 (Title to Property and Assets),
3.6(c)(iii) (Sufficiency of Intellectual Property Rights) and 3.10 (Health Care Compliance) hereof shall survive the Closing for the relevant statute of limitations, including any extensions thereof. No investigation made
by any of the parties hereto shall in any way limit the representations and warranties of the parties. Each party hereto shall be entitled to rely upon the representations and warranties of the other parties set forth in this Agreement. The
termination of the representations and warranties provided herein shall not affect the rights of a party in respect of any claim made by such party in a writing received by the other party prior to the expiration of the applicable survival period
provided herein. All covenants, agreements and other obligations of the Seller Parties and the Purchaser set forth in this Agreement that are to be performed following the Closing Date shall survive the Closing and continue in full force and effect
until such covenants, agreements and other obligations are performed in accordance with the terms of this Agreement. 
 9.2
Indemnification by the Seller Parties. Except as otherwise limited by this Article IX, the Seller Parties, jointly and severally, shall indemnify and hold harmless the Purchaser and its Affiliates, parents, subsidiaries,
officers, directors, employees, agents, independent contractor salespersons, successors and assigns (collectively, the “Purchaser Indemnified Parties”) from any and all liabilities, losses, damages, claims, costs and
expenses, interest, awards, judgments and penalties (whether or not arising out of third-party claims) (including, without limitation, costs of mitigation, losses in connection with any Environmental Law, lost profits and other losses resulting from
any shutdown or curtailment of operations, reasonable attorneys’ fees and expenses and any and all amounts paid in investigation, defense or settlement of any or all of the foregoing) (“Losses”), arising out of or
resulting from (i) any or all misrepresentations or breaches of warranty by the Seller Parties contained herein or in any document delivered hereunder; (ii) the breach of any or all covenants or agreements by the Seller Parties contained
herein or in any document delivered hereunder; (iii) any Losses of the Purchaser arising out of or resulting from the failure of the Seller Parties to comply with any applicable bulk sales laws in the United States; (iv) any Retained
Liabilities; (v) except to the extent constituting an Assumed Liability, or otherwise indemnifiable under Section 9.3, all Liabilities arising out of the ownership or operation of KNE, the Acquired Assets or the
Business prior to the Closing Date; (vi) (A) relating to time periods prior to, on or after the Closing Date, resulting from or in connection with (x) the employment relationships of the KNE Lay-Off Employees and the termination of
such employment relationships (including, without limitation, salary payments, bonus payments severance payments, social security charges, vacation entitlements, payments as a result of post-contractual non compete provisions, costs of any court
proceedings) and (y) the KNE Lay-Off Employee Ancillary Contracts and the termination of such contracts (including, without limitation any payment obligations and other obligations towards the respective other parties to such contracts prior to
their effective termination), and (B)

  

 60 

 
relating to the time period prior to or on the Closing Date and resulting from or in connection with the employment relationships of the KNE Other Employees
(including, without limitation, any payment obligations as a result of unpaid overtime); (vii) if the German Contract Condition is not satisfied prior to the Closing, any Liability of KNE arising as a result of the termination by KNE of the
German Contract so long as such termination is made upon at least sixty (60) days prior written notice and is effective no later than February 1, 2010; and (viii) any Taxes of KNE with respect to any Pre-Closing Tax Period and the
unpaid Taxes of any Person (other than KNE) under Treasury Regulations Section 1.1502-6 (or any similar Laws), as a transferee or successor, by contract, or otherwise. For purposes of Section 9.2(viii), the Taxes of KNE for any Straddle
Period shall be allocated as provided in Section 6.6(b). It is clarified, for the avoidance of doubt, that the Seller Parties’ indemnification obligation pursuant to (vi)(A) shall also apply in the event that a termination of the KNE
Lay-Off Employees and/or the KNE Lay-Off Employee Ancillary Contracts is not legally possible, or is not effected by KNE in accordance with Section 6.8, or is effected by KNE only after the Closing Date and that such obligation shall include,
without limitation, indemnification of the Purchaser and KNE for any payments required under the respective employment contract or KNE Lay-Off Employee Ancillary Contract through the effective termination of such contract. Notwithstanding the
foregoing, in no event shall any Seller Party have any indemnification obligation pursuant to this Section 9.2 with respect to any Losses (or portion thereof) for which a liability or accrual has been reflected in the KNE Closing
Balance Sheet for such Losses and taken into account in the Base Purchase Price Determination Certificate as a deduction in the calculation of the Final Purchase Price. 
 9.3 Indemnification by the Purchaser. Except as otherwise limited by this Article IX, the Seller Parties and their respective Affiliates, agents, parents, subsidiaries, officers, directors,
employees, agents, independent contractor salespersons, successors and assigns (collectively, the “Seller Indemnified Parties”) shall be indemnified and held harmless by the Purchaser for any and all Losses arising out of or
resulting from (i) any and all misrepresentations or breach of warranty by the Purchaser contained herein or in any document delivered hereunder, (ii) the breach of any covenant or agreement by the Purchaser contained herein or in any
document delivered hereunder to which the Purchaser is a party, (iii) all Assumed Liabilities; (iv) all Liabilities arising out of the ownership or operation of KNE, the Acquired Assets or the Business on or after the Closing Date, except
to the extent such liabilities constitute a Retained Liability or are otherwise indemnifiable under Section 9.2; and (v) all Taxes arising out of the transfer, ownership or operation of the Acquired Assets following the
Closing Date, except to the extent such Taxes constitute Transfer Taxes or are otherwise addressed in Section 14.2 of the Manufacturing Agreement. 
 9.4 General Indemnification Provisions. 
 (a) For the purposes of this Section, the term
“Indemnitee” shall refer to the Person or Persons indemnified, or entitled, or claiming to be entitled, to be indemnified, pursuant to the provisions of this Article IX as the case may be; and the term
“Indemnitor” shall refer to the Person having the obligation to indemnify pursuant to this Article IX. The term “Losses” is not limited to matters asserted by third parties, but includes Losses
incurred or sustained by an Indemnitee in the absence of third party claims, and payments by the Indemnitee shall not be a condition precedent to recovery. 
  

 61 

 (b) An Indemnitee shall give the Indemnitor prompt written notice of any matter which an Indemnitee has
determined has given or could give rise to a right of indemnification under this Agreement as soon as practicable after the Indemnitee becomes aware of such matter, stating the amount of Losses, if known, and the method of computation thereof, all
with reasonable particularity and containing a reference to the provisions of this Agreement in respect of which such right of indemnification is claimed or arises. The obligations and liabilities of an Indemnitor under this Article IX
with respect to Losses arising from claims of any third party that are subject to the indemnification provided for in this Article IX (“Third Party Claims”) shall be governed by the following additional terms
and conditions: if an Indemnitee shall receive notice of any Third Party Claim, the Indemnitee shall give the Indemnitor prompt written notice of such Third Party Claim as promptly as practicable (and in any event within fifteen (15) calendar
days after the service of the citation or summons) and shall permit the Indemnitor, at its option, to participate in the defense of such Third Party Claim by counsel of its own choice and at its expense; provided that such counsel is reasonably
acceptable to Indemnitee; provided further that the failure to provide such notice shall not relieve the Indemnitor form any of its obligations under this Article IX except to the extent the Indemnitor is materially prejudiced by such
failure. The Indemnitor shall also be entitled, at its option, to assume and control the defense of such Third Party Claim at its cost, risk and expense and through counsel of its choice if it gives notice, within fifteen (15) calendar days
after receiving written notice of such claim from the Indemnitee, of the Indemnitor’s intention to do so to the Indemnitee, unless the named parties to such action or proceeding include both the Indemnitor and the Indemnitee and the Indemnitee
has been advised by counsel that there may be one or more legal defenses available to such Indemnitee that are different from or additional to those available to the Indemnitor. If the Indemnitor exercises its right to undertake the defense against
any such Third Party Claim as provided above, the Indemnitee shall cooperate with the Indemnitor in such defense and make available to the Indemnitor, at the Indemnitor’s expense, all witnesses, pertinent records, materials and information in
its possession or under its control relating thereto as is reasonably required by the Indemnitor. Similarly, in the event the Indemnitee is, directly or indirectly, conducting the defense against any such Third Party Claim, the Indemnitor shall
cooperate with the Indemnitee in such defense and make available to it all such witnesses, records, materials and information in its possession or under its control relating thereto as is reasonably required by the Indemnitee. No such Third Party
Claim, except the settlement thereof which involves the payment of money only and for which the Indemnitee is fully indemnified by the Indemnitor, may be settled by the Indemnitor without the written consent of the Indemnitee. If the Indemnitor
fails to assume the defense of such Third Party Claim within fifteen (15) calendar days after receipt of the notice thereof, the Indemnitee against which such claim has been asserted will (upon delivering notice to such effect to the
Indemnitor) have the right to undertake, at the Indemnitor’s cost and expense, the defense, compromise or settlement of such claim on behalf of and for the account and risk of the Indemnitor and the Indemnitor will be bound by any determination
made in such claim or compromise or settlement effected by the Indemnitee. 
 9.5 Limits on Indemnification. 
 (a) Basket on Losses of Purchaser Indemnified Parties. Notwithstanding anything to the contrary set forth in this Agreement (but subject to the
proviso set forth in this sentence), neither Seller Party shall be liable to any Purchaser Indemnified Party under Section  

  

 62 

 
9.2(i) unless the aggregate Losses incurred by the Purchaser Indemnified Parties with respect to which indemnification is to be provided
hereunder exceed Two Hundred Thousand Dollars ($200,000) (the “Basket Threshold”), in which case the Seller Parties shall be liable to the Purchaser Indemnified Parties for the Losses included in the Basket Threshold;
provided, however, that the limitations set forth in this Section 9.5(a) and application of the Basket Threshold shall not apply to (i) any Losses incurred by any Purchaser Indemnified Party arising out of or
otherwise by virtue of any inaccuracy of the representations and warranties contained in Sections 3.1 (Organization), 3.2(a) (Authority), 3.3 (Tax Matters), 3.5 (Title to Property and Assets),
3.6(c)(iii) (Sufficiency of Intellectual Property Rights) and 3.10 (Health Care Compliance) of this Agreement or (ii) any Losses arising out of fraud, willful misrepresentation or willful misconduct on the part of the
Seller Parties. 
 (b) Cap on Losses of Purchaser Indemnified Parties. The aggregate amount required to be paid by Seller Parties
under Section 9.2(i) shall not exceed Five Million Dollars ($5,000,000) (the “Cap”); provided, however, that the Cap shall not apply to (i) any Losses of the Purchaser Indemnified Parties
arising out of or otherwise by virtue of any inaccuracy in any of the representations and warranties contained in Sections 3.1 (Organization), 3.2(a) (Authority), 3.3 (Tax Matters), 3.5
(Title to Property and Assets), 3.6(c)(iii) (Sufficiency of Intellectual Property Rights) and 3.10 (Health Care Compliance) of this Agreement and no indemnification payment made by the Seller Parties with respect to any such
inaccuracy shall be considered in determining whether the Cap has been satisfied or (ii) any Losses arising out of fraud, willful misrepresentation or willful misconduct on the part of the Seller Parties. 
 (c) Neither the exercise of nor the failure to exercise any available right of setoff will constitute an election of remedies or limit the Purchaser in
any manner in the enforcement of any other remedies that may be available to it. If the Purchaser elects to exercise any such right of setoff, the Purchaser shall first submit a notice of claim to the Seller Parties in accordance with the procedures
set forth herein and the Purchaser’s exercise of such right of setoff with respect to such claim shall be subject to the dispute resolution provisions set forth herein. 
 (d) If any Losses sustained by an Indemnitee are covered by an insurance policy or an indemnification, contribution or similar obligation of another
Person (other than an Affiliate of such Indemnitee), the Indemnitee shall use commercially reasonable efforts to collect such insurance proceeds or indemnity, contribution or similar payments. If the Indemnitee receives such insurance proceeds or
indemnity, contribution or similar payments prior to being indemnified with respect to such Losses under Sections 9.2 or 9.3, the payment with respect to such Losses shall be reduced by the net amount of such insurance
proceeds or indemnity, contribution or similar payments to the extent related to such Losses, less reasonable attorney’s fees and other expenses incurred in connection with such recovery. If the Indemnitee receives such insurance proceeds or
indemnity, contribution or similar payments after being indemnified and held harmless by an Indemnitor with respect to such Losses, the Indemnitee shall pay to the Indemnitor the net amount of such insurance proceeds or indemnity, contribution or
similar payment to the extent related to such Losses, less reasonable attorney’s fees and other expenses incurred in connection with such recovery. If any Indemnitee receives payment under this Article IX on account of a
claim that an Indemnitor believes in good faith is covered by an insurance policy or an indemnification, contribution or similar obligation of another Person 

  

 63 

 
(other than an Affiliate of such Indemnitee), then the Indemnitee shall on written request of the Indemnitor (i) assign, to the extent assignable, its
rights under such insurance policy or indemnification, contribution or similar obligation with respect to such claim to the Indemnitor and (ii) if requested to do so by the Indemnitor, the Indemnitee shall reasonably cooperate with the
Indemnitor, to collect any such insurance or indemnification, contribution or similar obligation. In all cases, the foregoing shall be subject to any subrogation rights of Indemnitor’s insurers. 
 (e) Notwithstanding anything to the contrary set forth in this Agreement (except for the last sentence of this Section 9.5(e)), the
obligations of the Seller Parties to indemnify the Purchaser pursuant to Sections 9.2(i) and 9.2(ii) shall be the Purchaser’s sole and exclusive remedy against the Seller Parties, except that this
Section 9.5(e) shall not apply in the case of fraud, willful misrepresentation or willful misconduct in connection with any representation, warranty or covenant of the Seller Parties. Notwithstanding anything to the contrary
contained in this Section 9.5(e), the provisions of this Section 9.5(e) shall not apply to any claim by the Purchaser against the Seller Parties based upon a failure of the Seller Parties to transfer any of the
Acquired Assets pursuant to the terms of this Agreement. 
 (f) Each Indemnitee shall use commercially reasonable efforts to mitigate any
Losses for which such Indemnitee seeks indemnification. 
 9.6 Tax Treatment of Indemnification Payments. To the extent permitted by
Law, indemnification payments made pursuant to this Agreement shall constitute adjustments to the Final Base Purchase Price and to the Post-Closing Payment hereunder, and shall be treated as such by the Purchaser and the Seller Parties on their Tax
Returns, in each case unless otherwise agreed in writing. 
 ARTICLE X 
 MISCELLANEOUS 
 10.1 Notices. All notices and other communications
hereunder shall be in writing and shall be deemed given if delivered personally, telecopied (with a confirmation thereof), two (2) Business Days after being mailed by registered or certified mail (return receipt requested), or the Business Day
after being sent if sent for next day delivery to a domestic address by recognized overnight delivery service (e.g., Federal Express) to the parties at the following addresses (or at such other address for a party as shall be specified by like
notice): 
  

	 	(a)	if to the Purchaser: 

 The Spectranetics Corporation

 9965 Federal Drive 
 Colorado
Springs, CO 80921 
 Telephone: (719) 447-2000 
 Telecopier: (719) 447-2022 
 Attention: Chief Executive Officer 
  

 64 

 with a copy to: 
 The Spectranetics Corporation 
 9965 Federal Drive 
 Colorado Springs, CO 80921 
 Telephone:
(719) 447-2000 
 Telecopier: (719) 447-2022 
 Attention: General Counsel 
  

	 	(b)	if to the Seller Parties: 

 Kensey Nash Corporation

 735 Pennsylvania Drive 
 Exton,
PA 19341 
 Telephone: (484) 713-3100 
 Telecopier: (484) 713-2900 
 Attention: Joseph W. Kaufmann 
 with a copy to: 
 Katten Muchin Rosenman LLP

 525 W. Monroe Street 
 Chicago,
IL 60661 
 Telephone: (312) 902-5411 
 Telecopier: (312) 902-1061 
 Attention: David R. Shevitz, Esq. and Kimberly Smith, Esq. 
 10.2 Interpretation. When a reference is made in this Agreement to articles or sections, such reference shall be, respectively, to an article or a
section of this Agreement unless otherwise indicated. The table of contents and headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. Each reference
herein to a Schedule or Exhibit refers to the item identified separately in writing by the parties as the described Schedule or Exhibit to this Agreement. Every matter, document and item referred to, set forth or described herein under any section
of the Company Disclosure Schedule attached hereto shall be deemed to be disclosure under all relevant sections of the Company Disclosure Schedule and shall be deemed to qualify each representation and/or warranty of the Seller Parties in this
Agreement, to the extent such matter, document or item would reasonably be expected to pertain and such application is reasonably apparent from the face of the disclosure of such matter, document or item, notwithstanding the omission of a reference
or cross-reference thereto. Whenever the words “include,” “includes” or “including” are used in this Agreement they shall be deemed to be followed by the words “without limitation.” 
 10.3 Counterparts. This Agreement may be executed (including by facsimile transmission or .pdf) in two or more counterparts, all of which shall be
considered one and the same agreement. 
  

 65 

 10.4 Entire Agreement; No Third-Party Beneficiaries. This Agreement, the documents and the
instruments executed and delivered in connection herewith and the Confidentiality Agreements constitute the entire agreement and supersede all prior agreements and understandings, both written and oral, among the parties and between the Purchaser
and the Seller Parties with respect to the subject matter hereof, and are not intended to confer upon any Person other than the parties hereto any rights or remedies hereunder. 
 10.5 Governing Law. This Agreement shall be governed by, construed and enforced in accordance with the Laws of the State of Delaware without
regard to any applicable conflicts of law rules or principles. 
 10.6 Consent to Jurisdiction; Venue; Waiver of Certain Damages and Jury
Trial. 
 (a) Except where it is pursuant to the terms of this Agreement entitled to injunctive relief, prior to commencing any litigation
in connection with this Agreement or the other Transaction Documents, each party hereto shall use commercially reasonable efforts to cause its chief executive officer to confer with the chief executive officers of the other parties hereto for a
period of at least 30 days, and each party hereto shall use its commercially reasonable efforts to resolve such dispute. During such 30-day period, the party seeking to commence such litigation shall attend no fewer than three (3) full business
days of meetings at the other party’s principal executive offices. Only after compliance with the provisions of this Section 10.6(a) may a party hereto commence an action in connection with this Agreement or the other
Transaction Documents. 
 (b) Each party hereto hereby submits to the exclusive jurisdiction of the United States District Court for the
District of Delaware and of any Delaware state court sitting in the County of New Castle, State of Delaware for purposes of all legal proceedings arising out of or relating to this Agreement or the transactions contemplated hereby. Each party hereto
irrevocably waives, to the fullest extent permitted by law, any objection which it may now or hereafter have to the laying of the venue of any such proceeding brought in such a court and any claim that any such proceeding brought in such a court has
been brought in an inconvenient forum, and the parties hereto irrevocably agree that all such proceedings shall be heard and determined in such a Delaware state or federal court. The parties hereby consent to and grant any such court jurisdiction
over the person of such parties and over the subject matter of such dispute and agree that mailing of process or other papers in connection with any such action or proceeding in the manner provided in Section 10.1 or in such other
manner as may be permitted by law shall be valid and sufficient service thereof. 
 (c) Each party hereto waives any claim to punitive,
exemplary or multiplied damages from the other; provided, however, that this waiver shall not be deemed to prevent any Purchaser Indemnified Party or Seller Indemnified Party from recovering Losses incurred by such Purchaser
Indemnified Party or Seller Indemnified Party, as the case may be, as a result of any claim (i) from any third party for any such punitive, exemplary or multiplied damages imposed upon such Purchaser Indemnified Party or Seller Indemnified
Party and as to which claim such Purchaser Indemnified Party or Seller Indemnified Party, as the case may be, is 

  

 66 

 
otherwise entitled to indemnification under Section 9.2 in the case of Purchaser Indemnified Parties or Section 9.3 in
the case of Seller Indemnified Parties or (ii) for fraud. 
 (d) Waiver of Jury Trial EACH OF THE PARTIES HERETO HEREBY
IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY OF ANY CLAIM OR CAUSE OF ACTION IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS OR EVENTS CONTEMPLATED HEREBY OR ANY COURSE OF CONDUCT, COURSE OF DEALING,
STATEMENTS (WHETHER VERBAL OR WRITTEN) OR ACTIONS OF ANY PARTY HERETO. THE PARTIES HERETO EACH AGREE THAT ANY AND ALL SUCH CLAIMS AND CAUSES OF ACTION SHALL BE TRIED BY THE COURT WITHOUT A JURY. EACH OF THE PARTIES HERETO FURTHER WAIVES ANY RIGHT TO
SEEK TO CONSOLIDATE ANY SUCH LEGAL PROCEEDING IN WHICH A JURY TRIAL HAS BEEN WAIVED WITH ANY OTHER LEGAL PROCEEDING IN WHICH A JURY TRIAL CANNOT OR HAS NOT BEEN WAIVED. 
 10.7 Assignment. Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned by any of the parties hereto
(whether by operation of law or otherwise) without the prior written consent of the other parties; except that the Purchaser shall be entitled to assign this Agreement in whole or in part to any of its Affiliates (in which case the Purchaser shall
remain liable for all obligations of the Purchaser hereunder, including the performance or nonperformance of any actions or omissions of its Affiliates) upon reasonable advance notice to the Seller Parties. Subject to the preceding sentence, this
Agreement will be binding upon, inure to the benefit of and be enforceable by the parties and their respective permitted successors and assigns. 
 10.8 Amendment. This Agreement may not be amended except by an instrument in writing signed on behalf of each of the parties hereto. 
 10.9 Extension; Waiver. At any time prior to the Closing, the parties hereto may, to the extent legally allowed, (i) extend the time for the performance of any of the obligations or the other acts of the
other parties hereto, (ii) waive any inaccuracies in the representations or warranties contained herein or in any document delivered pursuant hereto, and (iii) waive compliance with any of the agreements or conditions contained herein. Any
agreement on the part of a party hereto to any such extension or waiver shall be valid only if set forth in a written instrument signed on behalf of such party. Any such waiver by a party of a condition to closing of this Agreement shall also
operate as a waiver and release of any corresponding covenant, agreement or other obligation relating to the same subject matter set forth in this Agreement. 
 10.10 Severability. If any provision of this Agreement is held to be illegal, invalid or unenforceable under any present or future Law or regulation, and if the rights or obligations of any party hereto under
this Agreement will not be materially and adversely affected thereby, (i) such provision will be fully severable, (ii) this Agreement will be construed and enforced as if such illegal, invalid or unenforceable provision had never comprised
a part hereof, (iii) the remaining provisions of this Agreement will remain in full force and effect and will not be affected by the illegal, invalid or unenforceable provision or by its severance from 

  

 67 

 
this Agreement and (iv) in lieu of such illegal, invalid or unenforceable provision, there will be added automatically as a part of this Agreement a
legal, valid and enforceable provision as similar in terms to such illegal, invalid or unenforceable provision as may be possible. Notwithstanding the foregoing, no illegality, invalidity or unenforceability of any provision of this Agreement or
other agreement between the parties shall affect the validity and enforceability of Section 2.6 and the obligation of the Purchaser to make the Post-Closing Payment thereunder. 
 10.11 Company Disclosure Schedule. Except as otherwise provided in the Company Disclosure Schedule, all capitalized terms therein shall have the
meanings assigned to them in this Agreement. Matters reflected in the Company Disclosure Schedule are not necessarily limited to matters required by this Agreement to be disclosed. No disclosure made in the Company Disclosure Schedule shall
constitute an admission or determination that any fact or matter so disclosed is material, would have a material adverse effect, meets a dollar or other threshold set forth in this Agreement , and no Person shall use the fact of the setting of an
amount or the inclusion of such facts or matters in any dispute or controversy as to whether any obligation, amount, fact or matter is or is not material for purposes of this Agreement. Any reference to a section or subsection in the Company
Disclosure Schedule refers to that section or subsection of this Agreement, unless the context requires otherwise. No disclosure in the Company Disclosure Schedule relating to any possible breach or violation of any agreement, law or regulation
shall be construed as an admission or indication to any third party that any such breach or violation exists or has actually occurred. 
 10.12 License. Seller Parties hereby grant to Purchaser a worldwide, royalty-free, sublicenseable, perpetual, irrevocable, non-exclusive license, under any and all Proprietary Rights owned or otherwise controlled by any of the Seller
Parties that are not transferred by Seller Parties to Purchaser under this Agreement but that are necessary for the conduct of the Business, outside of the Licensed Field (as such term is defined in the License Agreement), to manufacture, have
manufactured, import, use, sell, offer for sale, research, develop, commercialize, import, export, distribute, and market the Acquired Technology and any improvement thereto, and to modify, reproduce, distribute, transmit, display, and produce
derivative works of design documents and other copyrighted materials and documentation in connection with the Business. 
 [Signature page
follows.] 
  

 68 

 IN WITNESS WHEREOF, the parties have executed and delivered this Asset Purchase Agreement as of the date first written
above. 
  

			
	KENSEY NASH CORPORATION
		
	By:	 	 /s/ Joseph W. Kaufmann

	Name:	 	Joseph W. Kaufmann
	Title:	 	Chief Executive Officer, President
		 	and Secretary
	
	ILT ACQUISITION SUB, INC.
		
	By:	 	 /s/ Joseph W. Kaufmann

	Name:	 	Joseph W. Kaufmann
	Title:	 	President
	
	KENSEY NASH HOLDING CORPORATION
		
	By:	 	 /s/ Joseph W. Kaufmann

	Name:	 	Joseph W. Kaufmann
	Title:	 	President
	
	THE SPECTRANETICS CORPORATION
		
	By:	 	 /s/ Guy A. Childs

	Name:	 	Guy A. Childs
	Title:	 	Vice President and Chief Financial
		 	Officer2008 Stock Awards and Incentive Plan

 Exhibit 4.2 
 ENCORE BANCSHARES, INC. 
 2008 STOCK AWARDS AND INCENTIVE PLAN 
 I. PURPOSE 
 The purpose of the ENCORE
BANCSHARES, INC. 2008 STOCK AWARDS AND INCENTIVE PLAN (the “Plan”) is to provide a means through which Encore Bancshares, Inc., a Texas corporation (the “Company”), and its Affiliates, may attract able persons to
enter the employ of the Company and its Affiliates and to provide a means whereby those employees, directors and consultants, upon whom the responsibilities of the successful administration and management of the Company and its Affiliates rest, and
whose present and potential contributions to the welfare of the Company and its Affiliates are of importance, can acquire and maintain stock ownership, thereby strengthening their concern for the welfare of the Company and its Affiliates and their
desire to remain in the Company’s and its Affiliates’ employ. A further purpose of the Plan is to provide such employees, directors and consultants with additional incentive and reward opportunities designed to enhance the profitable
growth of the Company. Accordingly, the Plan provides for granting Incentive Stock Options, Nonqualified Stock Options, Stock Appreciation Rights, Restricted Stock Awards, Performance Awards, 
 Phantom Stock Awards, or any combination of the foregoing, as is best suited to the circumstances of the particular employee, director or consultant as
provided herein. 
 II. DEFINITIONS 
 The following definitions shall be applicable throughout the Plan unless specifically modified by any paragraph: 
 (a) “Affiliate” means any Parent Corporation and any Subsidiary Corporation. 
 (b) “Award” means, individually
or collectively, any Option, Restricted Stock Award, Phantom Stock Award, Performance Award or Stock Appreciation Right. 
 (c)
“Board” means the Board of Directors of the Company. 
 (d) “Change of Control” means the occurrence of any of the
following events: (i) the Company shall not be the surviving entity in any merger, consolidation or other reorganization (or survives only as a subsidiary of an entity other than a previously wholly-owned subsidiary of the Company),
(ii) the Company’s subsidiary bank is merged or consolidated into, or otherwise acquired by, an entity other than a wholly-owned subsidiary of the Company, (iii) the Company sells, leases or exchanges all or substantially all of its
assets to any other person or entity (other than a wholly-owned subsidiary of the Company), (iv) the Company is to be dissolved and liquidated, (v) any person or entity, including a “group” as contemplated by
Section 13(d)(3) of the 1934 Act, acquires or gains ownership or control (including, without limitation, power to vote) of more than 50% of the outstanding shares of the Company’s voting stock (based upon voting power), or (vi) as a
result of or in connection with a contested election of directors, the persons who were directors of the Company before such election shall cease to constitute a majority of the Board. Notwithstanding anything herein to the contrary, and only to the
extent that an Award is subject to Code Section 409A and would not otherwise comply with Code Section 409A, a “Change of Control” shall occur only to the extent that the definition of “Change of Control” set forth above
may be interpreted to be consistent with Code Section 409A and the applicable Internal Revenue Service and Treasury Department regulations thereunder. 
 (e) “Change of Control Value” shall mean with respect to a Change of Control (i) the per share price offered to shareholders of the Company in any merger, consolidation, reorganization, sale of assets
or dissolution transaction, (ii) the price per share offered to shareholders of the Company in any tender offer, exchange offer or 

 
sale or other disposition of outstanding voting stock of the Company, or (iii) if such Change of Control occurs other than as described in clause
(i) or clause (ii), the Fair Market Value per share of the shares into which Awards are exercisable, as determined by the Committee, whichever is applicable. In the event that the consideration offered to shareholders of the Company consists of
anything other than cash, the Committee shall determine the fair cash equivalent of the portion of the consideration offered which is other than cash. 
 (f) “Code” means the Internal Revenue Code of 1986, as amended. Reference in the Plan to any section of the Code shall be deemed to include any amendments or successor provisions to any section and any
regulations under such section. 
 (g) “Committee” means the Compensation Committee of the Board which shall be constituted
entirely of not less than two (2) non-employee directors (within the meaning of Rule 16b-3), each of whom shall be an “outside director,” within the meaning of section 162(m) of the Code and applicable interpretive authority
thereunder. The Committee shall be appointed by and serve at the pleasure of the Board. 
 (h) “Company” means Encore Bancshares,
Inc. 
 (i) A “consultant” means an individual (other than a director) who performs services for the Employer as an independent
contractor. 
 (j) A “covered employee” means an individual described in Code Section 162(m)(3). 
 (k) A “director” means an individual who is serving on the Board or on the board of directors of an Affiliate on the date the Plan is adopted
by the Board or who is elected to the Board or the board of directors of an Affiliate after such date. 
 (l) An “employee” means
any person (including an officer or a director) in an employment relationship with the Company or any Affiliate. 
 (m) “Employer”
means the Company or an Affiliate. 
 (n) “Fair Market Value” means, as of any specified date, the mean of the high and low sales
prices of the Stock (i) reported by any interdealer quotation system on which the Stock is quoted on that date or (ii) if the Stock is listed on a national stock exchange, reported on the stock exchange composite tape on that date; or, in
either case, if no prices are reported on that date, on the last preceding date on which such prices of the Stock are so reported. If the Stock is traded over the counter at the time a determination of its fair market value is required to be made
hereunder, its fair market value shall be deemed to be equal to the average between the reported high and low or closing bid and asked prices of Stock on the most recent date on which Stock was publicly traded. In the event Stock is not publicly
traded at the time a determination of its value is required to be made hereunder, the determination of its fair market value shall be made by the Committee in such manner as it deems appropriate, consistent with Treasury regulations and other formal
Internal Revenue Service guidance under Code Section 409A, with the intent that Options and Stock Appreciation Rights granted under this Plan shall not constitute deferred compensation subject to Code Section 409A. 
 (o) “Holder” means an individual who has been granted an Award. 
 (p) “Incentive Stock Option” means an incentive stock option within the meaning of section 422(b) of the Code. 
 (q) “1934 Act” means the Securities Exchange Act of 1934, as amended. 
 (r) “Nonqualified
Stock Option” means an option granted under Paragraph VII of the Plan to purchase Stock which does not constitute an Incentive Stock Option. 
  

 2 

 (s) “Option” means an Award granted under Paragraph VII of the Plan and includes both Incentive
Stock Options to purchase Stock and Nonqualified Stock Options to purchase Stock. 
 (t) “Option Agreement” means a written
agreement between the Company and a Holder with respect to an Option. 
 (u) “Parent Corporation” means a “parent
corporation” of the Company within the meaning of Code Section 424(e). 
 (v) “Performance Award” means an Award granted
under Paragraph X of the Plan. 
 (w) “Performance Award Agreement” means a written agreement between the Company and a Holder
with respect to a Performance Award. 
 (x) “Phantom Stock Award” means an Award granted under Paragraph XI of the Plan.

 (y) “Phantom Stock Award Agreement” means a written agreement between the Company and a Holder with respect to a Phantom Stock
Award. 
 (z) “Plan” means the Encore Bancshares, Inc. 2008 Stock Awards and Incentive Plan, as amended from time to time.

 (aa) “Restricted Stock Agreement” means a written agreement between the Company and a Holder with respect to a Restricted Stock
Award. 
 (bb) “Restricted Stock Award” means an Award granted under Paragraph IX of the Plan. 
 (cc) “Rule 16b-3” means SEC Rule 16b-3 promulgated under the 1934 Act, as such may be amended from time to time, and any successor rule,
regulation or statute fulfilling the same or a similar function. 
 (dd) “Spread” means, in the case of a Stock Appreciation Right,
an amount equal to the excess, if any, of the Fair Market Value of a share of Stock on the date such right is exercised over the exercise price of such Stock Appreciation Right. 
 (ee) “Stock” means the common stock, $1.00 par value of the Company. 
 (ff) “Stock Appreciation Right” means an Award granted under Paragraph VIII of the Plan. 
 (gg) “Stock Appreciation Rights Agreement” means a written agreement between the Company and a Holder with respect to an Award of Stock
Appreciation Rights. 
 (hh) “Subsidiary Corporation” means a “subsidiary corporation” of the Company within the meaning
of Code Section 424(f). 
 III. EFFECTIVE DATE AND DURATION OF THE PLAN 
 This Plan shall be effective on March 13, 2008 which is the date of its adoption by the Board (the “Effective Date”), subject to the
approval of the Plan by the Company’s shareholders within twelve months after the Effective Date. If the Plan is not so approved by the Company’s shareholders, (a) the Plan shall not be effective, and (b) any grants of Awards
under the Plan shall immediately expire and be of no force and effect. No Awards may be granted under the Plan after the tenth anniversary of the Effective Date. The Plan shall remain in effect until all Awards granted under the Plan have been
satisfied or expired. 
  

 3 

 IV. ADMINISTRATION 
 (a) Committee. The Plan shall be administered by the Committee. The Committee shall hold its meetings at such times and places as it may determine. A majority of its members shall constitute a quorum, and all
determinations of the Committee shall be made by not less than a majority of its members. Any decision or determination reduced to writing and signed by a majority of the members shall be fully effective as if it had been made by a majority vote of
its members at a meeting duly called and held. The Committee may designate the Secretary of the Company or other Company employees to assist the Committee in the administration of this Plan, and may grant authority to such persons to execute Award
agreements or other documents on behalf of the Committee and the Company. 
 (b) Powers. Subject to the provisions of the Plan, the
Committee shall have sole authority, in its discretion, to determine which employees, directors or consultants shall receive an Award, the time or times when such Award shall be made, whether an Incentive Stock Option, Nonqualified Option or Stock
Appreciation Right shall be granted, the number of shares of Stock which may be issued under each Option, Stock Appreciation Right or Restricted Stock Award, and the value of each Performance Award and Phantom Stock Award. In making such
determinations the Committee may take into account the nature of the services rendered by the respective employees, their present and potential contributions to the Employer’s success and such other factors as the Committee in its discretion
shall deem relevant. The Committee, in its sole discretion, and subject to Code Section 409A and other applicable laws, may waive compliance with any provision of any Award, or any related agreement, may extend the date through which any Award
is exercisable, and/or may accelerate the earliest date on which such Award becomes exercisable, vested, free from restrictions or payable, provided in each case such action does not adversely affect the rights of the Holder. 
 (c) Additional Powers. The Committee shall have such additional powers as are delegated to it by the other provisions of the Plan. Subject to the
express provisions of the Plan, the Committee is authorized to construe the Plan and the respective agreements executed thereunder, to prescribe such rules and regulations relating to the Plan as it may deem advisable to carry out the Plan, and to
determine the terms, restrictions and provisions of each Award, including such terms, restrictions and provisions as shall be requisite in the judgment of the Committee to cause designated Options to qualify as Incentive Stock Options, and to make
all other determinations necessary or advisable for administering the Plan. The Committee may correct any defect or supply any omission or reconcile any inconsistency in any agreement relating to an Award in the manner and to the extent it shall
deem expedient to carry it into effect. The determinations of the Committee on the matters referred to in this Article IV shall be conclusive. 
 (d) Expenses. All expenses and liabilities incurred by the Committee in the administration of this Plan shall be borne by the Company. The Committee may employ attorneys, consultants, accountants or other persons to assist the
Committee in the carrying out of its duties hereunder. 
 V. STOCK SUBJECT TO THE PLAN 
 (a) Stock Grant and Award Limits. The Committee may from time to time grant Awards to one or more employees, directors or consultants determined
by it to be eligible for participation in the Plan in accordance with the provisions of Paragraph VI. Subject to Paragraph XII, the maximum aggregate number of shares of Stock that may be issued under the Plan is 500,000, any or all of
which may be issued through Incentive Stock Options. Shares of Stock shall be deemed to have been issued under the Plan only to the extent actually issued and delivered pursuant to an Award. To the extent that an Award (other than an Award of
Restricted Stock) lapses or is canceled or the rights of its Holder terminate or the Award is settled in cash, any Stock subject to such Award shall again be available for grant under an Award. Should any shares of Restricted Stock be forfeited,
such shares may not again be subject to an Award under the Plan. Any shares of Stock which may remain unissued and which are not subject to outstanding Awards at the termination of this Plan shall cease to be reserved for the purpose of this Plan,
but until termination of this Plan or the termination of the last of the Awards granted under this Plan, whichever last occurs, the Company shall at all times reserve a sufficient number of shares to meet the requirements of this Plan. 

 

 4 

 Notwithstanding any provision in the Plan to the contrary, no more than 100,000 shares of Stock may be
subject to Options granted under the Plan to any one individual during any one year period, no more than 50,000 shares of Stock may be subject to Stock Appreciation Rights granted under the Plan to any one individual during any one year period, and
no more than 100,000 shares of Stock may be granted under the Plan as a Restricted Stock Award to any one individual during any one year period. The number of shares of Stock that may be issued to individuals as set forth in the preceding sentence
shall be subject to adjustment in the same manner as provided in Section XII hereof with respect to shares of Stock subject to Options, Stock Appreciation Rights or Restricted Stock Awards then outstanding. The limitations set forth in this
paragraph shall be applied in a manner which will permit compensation generated under the Plan with respect to “covered employees” to constitute “performance-based” compensation for purposes of Section 162(m) of the Code,
including, without limitation, counting against such maximum number of shares of Stock, to the extent required under Section 162(m) of the Code and applicable interpretive authority thereunder, any shares of Stock subject to Options or Stock
Appreciation Rights that expire, are canceled or repriced or Restricted Stock Awards that are forfeited. 
 (b) Stock Offered. The
stock to be offered pursuant to the grant of an Award may be authorized but unissued Stock or Stock previously issued and outstanding and reacquired by the Company. 
 VI. ELIGIBILITY 
 The Committee, in its sole discretion, shall determine who shall receive Awards
under the Plan. Awards other than Incentive Stock Options may be granted to all employees, directors and consultants of the Company or its Affiliates, including Affiliates that become such after adoption of the Plan. Incentive Stock Options may be
granted to all employees of the Company or its Affiliates, including Affiliates that become such after adoption of the Plan. A recipient of an Award must be an employee, director or consultant at the time the Award is granted. An Award may be
granted on more than one occasion to the same person, and, subject to the limitations set forth in the Plan, such Award may include an Incentive Stock Option or a Nonqualified Stock Option, a Stock Appreciation Right, a Restricted Stock Award, a
Performance Award, a Phantom Stock Award or any combination thereof. 
 VII. STOCK OPTIONS 
 (a) Option Period. The term of each Option shall be as specified by the Committee at the date of grant. 
 (b) Limitations on Exercise of Option. An Option shall be exercisable in whole or in such installments and at such times as determined by the
Committee. 
 (c) Special Limitations on Incentive Stock Options. Except as otherwise provided under the Code or applicable
regulations, to the extent that the aggregate Fair Market Value (determined at the time the option is granted) of the Stock with respect to which Incentive Stock Options (determined without regard to this sentence) are exercisable for the first time
by any Holder during any calendar year under all plans of the Company and its Parent Corporation or Subsidiary Corporations exceeds $100,000, such options shall be treated as Nonqualified Stock Options. The Committee shall determine, in accordance
with applicable provisions of the Code, Treasury Regulations and other administrative pronouncements, which of a Holder’s Incentive Stock Options will not constitute Incentive Stock Options because of such limitation and shall notify the Holder
of such determination as soon as practicable after such determination. No Incentive Stock Option shall be granted to an individual if, at the time the Option is granted, such individual owns stock possessing more than 10% of the total combined
voting power of all classes of stock of the Company or of its Parent Corporation or Subsidiary Corporation, within the meaning of section 422(b)(6) of the Code, unless (i) at the time such Option is granted the exercise price is at least
110% of the Fair Market Value of the Stock subject to the Option and (ii) such Option by its terms is not exercisable after the expiration of five years from the date of grant. 
  

 5 

 (d) Option Agreement. Each Option shall be evidenced by an Option Agreement in such form and
containing such provisions not inconsistent with the provisions of the Plan as the Committee from time to time shall approve, including, without limitation, provisions to qualify an Incentive Stock Option under section 422 of the Code. An
Option Agreement may provide for the payment of the exercise price, in whole or in part, by (i) cash, cashier’s check, bank draft, or postal or express money order payable to the order of the Company, (ii) subject to the approval by
the Committee, certificates representing “mature shares” of Stock theretofore owned by the Holder duly endorsed for transfer to the Company, or (iii) any combination of the preceding, equal in value to the full amount of the exercise
price. For purposes of this Plan, “mature shares” means shares of Stock for which the Holder has good title, free and clear of all liens and encumbrances, transferability restrictions or risk of forfeiture, and which the Holder has held
for at least six months. Each Option shall specify the effect of termination of employment or service as a director or consultant (by retirement, disability, death or otherwise) on the exercisability of the Option. An Option Agreement may also
include, without limitation, provisions relating to (i) vesting of Options, subject to the provisions hereof accelerating such vesting on a Change of Control, (ii) tax matters (including provisions (y) permitting the delivery of
additional shares of Stock or the withholding of shares of Stock from those acquired upon exercise to satisfy federal or state income tax withholding requirements and (z) dealing with any other applicable employee wage withholding
requirements), and (iii) any other matters not inconsistent with the terms and provisions of this Plan that the Committee shall in its sole discretion determine. The terms and conditions of the respective Option Agreements need not be
identical. 
 (e) Exercise Price and Payment. The price at which a share of Stock may be purchased upon exercise of an Option shall be
determined by the Committee, but (i) such exercise price shall never be less than the Fair Market Value of Stock on the date the Option is granted and (ii) such exercise price shall be subject to adjustment as provided in
Paragraph XII. The Option or portion thereof may be exercised by delivery of an irrevocable notice of exercise to the Company. The exercise price of the Option or portion thereof shall be paid in full in the manner prescribed by the Committee.

 (f) Shareholder Rights and Privileges. The Holder shall be entitled to all the privileges and rights of a shareholder only with
respect to such shares of Stock as have been purchased under the Option and for which certificates of stock have been registered in the Holder’s name. 
 (g) Options and Rights in Substitution for Stock Options Granted by Other Corporations. Options and Stock Appreciation Rights may be granted under the Plan from time to time in substitution for stock options
held by individuals employed by corporations who become employees as a result of a merger or consolidation of the employing corporation with the Company, an Affiliate, or any Subsidiary Corporation, or the acquisition by the Company, an Affiliate or
a Subsidiary Corporation of the assets of the employing corporation, or the acquisition by the Company, an Affiliate or a Subsidiary Corporation of stock of the employing corporation with the result that such employing corporation becomes a
Subsidiary Corporation. 
 (h) All Options granted under this Plan are subject to, and may not be exercised before, the approval of this Plan
by the shareholders of the Company prior to the first anniversary date of the Board meeting held to approve this Plan, by the affirmative vote of the holders of a majority of the outstanding shares of the Company present, or represented by proxy,
and entitled to vote at a meeting at which a quorum is present, or by written consent in accordance with the laws of the State of Texas. 
 VIII. STOCK APPRECIATION RIGHTS 
 (a) Stock Appreciation Rights. A Stock Appreciation Right is the right to receive
an amount equal to the Spread with respect to a share of Stock upon the exercise of such Stock Appreciation Right. Stock Appreciation Rights may be granted in connection with the grant of an Option, in which case the Option Agreement will provide
that exercise of Stock Appreciation Rights will result in the surrender of the right to purchase the shares under the Option as to which the Stock Appreciation Rights were exercised. Alternatively, Stock Appreciation 

  

 6 

 
Rights may be granted independently of Options in which case each Award of Stock Appreciation Rights shall be evidenced by a Stock Appreciation Rights
Agreement which shall contain such terms and conditions as may be approved by the Committee. The Spread with respect to a Stock Appreciation Right may be payable either in cash, shares of Stock with a Fair Market Value equal to the Spread or in a
combination of cash and shares of Stock. With respect to Stock Appreciation Rights that are subject to Section 16 of the 1934 Act, however, the Committee shall, except as provided in Paragraph XII(c), retain sole discretion (i) to
determine the form in which payment of the Stock Appreciation Right will be made (i.e., cash, securities or any combination thereof) or (ii) to approve an election by a Holder to receive cash in full or partial settlement of Stock
Appreciation Rights. Each Stock Appreciation Rights Agreement shall specify the effect of termination of employment or service as a director or consultant (by retirement, disability, death or otherwise) on the exercisability of the Stock
Appreciation Rights. 
 (b) Other Terms and Conditions. At the time of such Award, the Committee may, in its sole discretion,
prescribe additional terms, conditions or restrictions relating to Stock Appreciation Rights. Such additional terms, conditions or restrictions shall be set forth in the Stock Appreciation Rights Agreement made in conjunction with the Award. Such
Stock Appreciation Rights Agreements may also include, without limitation, provisions relating to (i) vesting of Awards, subject to the provisions hereof accelerating vesting on a Change of Control, (ii) tax matters (including
provisions covering applicable wage withholding requirements), and (iii) any other matters not inconsistent with the terms and provisions of this Plan, that the Committee shall in its sole discretion determine. The terms and
conditions of the respective Stock Appreciation Rights Agreements need not be identical. 
 (c) Exercise Price. The exercise price of
each Stock Appreciation Right shall be determined by the Committee, but such exercise price (i) shall never be less than the Fair Market Value of a share of Stock on the date the Stock Appreciation Right is granted (or such greater exercise
price as may be required if such Stock Appreciation Right is granted in connection with an Incentive Stock Option that must have an exercise price equal to 110% of the Fair Market Value of the Stock on the date of grant pursuant to Paragraph VII(c))
and (ii) shall be subject to adjustment as provided in Paragraph XII. 
 (d) Exercise Period. The term of each Stock
Appreciation Right shall be as specified by the Committee at the date of grant. 
 (e) Limitations on Exercise of Stock Appreciation
Right. A Stock Appreciation Right shall be exercisable in whole or in such installments and at such times as determined by the Committee. 
 IX. RESTRICTED STOCK AWARDS 
 (a) Forfeiture Restrictions to be Established by the Committee. Shares of Stock that
are the subject of a Restricted Stock Award shall be subject to restrictions on disposition by the Holder and an obligation of the Holder to forfeit and surrender the shares to the Company under certain circumstances (the “Forfeiture
Restrictions”). The Forfeiture Restrictions shall be determined by the Committee in its sole discretion and set forth in the Restricted Stock Agreement, and the Committee may provide that the Forfeiture Restrictions shall lapse upon
(i) the attainment of one or more performance goals established by the Committee that are based on (1) the price of a share of Stock, (2) the Company’s earnings per share, (3) the Company’s net earnings, (4) the
earnings of a business unit of the Company designated by the Committee, (5) the return on shareholders’ equity achieved by the Company, (6) the Company’s return on assets, (7) the Company’s net interest margin, or
(8) the Company’s efficiency ratio, (ii) the Holder’s continued employment with the Employer for a specified period of time, or (iii) a combination of the factors listed in clauses (i) and (ii) of this sentence.
Each Restricted Stock Award may have different Forfeiture Restrictions, in the discretion of the Committee. The Forfeiture Restrictions applicable to a particular Restricted Stock Award shall not be changed except as permitted by
Paragraph IX(b) or Paragraph XII. 
  

 7 

 (b) Other Terms and Conditions. Stock
awarded pursuant to a Restricted Stock Award shall be represented by a stock certificate registered in the name of the Holder of such Restricted Stock Award. Unless otherwise provided in the Restricted Stock Agreement, the Holder shall have the
right to receive dividends with respect to Stock subject to a Restricted Stock Award, to vote Stock subject thereto and to enjoy all other shareholder rights, except that (i) the Holder shall not be entitled to delivery of the stock certificate
until the Forfeiture Restrictions shall have expired, (ii) the Company shall retain custody of the Stock until the Forfeiture Restrictions shall have expired, (iii) the Holder may not sell, transfer, pledge, exchange, hypothecate or
otherwise dispose of the Stock until the Forfeiture Restrictions shall have expired, and (iv) a breach of the terms and conditions established by the Committee pursuant to the Restricted Stock Agreement shall cause a forfeiture of the
Restricted Stock Award. Unless otherwise provided in a Restricted Stock Agreement, dividends payable with respect to a Restricted Stock Award will be paid to a Holder in cash on the day on which the corresponding dividend on shares of Stock is paid
to shareholders, or as soon as administratively practicable thereafter, but in no event later than the fifteenth (15th) day of the third
calendar month following the day on which the corresponding dividend on shares of Stock is paid to shareholders. The Committee may provide in a Restricted Stock Agreement that payment of dividends with respect to a Restricted Stock Award shall be
subject to the attainment of one or more performance goals established by the Committee that are based on the criteria set forth in paragraph (a) above. 
 At the time of such Award, the Committee may, in its sole discretion, prescribe additional terms, conditions or restrictions relating to Restricted Stock Awards, including, but not limited to, rules pertaining to the
termination of employment or service as a director or consultant (by retirement, disability, death or otherwise) of a Holder prior to expiration of the Forfeiture Restrictions. Such additional terms, conditions or restrictions shall be set forth in
a Restricted Stock Agreement made in conjunction with the Award. Such Restricted Stock Agreement may also include, without limitation, provisions relating to (i) vesting of Awards, subject to any provisions hereof accelerating vesting on a
Change of Control, (ii) tax matters (including provisions (y) covering any applicable employee wage withholding requirements and (z) requiring or prohibiting an election by the Holder under section 83(b) of the Code), and
(iii) any other matters not inconsistent with the terms and provisions of this Plan that the Committee shall in its sole discretion determine. The terms and conditions of the respective Restricted Stock Agreements need not be identical.

 (c) Payment for Restricted Stock. The Committee shall determine the amount and form of any payment for Stock received pursuant to a
Restricted Stock Award, provided that in the absence of such a determination, a Holder shall not be required to make any payment for Stock received pursuant to a Restricted Stock Award, except to the extent otherwise required by law. 
 (d) Agreements. At the time any Award is made under this Paragraph IX, the Company and the Holder shall enter into a Restricted Stock
Agreement setting forth each of the matters as the Committee may determine to be appropriate. The terms and provisions of the respective Restricted Stock Agreements need not be identical. 
 (e) Certification. With respect to a Restricted Stock Award granted to a “covered employee,” if the lapse of the Forfeiture Restrictions
imposed upon such Restricted Stock Award, or the payment of dividends with respect to such Restricted Stock Award, is conditioned in whole or in part on the attainment of performance goals, the Committee shall certify in writing whether such
performance goals and any other conditions on the lapse of Forfeiture Restrictions or payment of dividends have been satisfied. 
 X.
PERFORMANCE AWARDS 
 (a) Performance Period. The Committee shall establish, with respect to and at the time of grant of each
Performance Award, a performance period over which the performance of the Holder shall be measured. 
 (b) Performance Awards. Each
Performance Award shall have a maximum value established by the Committee at the time of such Award. 
  

 8 

 (c) Performance Measures. Prior to or upon the commencement of each performance period (or at such
later time as may be permitted for qualified performance-based compensation under Section 162(m) and the regulations thereunder), the Committee shall establish written performance goals for each Performance Award granted to a Holder for such
performance period. The performance goals shall be based on one or more of the following criteria: (1) the price of a share of Stock, (2) the Company’s earnings per share, (3) the Company’s net earnings, (4) the
earnings of a business unit of the Company designated by the Committee, (5) the return on shareholders’ equity achieved by the Company, (6) the Company’s return on assets, (7) the Company’s net interest margin, or
(8) the Company’s efficiency ratio. 
 At the time of establishing the performance goals, the Committee shall specify (i) the
formula to be used in calculating the compensation payable to a Holder if the performance goals are obtained, and (ii) the individual employee or class of employees to which the formula applies. The Committee may also specify a minimum
acceptable level of achievement of the relevant performance goals, as well as one or more additional levels of achievement, and a formula to determine the percentage of the Performance Award deemed to have been earned by the Holder upon attainment
of each such level of achievement, which percentage may exceed 100%. The performance goals and amount of each Performance Award need not be the same as those relating to any other Performance Award, whether made at the same or a different time.
Notwithstanding the terms of any Performance Award, the maximum payout under this Plan pursuant to a Performance Award to any individual for any calendar year shall not exceed $500,000. 
 Notwithstanding the terms of any Performance Award, the Committee, in its sole and absolute discretion, may reduce the amount of the Performance Award
payable to any Holder for any reason, including the Committee’s judgment that the performance goals have become an inappropriate measure of achievement, a change in the employment status, position or duties of the Holder, unsatisfactory
performance of the Holder, or the Holder’s service for less than the entire performance period. Notwithstanding the foregoing, the reduction of a Performance Award payable to a Holder may not result in an increase in the amount of a Performance
Award payable to another Holder. 
 (d) Awards Criteria. In determining the value of Performance Awards, the Committee shall take into
account a Holder’s responsibility level, contributions, performance, potential, other Awards and such other considerations as it deems appropriate. 
 (e) Certification. Promptly after the date on which the necessary information for a particular performance period becomes available, the Committee shall determine, and certify in writing (with respect to each
Holder who is a “covered employee”), the extent to which the Performance Award for such performance period has been earned, through the achievement of the relevant performance goals, by each Holder for such performance period. 

(f) Payment. After the Committee has determined and certified in writing (if required with respect to a “covered employee”) the
extent to which a Performance Award has been earned, the Holder of a Performance Award shall be entitled to receive payment of an amount, not exceeding the maximum value of the Performance Award, based on the achievement of the performance measures
for such performance period, as determined by the Committee. Payment of a Performance Award will be made in the calendar year immediately following the calendar year in which the performance period ends, and may be made in cash, Stock or a
combination thereof, as determined by the Committee. Payment shall be made in a lump sum. Any payment to be made in Stock shall be based on the Fair Market Value of the Stock on the payment date. 
 (g) Termination of Employment. A Performance Award shall terminate if the Holder does not remain continuously in the employ of the Employer at all
times during the applicable performance period, except as may be determined by the Committee or as may otherwise be provided in the Award at the time granted. 
  

 9 

 (h) Agreements. At the time any Award is made under this Paragraph X, the Committee may
require the Holder to enter into a Performance Award Agreement with the Company setting forth each of the matters contemplated hereby, and, in addition such matters are set forth in Paragraph IX(b) as the Committee may determine to be
appropriate. The terms and provisions of the respective agreements need not be identical. 
 XI. PHANTOM STOCK AWARDS 
 (a) Phantom Stock Awards. Phantom Stock Awards are rights to receive shares of Stock (or cash in an amount equal to the Fair Market Value
thereof), or rights to receive an amount equal to any appreciation in the Fair Market Value of Stock (or portion thereof) over a specified period of time, which vest over a period of time or upon the occurrence of an event (including without
limitation a Change of Control) as established by the Committee, without payment of any amounts by the Holder thereof (except to the extent otherwise required by law) or satisfaction of any performance criteria or objectives. Each Phantom Stock
Award shall have a maximum value established by the Committee at the time of such Award. 
 (b) Award Period. The Committee shall
establish, with respect to and at the time of each Phantom Stock Award, a period over which or the event upon which the Award shall vest with respect to the Holder. 
 (c) Awards Criteria. In determining the value of Phantom Stock Awards, the Committee shall take into account an employee’s responsibility level, performance, potential, other Awards and such other
considerations as it deems appropriate. 
 (d) Payment. Following the end of the vesting period for a Phantom Stock Award, but in no
event later than March 15 of the calendar year immediately following the calendar year in which the vesting period ends, the Holder of a Phantom Stock Award shall be entitled to receive payment of an amount, not exceeding the maximum value of
the Phantom Stock Award, based on the then vested value of the Award. Payment of a Phantom Stock Award may be made in cash, Stock or a combination thereof as determined by the Committee. Payment shall be made in a lump sum. Any payment to be made in
Stock shall be based on the Fair Market Value of the Stock on the payment date. Cash dividend equivalents may be paid during or after the vesting period with respect to a Phantom Stock Award, as determined by the Committee. 
 (e) Termination of Employment. A Phantom Stock Award shall terminate if the Holder does not remain continuously in the employ of the Employer at
all times during the applicable vesting period, except as may be determined by the Committee or as may otherwise be provided in the Award at the time granted. 
 (f) Agreements. At the time any Award is made under this Paragraph XI, the Company and the Holder shall enter into a Phantom Stock Award Agreement setting forth each of the matters contemplated hereby and,
in addition, such matters as are set forth in Paragraph IX(b) as the Committee may determine to be appropriate. The terms and provisions of the respective agreements need not be identical. 
 XII. RECAPITALIZATION OR REORGANIZATION 
 (a) The shares with respect to which Awards may be granted are shares of Stock as presently constituted, but if, and whenever, prior to the expiration of an Award theretofore granted, the Company shall effect a subdivision or consolidation
by the Company, the number of shares of Stock with respect to which such Award may thereafter be exercised or satisfied, as applicable, (i) in the event of an increase in the number of outstanding shares shall be proportionately increased, and
the exercise price per share shall be proportionately reduced, and (ii) in the event of a reduction in the number of outstanding shares shall be proportionately reduced, and the exercise price per share shall be proportionately increased.

  

 10 

 (b) If the Company recapitalizes or otherwise changes its capital structure, thereafter upon any exercise
or satisfaction, as applicable, of an Award theretofore granted the Holder shall be entitled to (or entitled to purchase, if applicable) under such Award, in lieu of the number of shares of Stock then covered by such Award, the number and class of
shares of stock and securities to which the Holder would have been entitled pursuant to the terms of the recapitalization if, immediately prior to such recapitalization, the Holder had been the holder of record of the number of shares of Stock then
covered by such Award. 
 (c) In the event of a Change of Control, all outstanding Awards shall immediately vest and become exercisable or
satisfiable, as applicable, and the Committee, in its discretion, may take any other action with respect to outstanding Awards that it deems appropriate, which action may vary among Awards granted to individual Holders; provided, however, that such
action shall not reduce the value of an Award. In particular, with respect to Options, the actions the Committee may take upon a Change of Control include, but are not limited to, the following: (i) accelerating the time at which Options then
outstanding may be exercised so that such Options may be exercised in full for a limited period of time on or before a specified date (before or after such Change of Control) fixed by the Committee, after which specified date all unexercised Options
and all rights of Holders thereunder shall terminate, (ii) requiring the mandatory surrender to the Company by selected Holders of some or all of the outstanding Options held by such Holders (irrespective of whether such Options are then
exercisable) as of a date, before or after such Change of Control, specified by the Committee, in which event the Committee shall thereupon cancel such Options and the Company shall pay to each such Holder an amount of cash per share equal to the
excess, if any, of the Change of Control Value of the shares subject to such Option over the exercise price(s) under such Options for such shares, (iii) make such adjustments to Options then outstanding as the Committee deems appropriate to
reflect such Change of Control (provided, however, that the Committee may determine in its sole discretion that no adjustment is necessary to Options then outstanding), or (iv) provide that the number and class of shares of Stock covered by an
Option theretofore granted shall be adjusted so that such Option shall thereafter cover the number and class of shares of Stock or other securities or property (including, without limitation, cash) to which the Holder would have been entitled
pursuant to the terms of the agreement of merger, consolidation or sale of assets and dissolution if, immediately prior to such merger, consolidation or sale of assets and dissolution, the Holder had been the holder of record of the number of shares
of Stock then covered by such Option. The provisions contained in this paragraph shall not terminate any rights of the Holder to further payments pursuant to any other agreement with the Company following a Change of Control. 
 (d) In the event of changes in the outstanding Stock by reason of recapitalization, reorganizations, mergers, consolidations, combinations, exchanges or
other relevant changes in capitalization occurring after the date of the grant of any Award and not otherwise provided for by this Paragraph XII, any outstanding Awards and any agreements evidencing such Awards shall be subject to adjustment by
the Committee at its discretion as to the number and price of shares of Stock or other consideration subject to such Awards. In the event of any such change in the outstanding Stock, the aggregate number of shares available under the Plan may be
appropriately adjusted by the Committee, whose determination shall be conclusive. 
 (e) The existence of the Plan and the Awards granted
hereunder shall not affect in any way the right or power of the Board or the shareholders of the Company to make or authorize any adjustment, recapitalization, reorganization or other change in the Company’s capital structure or its business,
any merger or consolidation of the Company, any issue of debt or equity securities ahead of or affecting Stock or the rights thereof, the dissolution or liquidation of the Company or any sale, lease, exchange or other disposition of all or any part
of its assets or business or any other corporate act or proceeding. 
 (f) Any adjustment provided for in Subparagraphs (a), (b),
(c) or (d) above shall be subject to any required shareholder action. 
 (g) Except as hereinbefore expressly provided, the
issuance by the Company of shares of stock of any class or securities convertible into shares of stock of any class, for cash, property, labor or services, upon direct sale, upon the exercise of rights or warrants to subscribe therefor, or upon
conversion of shares of obligations of the 

  

 11 

 
Company convertible into such shares or other securities, and in any case whether or not for fair value, shall not affect, and no adjustment by reason
thereof shall be made with respect to, the number of shares of Stock subject to Awards theretofore granted or the exercise price per share, if applicable. 
 XIII. AMENDMENT AND TERMINATION OF THE PLAN 
 The Board in its discretion may terminate the Plan at
any time with respect to any shares for which Awards have not theretofore been granted. The Board shall have the right to alter or amend the Plan or any part thereof from time to time; provided that, except as provided herein or in an agreement
governing an Award, no change in any Award theretofore granted may be made which would impair the rights of the Holder without the consent of the Holder (unless such change is required in order to cause the benefits under the Plan to qualify as
performance-based compensation within the meaning of section 162(m) of the Code, if applicable, and applicable interpretive authority thereunder), and provided, further, that the Board may not, without approval of the shareholders, amend the
Plan: 
 (a) to increase the maximum number of shares which may be issued on exercise or surrender of an Award, except as provided in
Paragraph XII; 
 (b) to change the class of employees eligible to receive Awards or materially increase the benefits accruing to
employees under the Plan; 
 (c) to extend the maximum period during which Awards may be granted under the Plan; 
 (d) to modify materially the requirements as to eligibility for participation in the Plan; 
 (e) to decrease any authority granted to the Committee hereunder in contravention of Rule 16b-3; or 
 (f) if such approval is required to comply with Rule 16b-3, if applicable, any rule of any stock exchange or automated quotation system on which
Stock may then be listed or quoted, or Sections 162(m) or 422 of the Code or any successor provisions, if applicable. 
 XIV. MISCELLANEOUS

 (a) No Right to An Award. Neither the adoption of the Plan by the Company nor any action of the Board or the Committee shall be
deemed to give an employee any right to be granted an Award to purchase Stock, a right to a Stock Appreciation Right, a Restricted Stock Award, a Performance Award or a Phantom Stock Award or any of the rights hereunder except as may be evidenced by
an Award or by an Option Agreement, Stock Appreciation Rights Agreement, Restricted Stock Agreement, Performance Award Agreement or Phantom Stock Award Agreement on behalf of the Company, and then only to the extent and on the terms and conditions
expressly set forth therein. The Plan shall be unfunded. The Company shall not be required to establish any special or separate fund or to make any other segregation of funds or assets to assure the payment of any Award. 
 (b) Employees’ Rights Unsecured. The right of an employee to receive Stock, cash or any other payment under this Plan shall be an unsecured
claim against the general assets of the Company. The Company may, but shall not be obligated to, acquire shares of Stock from time to time in anticipation of its obligations under this Plan, but a Holder shall have no right in or against any shares
of Stock so acquired. All Stock shall constitute the general assets of the Company and may be disposed of by the Company at such time and for such purposes as it deems appropriate. 
 (c) No Employment Rights Conferred. Nothing contained in the Plan shall (i) confer upon any employee any right with respect to continuation
of employment with any Employer or (ii) interfere in any way with the right of any Employer to terminate an employee’s employment at any time. 
  

 12 

 (d) Other Laws; Withholding. The Company shall not be obligated to issue any Stock pursuant to any
Award granted under the Plan at any time when the shares covered by such Award have not been registered under the Securities Act of 1933 and such other state and federal laws, rules or regulations as the Company or the Committee deems applicable
and, in the opinion of legal counsel for the Company, there is no exemption from the registration requirements of such laws, rules or regulations available for the issuance and sale of such shares. Unless the Awards and Stock covered by this Plan
have been registered under the Securities Act of 1933, or the Company has determined that such registration is unnecessary, each Holder exercising an Award under this Plan may be required by the Company to give representation in writing that such
Holder is acquiring such shares for his or her own account for investment and not with a view to, or for sale in connection with, the distribution of any part thereof. No fractional shares of Stock shall be delivered, nor shall any cash in lieu of
fractional shares be paid. The Company shall have the right to deduct in connection with all Awards any taxes required by law to be withheld and to require any payments required to enable it to satisfy its withholding obligations. 
 (e) No Restriction on Corporate Action. Nothing contained in the Plan shall be construed to prevent the Company, an Affiliate or any Subsidiary
from taking any corporate action which is deemed by the Company, an Affiliate or any Subsidiary to be appropriate or in its best interest, whether or not such action would have an adverse effect on the Plan or any Award made under the Plan. No
employee, beneficiary or other person shall have any claim against the Company, an Affiliate or any Subsidiary as a result of any such action. 
 (f) Restrictions on Transfer. An Award shall not be transferable otherwise than by will or the laws of descent and distribution and shall be exercisable during the Holder’s lifetime only by such Holder or the Holder’s
guardian or legal representative. 
 (g) Beneficiary Designation. Each Holder may name, from time to time, any beneficiary or
beneficiaries (who may be named contingently or successively) to whom any benefit under the Plan is to be paid in case of his or her death before he or she receives any or all of such benefit. Each designation will revoke all prior designations by
the same Holder, shall be in a form prescribed by the Committee, and will be effective only when filed by the Holder in writing with the Committee during his lifetime. In the absence of any such designation, benefits remaining unpaid at the
Holder’s death shall be paid to his estate. 
 (h) Rule 16b-3. It is intended that the Plan and any grant of an Award made to a
person subject to Section 16 of the 1934 Act meet all of the requirements of Rule 16b-3. If any provision of the Plan or any such Award would disqualify the Plan or such Award under, or would otherwise not comply with, Rule 16b-3,
such provision or Award shall be construed or deemed amended to conform to Rule 16b-3. 
 (i) Section 162(m). If the Company
is subject to Section 162(m) of the Code, it is intended that the Plan comply fully with and meet all the requirements of Section 162(m) of the Code so that Awards may, if intended, constitute “performance-based” compensation
within the meaning of such section. If any provision of the Plan would disqualify the Plan or would not otherwise permit the Plan to comply with Section 162(m) as so intended, such provision shall be construed or deemed amended to conform to
the requirements or provisions of Section 162(m); provided that no such construction or amendment shall have an adverse effect on the economic value to a Holder of any Award previously granted hereunder. 
 (j) Code Section 409A. It is intended that any grant of an Award to which section 409A of the Code is applicable shall satisfy all of
the requirements of such Code section and the applicable regulations issued thereunder to the extent necessary. 
 (k)
Indemnification. Each person who is or shall have been a member of the Committee or of the Board shall be indemnified and held harmless by the Company against and from any loss, cost, liability, or expense that may be imposed upon or
reasonably incurred by him in connection with or resulting from any claim, action, suit, or proceeding to which he may be a party or in which he may be involved by reason of any action taken or failure to act under the Plan and against and from any
and all amounts paid by him in settlement thereof, with the 

  

 13 

 
Company’s approval, or paid by him in satisfaction of any judgment in any such action, suit, or proceeding against him, provided he shall give the
Company an opportunity, at its own expense, to handle and defend the same before he undertakes to handle and defend it on his own behalf. The foregoing right of indemnification shall not be exclusive of any other rights or indemnification to which
such persons may be entitled under the Company’s Articles of Incorporation or Bylaws, as a matter of law, or otherwise, or any power that the Company may have to indemnify them or hold them harmless. 
 (l) Governing Law. This Plan shall be construed in accordance with the laws of the State of Texas. 
  

 14

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00142-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00142-of-00352.parquet"}]]